Annual Statements Open main menu

Genpact LTD - Quarter Report: 2019 September (Form 10-Q)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

(Mark One)

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period ended September 30, 2019

Or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period from              to             

Commission file number: 001-33626

 

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

 

 

Bermuda

 

98-0533350

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

Victoria Place, 5th Floor

31 Victoria Street

Hamilton HM 10

Bermuda

(441) 294-8000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive office)

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common shares, par value $0.01 per share

G

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”  “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

 

 

 

As of October 31, 2019, there were 189,956,225 common shares, par value $0.01 per share, of the registrant issued and outstanding.

 

 

 

 


TABLE OF CONTENTS

 

 

 

Item No.

 

 

 

Page No.

 

 

 

 

 

PART I

 

 

 

Financial Information

 

 

 

 

1.

 

Unaudited Consolidated Financial Statements

 

 

 

 

 

 

Consolidated Balance Sheets as of December 31, 2018 and September 30, 2019

 

1

 

 

 

 

Consolidated Statements of Income for the three and nine months ended September 30, 2018 and 2019

 

2

 

 

 

 

Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2018 and 2019

 

3

 

 

 

 

Consolidated Statements of Equity and Redeemable Non-controlling Interest for the three and nine months ended September 30, 2018 and Consolidated Statements of Equity for the three and nine months ended September 2019

 

5

 

 

 

 

Consolidated Statements of Cash Flows for the nine months ended September 30, 2018 and 2019

 

8

 

 

 

 

Notes to the Consolidated Financial Statements

 

9

 

 

2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

53

 

 

3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

71

 

 

4.

 

Controls and Procedures

 

71

 

 

 

 

 

 

 

PART II

 

 

 

Other Information

 

 

 

 

1.

 

Legal Proceedings

 

72

 

 

1A.

 

Risk Factors

 

72

 

 

2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

72

 

 

6.

 

Exhibits

 

72

 

 

 

 

 

 

 

SIGNATURES

 

74

 

 

 

 


PART I - FINANCIAL INFORMATION

 

Item 1.      Unaudited Consolidated Financial Statements

                                      

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share data and share count)

 

 

Notes

 

As of December 31,

2018

 

 

As of September 30,

2019

 

Assets

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

4

 

$

368,396

 

 

$

456,872

 

Accounts receivable, net

 

5

 

 

774,184

 

 

 

863,232

 

Prepaid expenses and other current assets

 

8

 

 

212,477

 

 

 

236,761

 

Total current assets

 

 

 

$

1,355,057

 

 

$

1,556,865

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

9

 

 

212,715

 

 

 

216,385

 

Operating lease right-of-use assets

 

 

 

 

 

 

 

299,868

 

Deferred tax assets

 

24

 

 

74,566

 

 

 

80,583

 

Investment in equity affiliates

 

25

 

 

836

 

 

 

 

Intangible assets, net

 

10

 

 

177,087

 

 

 

162,571

 

Goodwill

 

10

 

 

1,393,832

 

 

 

1,389,487

 

Contract cost assets

 

19

 

 

160,193

 

 

 

206,503

 

Other assets

 

 

 

 

155,159

 

 

 

185,499

 

Total assets

 

 

 

$

3,529,445

 

 

$

4,097,761

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

Short-term borrowings

 

11

 

$

295,000

 

 

$

245,000

 

Current portion of long-term debt

 

12

 

 

33,483

 

 

 

33,504

 

Accounts payable

 

 

 

 

42,584

 

 

 

20,954

 

Income taxes payable

 

24

 

 

33,895

 

 

 

84,537

 

Accrued expenses and other current liabilities

 

13

 

 

571,350

 

 

 

630,151

 

Operating leases liability

 

 

 

 

 

 

 

50,048

 

Total current liabilities

 

 

 

$

976,312

 

 

$

1,064,194

 

 

 

 

 

 

 

 

 

 

 

 

Long-term debt, less current portion

 

12

 

 

975,645

 

 

 

950,908

 

Operating leases liability

 

 

 

 

 

 

 

278,449

 

Deferred tax liabilities

 

24

 

 

8,080

 

 

 

4,413

 

Other liabilities

 

14

 

 

165,226

 

 

 

194,113

 

Total liabilities

 

 

 

$

2,125,263

 

 

$

2,492,077

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

 

 

 

 

 

 

 

 

Preferred shares, $0.01 par value, 250,000,000 authorized, none issued

 

 

 

 

 

 

 

 

Common shares, $0.01 par value, 500,000,000 authorized, 189,346,101 and  190,113,448 issued and outstanding as of December 31, 2018 and September 30, 2019, respectively

 

 

 

 

1,888

 

 

 

1,896

 

Additional paid-in capital

 

 

 

 

1,471,301

 

 

 

1,544,755

 

Retained earnings

 

 

 

 

438,453

 

 

 

588,714

 

Accumulated other comprehensive income (loss)

 

 

 

 

(507,460

)

 

 

(529,681

)

Total equity

 

 

 

$

1,404,182

 

 

$

1,605,684

 

Commitments and contingencies

 

27

 

 

 

 

 

 

 

 

Total liabilities and equity

 

 

 

$

3,529,445

 

 

$

4,097,761

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to the Consolidated Financial Statements.

1


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)

 

 

 

Three months ended September 30,

 

 

 

Nine months ended September 30,

 

 

Notes

2018

 

 

2019

 

 

 

2018

 

 

2019

 

Net revenues

19

$

747,978

 

 

$

888,799

 

 

 

$

2,165,451

 

 

$

2,579,804

 

Cost of revenue

20, 25

 

481,412

 

 

 

573,659

 

 

 

 

1,388,634

 

 

 

1,664,040

 

Gross profit

 

$

266,566

 

 

$

315,140

 

 

 

$

776,817

 

 

$

915,764

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

21, 25

 

168,010

 

 

 

194,537

 

 

 

 

515,285

 

 

 

582,251

 

Amortization of acquired intangible assets

10

 

9,372

 

 

 

6,960

 

 

 

 

29,134

 

 

 

23,565

 

Other operating (income) expense, net

22

 

(4,844

)

 

 

59

 

 

 

 

(4,913

)

 

 

90

 

Income from operations

 

$

94,028

 

 

$

113,584

 

 

 

$

237,311

 

 

$

309,858

 

Foreign exchange gains (losses), net

 

 

7,450

 

 

 

6,727

 

 

 

 

15,053

 

 

 

3,646

 

Interest income (expense), net

23

 

(9,139

)

 

 

(10,221

)

 

 

 

(27,646

)

 

 

(33,487

)

Other income (expense), net

26

 

5,385

 

 

 

704

 

 

 

 

30,683

 

 

 

5,067

 

Income before equity-method investment activity, net and income tax expense

 

$

97,724

 

 

$

110,794

 

 

 

$

255,401

 

 

$

285,084

 

Equity-method investment activity, net

 

 

(7

)

 

 

(5

)

 

 

 

(22

)

 

 

(16

)

Income before income tax expense

 

$

97,717

 

 

$

110,789

 

 

 

$

255,379

 

 

$

285,068

 

Income tax expense

24

 

24,114

 

 

 

22,669

 

 

 

 

53,268

 

 

 

62,385

 

Net income

 

$

73,603

 

 

$

88,120

 

 

 

$

202,111

 

 

$

222,683

 

Net loss attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

 

761

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

73,603

 

 

$

88,120

 

 

 

$

202,872

 

 

$

222,683

 

Net income available to Genpact Limited common shareholders

 

$

73,603

 

 

$

88,120

 

 

 

$

202,872

 

 

$

222,683

 

Earnings per common share attributable to Genpact Limited common shareholders

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.39

 

 

$

0.46

 

 

 

$

1.06

 

 

$

1.17

 

Diluted

 

$

0.38

 

 

$

0.45

 

 

 

$

1.04

 

 

$

1.14

 

Weighted average number of common shares used  in computing earnings per common share attributable to Genpact Limited common shareholders

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

190,024,924

 

 

 

190,599,049

 

 

 

 

190,991,405

 

 

 

190,071,418

 

Diluted

 

 

193,115,769

 

 

 

195,890,841

 

 

 

 

194,256,771

 

 

 

194,683,699

 

 

See accompanying notes to the Consolidated Financial Statements.

2


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

(In thousands, except per share data and share count)

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

Genpact Limited Shareholders

 

 

Redeemable Non-controlling interest

 

 

Genpact Limited Shareholders

 

 

Redeemable Non-controlling interest

 

 

Genpact

Limited

Shareholders

 

 

Redeemable

Non-

controlling

interest

 

 

Genpact

Limited

Shareholders

 

 

Redeemable

Non-

controlling

interest

 

Net income (loss)

$

73,603

 

 

$

 

 

$

88,120

 

 

$

 

 

$

202,872

 

 

$

(761

)

 

$

222,683

 

 

$

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation  adjustments

 

(58,134

)

 

 

 

 

 

(39,404

)

 

 

 

 

 

(141,150

)

 

 

(424

)

 

 

(24,677

)

 

 

 

Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)

 

(28,918

)

 

 

 

 

 

(11,360

)

 

 

 

 

 

(75,729

)

 

 

 

 

 

1,683

 

 

 

 

Retirement benefits, net of taxes

 

692

 

 

 

 

 

 

346

 

 

 

 

 

 

1,822

 

 

 

 

 

 

773

 

 

 

 

Other comprehensive income (loss)

 

(86,360

)

 

 

 

 

 

(50,418

)

 

 

 

 

 

(215,057

)

 

 

(424

)

 

 

(22,221

)

 

 

 

Comprehensive income (loss)

$

(12,757

)

 

$

 

 

$

37,702

 

 

$

 

 

$

(12,185

)

 

$

(1,185

)

 

$

200,462

 

 

$

 

 

See accompanying notes to the Consolidated Financial Statements.

3


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity and Redeemable Non-controlling Interest

For the nine months ended September 30, 2018

(Unaudited)

(In thousands, except share count)

 

 

 

Common shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable

 

 

 

No. of

Shares

 

 

Amount

 

 

Additional Paid-

in Capital

 

 

Retained

Earnings

 

 

Other Comprehensive

Income (Loss)

 

 

Total

Equity

 

 

non-controlling

interest

 

Balance as of January 1, 2018, as       previously reported

 

 

192,825,207

 

 

$

1,924

 

 

$

1,421,368

 

 

$

355,982

 

 

$

(355,230

)

 

$

1,424,044

 

 

$

4,750

 

Adoption of ASU 2014-091

 

 

 

 

 

 

 

 

 

 

 

17,924

 

 

 

 

 

 

17,924

 

 

 

 

Adjusted balance as of January 1, 2018

 

 

192,825,207

 

 

$

1,924

 

 

$

1,421,368

 

 

$

373,906

 

 

$

(355,230

)

 

$

1,441,968

 

 

$

4,750

 

Adoption of ASU 2018-02 (Note 7)

 

 

 

 

 

 

 

 

 

 

 

(2,265

)

 

 

2,265

 

 

 

 

 

 

 

Issuance of common shares on exercise of options (Note 16)

 

 

441,076

 

 

 

4

 

 

 

7,254

 

 

 

 

 

 

 

 

 

7,258

 

 

 

 

Issuance of common shares under the employee stock purchase plan (Note 16)

 

 

181,643

 

 

 

2

 

 

 

5,015

 

 

 

 

 

 

 

 

 

5,017

 

 

 

 

Net settlement on vesting of restricted share units (Note 16)

 

 

192,222

 

 

 

2

 

 

 

(1,665

)

 

 

 

 

 

 

 

 

(1,663

)

 

 

 

Net settlement on vesting of performance units (Note 16)

 

 

691,958

 

 

 

7

 

 

 

(13,291

)

 

 

 

 

 

 

 

 

(13,284

)

 

 

 

Stock repurchased and retired (Note 17)

 

 

(4,278,857

)

 

 

(43

)

 

 

4,000

 

 

 

(134,060

)

 

 

 

 

 

(130,103

)

 

 

 

Expenses related to stock repurchase (Note 17)

 

 

 

 

 

 

 

 

 

 

 

(82

)

 

 

 

 

 

(82

)

 

 

 

Stock-based compensation expense (Note 16)

 

 

 

 

 

 

 

 

32,158

 

 

 

 

 

 

 

 

 

32,158

 

 

 

 

Payment for acquisition of redeemable non-controlling interest

 

 

 

 

 

 

 

 

(1,165

)

 

 

 

 

 

 

 

 

(1,165

)

 

 

(3,565

)

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

202,872

 

 

 

 

 

 

202,872

 

 

 

(761

)

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(215,057

)

 

 

(215,057

)

 

 

(424

)

Dividend ($0.225 per common share, Note 17)

 

 

 

 

 

 

 

 

 

 

 

(42,901

)

 

 

 

 

 

(42,901

)

 

 

 

Balance as of  September 30, 2018

 

 

190,053,249

 

 

$

1,896

 

 

$

1,453,674

 

 

$

397,470

 

 

$

(568,022

)

 

$

1,285,018

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 Pursuant to transition to topic 606, Revenue from contract with customers, effective January 1, 2018

 

 

 

 

 

 

 

 

See accompanying notes to the Consolidated Financial Statements.

4


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity and Redeemable Non-controlling Interest

For the three months ended September, 30 2018

(Unaudited)

(In thousands, except share count)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

Redeemable

 

 

 

No. of

Shares

 

 

 

 

Amount

 

 

 

 

Additional Paid-

in Capital

 

 

 

 

Retained

Earnings

 

 

 

 

Comprehensive

Income (Loss)

 

 

 

 

Total

Equity

 

 

 

 

non-controlling

interest

 

Balance as of July 1, 2018

 

 

189,876,061

 

 

 

 

$

1,895

 

 

 

 

$

1,438,072

 

 

 

 

$

338,120

 

 

 

 

$

(481,662

)

 

 

 

$

1,296,425

 

 

 

 

$

                            —

 

Issuance of common shares on exercise of options (Note 16)

 

 

74,694

 

 

 

 

 

 

 

 

 

 

1,047

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,047

 

 

 

 

      

    

     —

Issuance of common shares under the employee stock purchase plan (Note 16)

 

 

66,692

 

 

 

 

 

1

 

 

 

 

 

1,839

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,840

 

 

 

 

 

 

Net settlement on vesting of restricted share units (Note 16)

 

 

35,802

 

 

 

 

 

 

 

 

 

 

(718

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(718

)

 

 

 

 

 

Net settlement on vesting of performance units (Note 16)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock repurchased and retired (Note 17)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses related to stock repurchase (Note 17)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

Stock-based compensation expense (Note 16)

 

 

 

 

 

 

 

 

 

 

 

 

13,434

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,434

 

 

 

 

-

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

73,603

 

 

 

 

 

 

 

 

 

 

73,603

 

 

 

 

 

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(86,360

)

 

 

 

 

(86,360

)

 

 

 

 

 

Dividend ($0.075 per common share, Note 17)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(14,253

)

 

 

 

 

 

 

 

 

$

(14,253

)

 

 

 

 

 

Balance as of  September 30, 2018

 

 

190,053,249

 

 

 

 

$

1,896

 

 

 

 

$

1,453,674

 

 

 

 

$

397,470

 

 

 

 

$

(568,022

)

 

 

 

$

1,285,018

 

 

 

 

$

-

 

 

See accompanying notes to the Consolidated Financial Statements.

 

 


5


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

For the nine months ended September 30, 2019

(Unaudited)

(In thousands, except share count)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Common shares

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

No. of

Shares

 

 

Amount

 

 

Additional Paid-

in Capital

 

 

Retained

Earnings

 

 

Comprehensive

Income (Loss)

 

 

Total

Equity

 

Balance as of January 1, 2019

 

 

189,346,101

 

 

$

1,888

 

 

$

1,471,301

 

 

$

438,453

 

 

$

(507,460

)

 

$

1,404,182

 

Issuance of common shares on exercise of options (Note 16)

 

 

622,494

 

 

 

6

 

 

 

9,499

 

 

 

 

 

 

 

 

 

9,505

 

Issuance of common shares under the employee stock purchase plan (Note 16)

 

 

195,221

 

 

 

2

 

 

 

6,442

 

 

 

 

 

 

 

 

 

6,444

 

Net settlement on vesting of restricted share units (Note 16)

 

 

557,917

 

 

 

6

 

 

 

(3,794

)

 

 

 

 

 

 

 

 

(3,788

)

Net settlement on vesting of performance units (Note 16)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock repurchased and retired (Note 17)

 

 

(608,285

)

 

 

(6

)

 

 

 

 

 

(23,895

)

 

 

 

 

 

(23,901

)

Expenses related to stock repurchase (Note 17)

 

 

 

 

 

 

 

 

 

 

 

(12

)

 

 

 

 

 

(12

)

Stock-based compensation expense (Note 16)

 

 

 

 

 

 

 

 

61,307

 

 

 

 

 

 

 

 

 

61,307

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

222,683

 

 

 

 

 

 

222,683

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(22,221

)

 

 

(22,221

)

Dividend ($0.255 per common share, Note 17)

 

 

 

 

 

 

 

 

 

 

 

(48,515

)

 

 

 

 

 

(48,515

)

Balance as of  September 30, 2019

 

 

190,113,448

 

 

$

1,896

 

 

$

1,544,755

 

 

$

588,714

 

 

$

(529,681

)

 

$

1,605,684

 

 

See accompanying notes to the Consolidated Financial Statements.


6


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity

(Unaudited)

For the three months ended September, 30 2019

(In thousands, except share count)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

Common shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

No. of

Shares

 

 

 

 

Amount

 

 

 

 

Additional Paid-

in Capital

 

 

 

 

Retained

Earnings

 

 

 

 

Comprehensive

Income (Loss)

 

 

 

 

Total

Equity

 

Balance as of July 1, 2019

 

 

190,486,041

 

 

 

 

$

1,899

 

 

 

 

$

1,520,025

 

 

 

 

$

540,709

 

 

 

 

$

(479,263

)

 

 

 

$

1,583,370

 

Issuance of common shares on exercise of options (Note 16)

 

 

115,997

 

 

 

 

 

1

 

 

 

 

 

2,227

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,228

 

Issuance of common shares under the employee stock purchase plan (Note 16)

 

 

60,875

 

 

 

 

 

1

 

 

 

 

 

2,243

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,244

 

Net settlement on vesting of restricted share units (Note 16)

 

 

58,820

 

 

 

 

 

1

 

 

 

 

 

(1,060

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,059

)

Net settlement on vesting of performance units (Note 16)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock repurchased and retired (Note 17)

 

 

(608,285

)

 

 

 

 

(6

)

 

 

 

 

 

 

 

 

 

(23,895

)

 

 

 

 

 

 

 

 

 

(23,901

)

Expenses related to stock repurchase (Note 17)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12

)

 

 

 

 

 

 

 

 

 

(12

)

Stock-based compensation expense (Note 16)

 

 

 

 

 

 

 

 

 

 

 

 

21,320

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21,320

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

88,120

 

 

 

 

 

 

 

 

 

 

88,120

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(50,418

)

 

 

 

 

(50,418

)

Dividend ($0.085 per common share, Note 17)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16,208

)

 

 

 

 

 

 

 

 

 

(16,208

)

Balance as of  September 30, 2019

 

 

190,113,448

 

 

 

 

$

1,896

 

 

 

 

$

1,544,755

 

 

 

 

$

588,714

 

 

 

 

$

(529,681

)

 

 

 

$

1,605,684

 

 

 

See accompanying notes to the Consolidated Financial Statements.

7


GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

Nine months ended September 30,

 

 

 

 

2018

 

 

 

2019

 

Operating activities

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

202,872

 

 

$

222,683

 

Net (loss) attributable to redeemable non-controlling interest

 

 

(761

)

 

 

 

Net income

 

$

202,111

 

 

$

222,683

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

47,612

 

 

 

70,234

 

Amortization of debt issuance costs (including loss on extinguishment of debt)

 

 

3,546

 

 

 

1,288

 

Amortization of acquired intangible assets

 

 

29,134

 

 

 

23,565

 

Write-down of intangible assets and property, plant and equipment

 

 

1,538

 

 

 

3,511

 

Reserve for doubtful receivables

 

 

1,705

 

 

 

7,169

 

Unrealized (gain) on revaluation of foreign currency asset/liability

 

 

(4,544

)

 

 

(4,862

)

Equity-method investment activity, net

 

 

22

 

 

 

16

 

Stock-based compensation expense

 

 

32,158

 

 

 

61,307

 

Deferred income taxes

 

 

(1,768

)

 

 

(6,946

)

Others, net

 

 

255

 

 

 

(2,621

)

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Increase in accounts receivable

 

 

(12,946

)

 

 

(97,269

)

Increase in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets

 

 

(96,300

)

 

 

(87,064

)

Decrease in accounts payable

 

 

(913

)

 

 

(20,670

)

Increase (decrease) in accrued expenses, other current liabilities, operating lease liabilities and other liabilities

 

 

(44,602

)

 

 

122,411

 

Increase in income taxes payable

 

 

45,798

 

 

 

48,567

 

Net cash provided by operating activities

 

$

202,806

 

 

$

341,319

 

Investing activities

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(68,027

)

 

 

(55,071

)

Payment for internally generated intangible assets (including intangibles under development)

 

 

(19,397

)

 

 

(26,261

)

Proceeds from sale of property, plant and equipment

 

 

499

 

 

 

1,621

 

Payment for business acquisitions, net of cash acquired

 

 

(108,105

)

 

 

(6,305

)

Payment for purchase of redeemable non-controlling interest

 

 

(4,730

)

 

 

 

Net cash used for investing activities

 

$

(199,760

)

 

$

(86,016

)

Financing activities

 

 

 

 

 

 

 

 

Repayment of capital/finance lease obligations

 

 

(1,954

)

 

 

(6,256

)

Payment of debt issuance costs

 

 

(4,293

)

 

 

 

Proceeds from long-term debt

 

 

129,186

 

 

 

 

Repayment of long-term debt

 

 

(157,686

)

 

 

(25,500

)

Proceeds from short-term borrowings

 

 

225,000

 

 

 

50,000

 

Repayment of short-term borrowings

 

 

(65,000

)

 

 

(100,000

)

Proceeds from issuance of common shares under stock-based compensation plans

 

 

12,275

 

 

 

15,949

 

Payment for net settlement of stock-based awards

 

 

(14,947

)

 

 

(3,177

)

Payment of earn-out/deferred consideration

 

 

(1,559

)

 

 

(12,790

)

Dividend paid

 

 

(42,901

)

 

 

(48,515

)

Payment for stock repurchased and retired

 

 

(130,103

)

 

 

(23,901

)

Payment for expenses related to stock repurchase

 

 

(82

)

 

 

(12

)

Net cash used for financing activities

 

$

(52,064

)

 

$

(154,202

)

Effect of exchange rate changes

 

 

(54,220

)

 

 

(12,625

)

Net increase (decrease) in cash and cash equivalents

 

 

(49,018

)

 

 

101,101

 

Cash and cash equivalents at the beginning of the period

 

 

504,468

 

 

 

368,396

 

Cash and cash equivalents at the end of the period

 

$

401,230

 

 

$

456,872

 

Supplementary information

 

 

 

 

 

 

 

 

Cash paid during the period for interest

 

$

35,082

 

 

$

31,633

 

Cash paid during the period for income taxes

 

$

54,920

 

 

$

65,562

 

Property, plant and equipment acquired under capital/finance lease obligations

 

$

1,832

 

 

$

3,587

 

 

See accompanying notes to the Consolidated Financial Statements

 

8


 

 

GENPACT LIMITED AND ITS SUBSIDIARIES

Notes to the Consolidated Financial Statements

(Unaudited)

(In thousands, except per share data and share count)

 

 

1. Organization

The Company is a global professional services firm that drives digitally-led innovation and runs digitally-enabled intelligent operations for its clients, guided by its experience running thousands of processes for hundreds of Fortune Global 500 clients.  The Company has over 93,000 employees serving clients in key industry verticals from more than 30 countries. 

 

2. Summary of significant accounting policies

 

(a) Basis of preparation and principles of consolidation

 

The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for reporting on Form 10-Q. Accordingly, they do not include certain information and note disclosures required by generally accepted accounting principles for annual financial reporting and should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

 

The unaudited interim consolidated financial statements reflect all adjustments that management considers necessary for a fair presentation of the results of operations for these periods. The results of operations for interim periods are not necessarily indicative of results for the full year.

 

The accompanying unaudited interim consolidated financial statements have been prepared on a consolidated basis and reflect the financial statements of Genpact Limited, a Bermuda company, and all of its subsidiaries that are more than 50% owned and controlled. When the Company does not have a controlling interest in an entity but exerts significant influence on the entity, the Company applies the equity method of accounting. All intercompany transactions and balances are eliminated in consolidation.

 

Non-controlling interest in subsidiaries that is redeemable outside of the Company’s control for cash or other assets is reflected in the mezzanine section between liabilities and equity in the consolidated balance sheets at the redeemable value, which approximates fair value. Redeemable non-controlling interest is adjusted to its fair value at each balance sheet date. Any resulting increases or decreases in the estimated redemption amount are affected by corresponding changes to additional paid in capital. The Company’s share of non-controlling interest in subsidiary earnings is reflected in net loss (income) attributable to redeemable non-controlling interest in the consolidated statements of income.

 

(b) Use of estimates

 

The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements. Significant items subject to such estimates and assumptions include the useful lives of property, plant and equipment, intangibles and goodwill, revenue recognition, reserves for doubtful receivables, valuation allowances for deferred tax assets, valuations of derivative financial instruments, the measurement of lease liabilities and right-of-use (“ROU”) assets, measurements of stock-based compensation, assets and obligations related to employee benefits, the nature and timing of the satisfaction of performance obligations, the standalone selling price of performance obligations, variable consideration, other obligations for revenue recognition, income tax uncertainties and other contingencies. Management believes that the estimates used in the preparation of the consolidated financial statements are reasonable. Although these estimates are based upon management’s best knowledge of current events and actions, actual results could differ from these estimates. Any changes in estimates are adjusted prospectively in the Company’s consolidated financial statements.

9


 

 

2. Summary of significant accounting policies (Continued)

 

(c) Business combinations, goodwill and other intangible assets

 

The Company accounts for its business combinations using the acquisition method of accounting in accordance with ASC 805, Business Combinations, by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, and any non-controlling interest in the acquired business, measured at their acquisition date fair values. Contingent consideration is included within the acquisition cost and is recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value as of each reporting date until the contingency is resolved. Changes in fair value are recognized in earnings. All assets and liabilities of the acquired businesses, including goodwill, are assigned to reporting units. Acquisition-related costs are expensed as incurred under selling, general and administrative expenses.

 

Goodwill represents the cost of acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased. Goodwill is not amortized but is tested for impairment at least on an annual basis on December 31, based on a number of factors, including operating results, business plans and future cash flows. The Company performs an assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on the assessment of events or circumstances, the Company performs a quantitative assessment of goodwill impairment if it determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on the quantitative impairment analysis, the carrying value of the goodwill of a reporting unit exceeds the fair value of such goodwill, an impairment loss is recognized in an amount equal to the excess. In addition, the Company performs a qualitative assessment of goodwill impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. See Note 10 for information and related disclosures.

 

Intangible assets acquired individually or with a group of other assets or in a business combination and developed internally are carried at cost less accumulated amortization based on their estimated useful lives as follows:

 

Customer-related intangible assets

 

2-11 years

Marketing-related intangible assets

 

2-8 years

Technology-related intangible assets

 

2-8 years

Other intangible assets

 

              3 years

 

 

 

10


 

 

2. Summary of significant accounting policies (Continued)

Intangible assets are amortized over their estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized.

In business combinations where the fair value of identifiable tangible and intangible net assets purchased exceeds the cost of the acquired business, the Company recognizes the resulting gain under “Other operating (income) expense, net” in the consolidated statements of income.

 

(d) Financial instruments and concentration of credit risk

 

Financial instruments that potentially subject the Company to concentration of credit risk are reflected principally in cash and cash equivalents, derivative financial instruments and accounts receivable. The Company places its cash and cash equivalents and derivative financial instruments with corporations and banks with high investment grade ratings, limits the amount of credit exposure with any one corporation or bank and conducts ongoing evaluations of the creditworthiness of the corporations an banks with which it does business. To reduce its credit risk on accounts receivable, the Company conducts ongoing credit evaluations of its clients. The General Electric Company (“GE”) accounted for 11% and 16% of receivables as of December 31, 2018 and September 30, 2019, respectively. GE accounted for 9% of total revenue for each of the nine and three months periods ended September 30, 2018, respectively, and 14% of total revenue for the nine and three month periods ended September 30, 2019, respectively.   

 

(e) Accounts receivable

 

Accounts receivable are recorded at the invoiced or to be invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in net cash provided by operating activities in the consolidated statements of cash flows. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and clients’ financial condition, the amount of receivables in dispute, and the current receivables’ aging and current payment patterns. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its clients.

 

(f) Revenue Recognition

 

The Company derives its revenue primarily from business process management including analytics, consulting and related digital solutions and information technology services which are provided primarily on a time-and-material, transaction or fixed-price basis. The Company recognizes revenue when the promised services are delivered to customers for an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services. Revenues from services rendered under time-and-material and transaction-based contracts are recognized as the services are provided. The Company’s fixed-price contracts include contracts for the customization of applications and maintenance and support services. Revenues from these contracts are recognized ratably over the term of the agreement. The Company accrues for revenue and unbilled receivables for services rendered between the last billing date and the balance sheet date.

 

The Company’s customer contracts sometimes also include incentive payments received for discrete benefits delivered or promised to be delivered to clients or service level agreements that could result in credits or refunds to the client. Revenues relating to such arrangements are accounted for as variable consideration when the amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur.

 

The Company records deferred revenue attributable to certain process transition activities where such activities do not represent separate performance obligations. Revenues relating to such transition activities are classified under contract liabilities and subsequently recognized ratably over the period in which the related services are performed. Costs relating to such transition activities are fulfillment costs which are directly related to the contract and result in the generation or enhancement of resources. Such costs are expected to be recoverable under the contract and are therefore classified as contract cost assets and recognized ratably over the estimated expected period of benefit under cost of revenue.

 

11


 

 

Revenues are reported net of value-added tax, business tax and applicable discounts and allowances. Reimbursements of out-of-pocket expenses received from clients have been included as part of revenues.

2. Summary of significant accounting policies (Continued)

 

Revenue for performance obligations that are satisfied over time is recognized in accordance with the methods prescribed for measuring progress. The input (cost expended) method has been used to measure progress towards completion as there is a direct relationship between input and productivity. Provisions for estimated losses, if any, on uncompleted contracts are recorded in the period in which such losses become probable based on the current contract estimates.

 

The Company enters into multiple-element revenue arrangements in which a client may purchase a combination of products or services. Revenue from multiple-element arrangements is recognized, for each element, based on an allocation of the transaction price to each performance obligation on a relative standalone basis.

 

Certain contracts may include offerings such as sale of licenses, which may be perpetual or subscription-based. Revenue from distinct perpetual licenses is recognized upfront at the point in time when the software is made available to the client. Revenue from distinct subscription-based licenses is recognized at the point in time it is transferred to the client. Revenue from any associated maintenance or ongoing support services is recognized ratably over the term of the contract. For a combined software license/services performance obligation, revenue is recognized over the period that the services are performed.

 

All incremental and direct costs incurred for acquiring contracts, such as certain sales commissions, are classified as contract cost assets. Such costs are amortized over the expected period of benefit and recorded under selling, general and administrative expenses.

 

Other upfront fees paid to clients are classified as contract assets. Such costs are amortized over the expected period of benefit and recorded as an adjustment to the transaction price and subtracted from revenue.

 

Timing of revenue recognition may differ from the timing of invoicing. If a payment is received in respect of services prior to the delivery of services, the payment is recognized as an advance from the client and classified as a contract liability. Contract assets and contract liabilities relating to the same client contract are offset against each other and presented on a net basis in the consolidated financial statements.

 

Significant judgments

 

The Company often enters into contracts with its clients that include promises to transfer multiple products and services to the client. Determining whether products and services are considered distinct performance obligations that should be accounted for separately rather than together may require significant judgment.

 

Judgment is also required to determine the standalone selling price for each distinct performance obligation. In instances where the standalone selling price is not directly observable, it is determined using information that may include market conditions and other observable inputs.

 

Client contracts sometimes include incentive payments received for discrete benefits delivered to clients or service level agreements that could result in credits or refunds to the client. Such amounts are estimated at contract inception and are adjusted at the end of each reporting period as additional information becomes available only to the extent that it is probable that a significant reversal of any incremental revenue will not occur.

 

(g) Changes in accounting policies

 

Except as described below, the Company has applied accounting policies consistently to all periods presented in these consolidated financial statements. The Company adopted Accounting Standards Codification Topic 842, Leases (“Topic 842”), effective January 1, 2019. The Company applied Topic 842 using the modified retrospective adoption approach, which involves recognizing new ROU assets and lease liabilities in its statement of financial position for various operating leases. Therefore, comparative information has not been adjusted and continues to be reported under ASC Topic 840.

 

 

 

12


 

 

 

 

 

2. Summary of significant accounting policies (Continued)

 

As a result of the Company’s adoption of this new standard, all leases are classified as either operating leases or finance leases and are recorded on the balance sheet. The accounting for finance leases (capital leases under ASC 840) is substantially unchanged. The Company has elected the “package of practical expedients,” which allows the Company not to reassess, under the new standard, its prior conclusions about lease identification, lease classification and initial direct costs. The Company has also elected the practical expedients to not separate lease and non-lease components for all of its leases and to use the recognition exemptions for lease contracts that, at the commencement date, have a lease term of 12

months or less and do not contain a purchase option (“short-term leases”). As of January 1, 2019, the date of the Company’s initial application of ASC 842, the Company recognized its lease liabilities measured as the present value of lease payments not yet paid, discounted using the discount rate for the lease as of the date of initial application. The ROU asset for each existing lease as of the date of initial application includes an initial measurement of the lease liability adjusted for any lease payments made to the lessor at or before the date of initial application, accrued lease payments and any lease incentives received or any initial direct costs incurred by the Company as of the date of initial application. As a result of adoption of the ASC 842, the Company recognized additional lease liabilities of $328,978, and ROU assets of $309,687.

  

Leases (effective January 1, 2019)

 

At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term of the contract, and (3) whether the Company has the right to direct the use of the asset. At the inception of a lease, the consideration in the contract is allocated to each lease component based on its relative standalone price to determine the lease payments. Leases entered into prior to January 1, 2019 have been accounted for under ASC 840 and were not reassessed.

 

Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of the above criteria.

 

For all leases at the lease commencement date, a ROU asset and a lease liability are recognized. The lease liability represents the present value of the lease payments under the lease. Lease liabilities are initially measured at the present value of the lease payments not yet paid, discounted using the discount rate for the lease at lease commencement. The lease liabilities are subsequently measured on an amortized cost basis. The lease liability is adjusted to reflect interest on the liability and the lease payments made during the period. Interest on the lease liability is determined as the amount that results in a constant periodic discount rate on the remaining balance of the liability.

 

The ROU asset represents the right to use the leased asset for the lease term. The ROU asset for each lease initially includes the amount of the initial measurement of the lease liability adjusted for any lease payments made to the lessor at or before the commencement date, accrued lease liabilities and any lease incentives received or any initial direct costs incurred by the Company.

 

The ROU asset of finance leases is subsequently measured at cost, less accumulated amortization and any accumulated impairment losses. The ROU asset of operating leases is subsequently measured from the carrying amount of the lease liability at the end of each reporting period and is therefore equal to the carrying amount of lease liabilities adjusted for (1) unamortized initial direct costs, (2) prepaid/(accrued) lease payments and (3) the unamortized balance of lease incentives received.

 

Leases with a lease term of 12 months or less from the commencement date that do not contain a purchase option are recognized as an expense on a straight-line basis over the lease term.

 

 

 

13


 

 

 

 

 

 

2. Summary of significant accounting policies (Continued)

 

Significant judgments

 

The Company determines the lease term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised.

 

Under certain of its leases, the Company has a renewal and termination option to lease assets for additional terms between one and five years. The Company applies judgment in evaluating whether it is reasonably certain to exercise the option to renew or terminate the lease. The Company considers all relevant factors that create an economic incentive for it to exercise the renewal or termination option. After the commencement date, the Company reassesses the lease term if there is a significant event or change in circumstances that is within the Company’s control and affects its ability to exercise (or not to exercise) the option to renew or terminate.

 

              The company has applied an incremental borrowing rate for the purpose of computing lease liabilities based on the rate prevailing in different geographies. Upon the Company’s adoption of ASC 842, the Company applied an incremental borrowing rate to leases existing as of January 1, 2019, the date of initial application.

 

Impact on consolidated financial statements

 

The following tables summarize the impact of the Company’s adoption of Topic 842 on its consolidated financial statements as of January 1, 2019. 

 

 

 

 

As reported December 31, 2018

Adoption of ASC 842 Increase/(Decrease)

 

Balance as of January 1, 2019

Prepaid expenses and other current assets

 

212,477

(3,529)

1

208,948

Operating lease ROU assets

 

-

273,732  

 

 

273,732  

 

Other assets: Finance lease ROU assets

 

-

35,955

6

35,955

Other assets

 

155,159

(5,126)

3

150,033

Property, plant and equipment, net

 

212,715

(2,343)

2

210,372

 

 

 

 

 

 

Accrued expenses and other current liabilities

 

571,350

(1,123)

4

570,227

Operating leases liability (current)

 

-

42,200

 

42,200

Operating leases liability (non-current)

 

-

258,378

 

258,378

Other liabilities

 

165,226

(767)

5

164,459

 

 

 

1.

Includes prepaid rent amounting to $3,160 and leasehold land amounting to $369, which have been reclassified to operating lease ROU assets and finance lease ROU assets, respectively.

 

2.

Represents vehicles recognized as capital leases under ASC 840 and reclassified as a finance lease ROU asset.

 

3.

Includes prepaid rent amounting to $284 and leasehold land amounting to $4,842, which have been reclassified to operating lease ROU assets and finance lease ROU assets, respectively.

 

4.

Includes accrued lease liabilities of $4,562 adjusted with operating lease ROU assets offset by additional current portion of finance lease liabilities of $3,439 recognized upon the adoption of ASC 842.

 

5.

Includes accrued lease liabilities of $25,728 adjusted with operating lease ROU assets offset by additional finance lease liabilities of $24,961 recognized upon the adoption of ASC 842.

 

6.

The balance is included in “other assets” in the consolidated balance sheet.

14


 

 

 

 

 

(h) Recently issued accounting pronouncements

 

The authoritative bodies release standards and guidance which are assessed by management for their impact on the Company’s consolidated financial statements.

 

15


 

 

2. Summary of significant accounting policies (Continued)

 

The Company has adopted the following recently released accounting standards:

 

The Company adopted ASC Topic 606, Revenue from Contracts with Customers, with a date of initial application of January 1, 2018 using the modified retrospective method, and the revenue recognition significant accounting policy is outlined in section (f) above.

 

The Company adopted ASC Topic 842, Leases, with a date of initial application of January 1, 2019 using the modified retrospective approach. The cumulative impact of the adoption of this standard has been described in section (g) above.

 

In March 2019, the Financial Accounting Standards Board (the “FASB”) issued ASU 2019-01, Leases (Topic 842): Codification Improvement. The new standard contains several amendments to clarify the codification more generally and/or to correct unintended application of guidance. The changes in the new standard eliminate the requirement for transition disclosures related to Topic 250-10-50-3. The guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Early application is permitted. In the quarter ended March 31, 2019, the Company adopted ASU 2019-01 effective January 1, 2019 and no prior periods have been adjusted.

 

In August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging.” The amendment expands an entity’s ability to hedge accounting to non-financial and financial risk components and requires changes in the fair value of hedging instruments to be presented in the same income statement line as a hedged item. The ASU also amends the presentation and disclosure requirements for the effect of hedge accounting. The ASU must be adopted using a modified retrospective approach with a cumulative effect adjustment recorded to the opening balance of retained earnings as of the initial application date. The ASU is effective for the Company beginning January 1, 2019, including interim periods in the fiscal year 2019. On January 1, 2019, the Company assessed the impact of this ASU and concluded that it does not have any impact on its consolidated results of operations, cash flows, financial position and disclosures.

 

In addition, the following recently released accounting standards have not yet been adopted by the Company.

 

In June 2016, the FASB issued ASU No. 2016-13, “Measurement of credit losses on financial instruments.” The ASU requires measurement and recognition of expected credit losses for financial assets held by the Company. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

 

In August 2018, the FASB issued ASU No. 2018-13, “Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The ASU modifies the disclosure requirements with respect to fair value measurements. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

 

In August 2018, the FASB issued ASU No. 2018-14, “Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans.” The ASU modifies the disclosure requirements with respect to defined benefit pension plans. The ASU is effective for the Company beginning January 1, 2021. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

 

In August 2018, the FASB issued ASU No. 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” The ASU modifies the capitalization requirements with respect to implementation costs incurred by the customer in a hosting arrangement that is a service contract. The ASU is effective for the Company beginning January 1, 2020. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

 

 

 

 

 

 

16


 

 

2. Summary of significant accounting policies (Continued)

 

In April 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments.” The ASU provides additional guidance on the recognition of credit losses and addresses partial-term fair value hedges, fair value hedge basis adjustments and certain transition requirements, among other things. The ASU also addresses the scope of the guidance on the requirement for remeasurement under ASC 820 when using the measurement alternative, certain disclosure requirements and which foreign currency-denominated equity securities must be remeasured at historical exchange rates. The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

 

In May 2019, the FASB issued ASU No. 2019-05, “Financial Instruments—Credit Losses (Topic 326).” The ASU provides final guidance that allows entities to make an irrevocable one-time election upon adoption of the new credit losses standard to measure financial assets measured at amortized cost (except held-to-maturity securities) using the fair value option.  The ASU is effective for the Company beginning January 1, 2020, including interim periods in fiscal year 2020. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its consolidated results of operations, cash flows, financial position and disclosures.

 

In July 2019, the FASB issued ASU 2019-07, Codification Updates to SEC Sections. This ASU amends various SEC paragraphs pursuant to the issuance of SEC Final Rule Releases No. 33-10532, Disclosure Update and Simplification, and Nos. 33-10231 and 33-10442, Investment Company Reporting Modernization. The S-X Rule 3-04 requires the presentation of changes in stockholders’ equity in the form of a reconciliation of the beginning balance to the ending balance for each period for which the statement of income is required to be filed with all the significant reconciling items. The Company has presented the changes in stockholders' equity through a separate statement of changes in equity for each of the current and comparative quarter and year-to-date interim periods beginning on April 1, 2019. The additional elements of the ASU did not have any material impact on the Company's Consolidated Financial Statements. This guidance was effective immediately upon issuance.

 

(i) Reclassification

 

Certain reclassifications have been made in the consolidated financial statements of prior periods to conform to the classification used in the current period. The impact of such reclassifications on the consolidated financial statements is not material.

17


 

 

3. Business acquisitions

 

 

A.

Certain acquisitions

 

(a) riskCanvas Holdings, LLC  

         

   On January 7, 2019, the Company acquired 100% of the outstanding equity interests in riskCanvas Holdings, LLC, a Delaware limited liability company, for total purchase consideration of $5,747. This amount includes cash consideration of $5,700, net of adjustment for working capital. No portion of the total consideration, payable in cash, was unpaid as of September 30, 2019. This acquisition expands the Company’s services in the areas of financial institution fraud, anti-money laundering and financial transaction surveillance and enhances its consulting capabilities for clients in the financial services industry.

       

In connection with this acquisition, the Company recorded $1,700 in customer-related intangibles, $1,400 in software-related intangibles and $100 in restrictive covenants. Goodwill arising from the acquisition amounted to $2,547, which has been allocated to the Company’s India reporting unit and is deductible for tax purposes. The goodwill represents primarily the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

 

Acquisition-related costs of $967 have been included in selling, general and administrative expenses as incurred. In connection with the transaction, the Company also acquired certain assets with a value of $660 and assumed certain liabilities amounting to $707. The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition.

 

(b) Barkawi Management Consultants GmbH & Co. KG and certain related entities

 

On August 30, 2018, the Company acquired 100% of the outstanding equity/partnership interests in Barkawi Management Consultants GmbH & Co. KG, a German limited partnership, and certain affiliated entities in the United States, Germany and Austria (collectively referred to as “Barkawi”) for total purchase consideration of $101,307. This amount includes cash consideration of $95,625, net of cash acquired of $5,682. The total purchase consideration paid by the Company was $100,969, resulting in a payable of $338, which is outstanding as of September 30, 2019. During the quarter ended June 30, 2019, the Company recorded certain measurement period adjustments. These adjustments did not have a significant impact on the Company’s consolidated statements of income, balance sheets or cash flows. This acquisition enhances the Company’s supply chain management consulting capabilities.

 

In connection with the acquisition of Barkawi, the Company recorded $10,200 in customer-related intangibles and $1,800 in marketing related intangibles, which have a weighted average amortization period of three years. Goodwill arising from the acquisition amounted to $79,928, which has been allocated to the Company’s India reporting unit and is partially deductible for tax purposes. The goodwill represents primarily the consulting expertise, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

 

Acquisition-related costs of $1,842 have been included in selling, general and administrative expenses as incurred. In connection with the transaction, the Company also acquired certain assets with a value of $17,314, assumed certain liabilities amounting to $8,827 and recognized a net deferred tax asset of $892. The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition.

 

(c) Commonwealth Informatics Inc.

 

On July 3, 2018, the Company acquired 100% of the outstanding equity interest in Commonwealth Informatics Inc. (“Commonwealth”), a Massachusetts corporation, for purchase consideration of $17,938. This amount includes cash consideration of $16,123, net of cash acquired of $1,477, and adjustments for working capital and indebtedness. No portion of the total consideration, payable in cash, was unpaid as of September 30, 2019. During the quarter ended March 31, 2019, the Company recorded certain measurement period adjustments. These adjustments did not have a significant impact on the Company’s consolidated statements of income, balance sheets or cash flows. This acquisition enhances the Company’s signal management and pharmacovigilance capabilities for clients in the life sciences industry.

         In connection with the acquisition of Commonwealth, the Company recorded $2,200 in customer-related intangibles and $2,600 in technology-related intangible assets, which have a weighted average amortization period of four years.

18


 

 

3. Business acquisitions (Continued)

 

Goodwill arising from the acquisition amounted to $11,587, which has been allocated to the Company’s India reporting unit and is deductible for tax purposes. The goodwill represents primarily the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with those of the Company.

 

Acquisition-related costs of $521 have been included in selling, general and administrative expenses as incurred. In connection with the transaction, the Company also acquired certain assets with a value of $2,583 and assumed certain liabilities amounting to $1,032. The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition.

 

19


 

 

4. Cash and cash equivalents

 

 

 

As of December 31,

 

 

As of September 30,

 

 

 

2018

 

 

2019

 

Cash and other bank balances

 

 

368,396

 

 

 

456,872

 

Total

 

$

368,396

 

 

$

456,872

 

 

 

5. Accounts receivable, net of reserve for doubtful receivables

The following table provides details of the Company’s reserve for doubtful receivables:

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2018

 

 

Nine months

ended September 30, 2019

 

Opening balance as of January 1

 

$

23,660

 

 

$

23,960

 

Additions charged/reversal released to cost and expense

 

 

1,857

 

 

 

7,169

 

Deductions/effect of exchange rate fluctuations

 

 

(1,557

)

 

 

(1,199

)

Closing balance

 

$

23,960

 

 

$

29,930

 

 

Accounts receivable were $798,144 and $893,162, and reserves for doubtful receivables were $23,960 and $29,930, resulting in net accounts receivable balances of $774,184 and $863,232 as of December 31, 2018 and September 30, 2019, respectively. In addition, accounts receivable due after one year amounting to $4,099 and $6,247 as of December 31, 2018 and September 30, 2019, respectively, are included under “other assets” in the consolidated balance sheets.

 

Accounts receivable from related parties were $99 and $94 as of December 31, 2018 and September 30, 2019, respectively.  There are no doubtful receivables in amounts due from related parties.

 

 

6. Fair value measurements

 

The Company measures certain financial assets and liabilities, including derivative instruments, at fair value on a recurring basis. The fair value measurements of these financial assets and liabilities were determined using the following inputs as of December 31, 2018 and September 30, 2019:

 

 

 

As of December 31, 2018

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

 

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable Inputs

 

 

Significant Other

Unobservable

Inputs

 

 

 

Total

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (Note a, c)

 

$

44,099

 

 

$

 

 

$

44,099

 

 

$

 

Deferred compensation plan assets (a, e)

 

 

1,613

 

 

 

 

 

 

 

 

 

1,613

 

Total

 

$

45,712

 

 

$

 

 

$

44,099

 

 

$

1,613

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earn-out consideration (Note b, d)

 

$

17,073

 

 

$

 

 

$

 

 

$

17,073

 

Derivative instruments (Note b, c)

 

 

35,245

 

 

 

 

 

 

35,245

 

 

 

 

Deferred compensation plan liability (b, f)

 

 

1,582

 

 

 

 

 

 

 

 

 

1,582

 

Total

 

$

53,900

 

 

$

 

 

$

35,245

 

 

$

18,655

 

20


 

 

 

 

6. Fair value measurements (Continued)

 

 

 

As of September 30, 2019

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

 

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

 

 

Significant Other

Observable

Inputs

 

 

Significant Other

Unobservable

Inputs

 

 

 

Total

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative instruments (Note a, c)

 

$

28,412

 

 

$

 

 

$

28,412

 

 

$

 

Deferred compensation plan assets (Note a, e)

 

 

9,906

 

 

 

 

 

 

 

 

 

9,906

 

Total

 

$

38,318

 

 

$

 

 

$

28,412

 

 

$

9,906

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earn-out consideration (Note b,  d)

 

$

477

 

 

$

 

 

$

 

 

$

477

 

Derivative instruments (Note b, c)

 

 

31,053

 

 

 

 

 

 

31,053

 

 

 

 

Deferred compensation plan liability (Note b, f)

 

 

9,642

 

 

 

 

 

 

 

 

 

9,642

 

Total

 

$

41,172

 

 

$

 

 

$

31,053

 

 

$

10,119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)

Included in “prepaid expenses and other current assets” and “other assets” in the consolidated balance sheets.

 

 

(b)

Included in “accrued expenses and other current liabilities” and “other liabilities” in the consolidated balance sheets.

 

 

(c)

The Company values its derivative instruments based on market observable inputs, including both forward and spot prices for the relevant currencies and interest rate indices for relevant interest rates. The quotes are taken from an independent market database.

 

 

(d)

The fair value of earn-out consideration, calculated as the present value of expected future payments to be made to the sellers of acquired businesses, was derived by estimating the future financial performance of the acquired businesses using the earn-out formula and performance targets specified in each purchase agreement and adjusting the result to reflect the Company’s estimate of the likelihood of achievement of such targets. Given the significance of the unobservable inputs, the valuations are classified in level 3 of the fair value hierarchy.

 

 

(e)

Deferred compensation plan assets consist of life insurance policies held under a Rabbi Trust. Assets held in the Rabbi Trust are valued based on the cash surrender value of the insurance contract, which is determined based on the fair value of the underlying assets included in the insurance portfolio and are therefore classified within level 3 of the fair value hierarchy.

 

 

(f)

The fair value of the deferred compensation plan liability is derived based on the fair value of the underlying assets in the insurance portfolio and is therefore classified within level 3 of the fair value hierarchy.

21


 

 

6. Fair value measurements (Continued)

 

The following table provides a roll-forward of the fair value of earn-out consideration categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2018 and 2019:

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Opening balance

 

$

23,609

 

 

$

3,463

 

 

$

24,732

 

 

$

17,073

 

Earn-out consideration payable in connection with acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

Payments made on earn-out consideration ((Note a)

 

 

(83

)

 

 

(3,000

)

 

 

(1,559

)

 

 

(17,098

)

Change in fair value of earn-out consideration (Note b)

 

 

(5,341

)

 

 

 

 

 

(5,974

)

 

 

 

Others (Note c)

 

 

55

 

 

 

14

 

 

 

1,041

 

 

 

502

 

Closing balance

 

$

18,240

 

 

$

477

 

 

$

18,240

 

 

$

477

 

 

(a) Includes the interest payment on earn-out consideration in excess of the acquisition date fair value, which is included in “cash flows from operating activities” amounting to $680 and $4,308 for three months and nine months ended September 30, 2019, respectively.

 

(b) Changes in the fair value of earn-out consideration are reported in “other operating (income) expense, net” in the consolidated statements of income.

 

(c) Others” is comprised of interest expense included in “interest income (expense), net” and the impact of changes in foreign exchange reported in “foreign exchange gains (losses), net” in the consolidated statements of income. This also includes a cumulative translation adjustment reported as a component of other comprehensive income (loss).

 

 

The following table provides a roll-forward of the fair value of deferred compensation plan assets categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2018 and 2019:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Opening balance

 

$

 

 

$

9,141

 

 

$

 

 

$

1,613

 

Additions (net of redemption)

 

 

595

 

 

 

579

 

 

 

595

 

 

 

7,564

 

Change in fair value of deferred compensation plan assets (Note a)

 

 

13

 

 

 

186

 

 

 

13

 

 

 

729

 

Others (Note b)

 

 

(20

)

 

 

 

 

 

(20

)

 

 

 

Closing balance

 

$

588

 

 

$

9,906

 

 

$

588

 

 

$

9,906

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Changes in the fair value of plan assets are reported in “other income (expense), net” in the consolidated statements of income.

 

(b) “Others” is comprised of certain administrative charges which are reported in “selling, general and administrative expenses” in the consolidated statements of income.

22


 

 

6. Fair value measurements (Continued)

The following table provides a roll-forward of the fair value of deferred compensation liabilities categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2018 and 2019:

 

 

Three months ended

September 30,

 

 

Nine months ended

September 30,

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Opening balance

 

$

 

 

$

8,994

 

 

$

 

 

 

1,582

 

Additions (net of redemption)

 

 

595

 

 

 

587

 

 

 

595

 

 

 

7,564

 

Change in fair value of deferred compensation plan liabilities (Note a)

 

 

3

 

 

 

61

 

 

 

3

 

 

 

496

 

Closing balance

 

$

598

 

 

$

9,642

 

 

$

598

 

 

 

9,642

 

 

(a) Changes in the fair value of deferred compensation liabilities are reported in “selling, general and administrative expenses” in the consolidated statements of income.

7. Derivative financial instruments

 

The Company is exposed to the risk of rate fluctuations on its foreign currency assets and liabilities and on foreign currency denominated forecasted cash flows and interest rates. The Company has established risk management policies, including the use of derivative financial instruments to hedge foreign currency assets and liabilities, foreign currency denominated forecasted cash flows and interest rate risk. These derivative financial instruments are largely deliverable and non-deliverable forward foreign exchange contracts and interest rate swaps. The Company enters into these contracts with counterparties that are banks or other financial institutions, and the Company considers the risk of non-performance by such counterparties not to be material. The forward foreign exchange contracts and interest rate swaps mature during a period of up to 51 months and the forecasted transactions are expected to occur during the same period.

 

The following table presents the aggregate notional principal amounts of outstanding derivative financial instruments together with the related balance sheet exposure: 

 

 

 

Notional principal amounts

(note a)

 

 

Balance sheet exposure asset

(liability) (note b)

 

 

 

As of December 31,

2018

 

 

As of September 30,

2019

 

 

As of December 31,

2018

 

 

As of September 30,

2019

 

Foreign exchange forward contracts denominated in:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United States Dollars (sell) Indian Rupees (buy)

 

$

1,439,000

 

 

$

1,239,000

 

 

$

(3,643

)

 

$

(7,997

)

United States Dollars (sell) Mexican Peso (buy)

 

 

 

 

 

3,000

 

 

 

 

 

 

109

 

United States Dollars (sell) Philippines Peso (buy)

 

 

55,800

 

 

 

49,650

 

 

 

(1,510

)

 

 

2

 

Euro (sell) United States Dollars (buy)

 

 

136,412

 

 

 

117,964

 

 

 

4,804

 

 

 

8,237

 

Pound Sterling (buy) United States Dollars (sell)

 

 

128

 

 

 

 

 

 

(128

)

 

 

 

Singapore Dollars (buy) United States Dollars (sell)

 

 

 

 

 

9,939

 

 

 

 

 

 

(159

)

Euro (sell) Romanian Leu (buy)

 

 

41,198

 

 

 

36,039

 

 

 

(299

)

 

 

(362

)

Japanese Yen (sell) Chinese Renminbi (buy)

 

 

40,568

 

 

 

37,024

 

 

 

(2,195

)

 

 

(2,127

)

Pound Sterling (sell) United States Dollars (buy)

 

 

27,517

 

 

 

13,705

 

 

 

495

 

 

 

1,070

 

Australian Dollars (sell) United States Dollars (buy)

 

 

89,780

 

 

 

50,760

 

 

 

3,548

 

 

 

4,093

 

       United States Dollars (sell) Hungarian Forint (buy)

 

 

 

 

 

6,000

 

 

 

 

 

 

(103

)

Interest rate swaps (floating to fixed)

 

 

507,425

 

 

 

485,060

 

 

 

7,782

 

 

 

(5,404

)

 

 

 

 

 

 

 

 

 

 

$

8,854

 

 

$

(2,641

)

 

(a)

Notional amounts are key elements of derivative financial instrument agreements but do not represent the amount exchanged by counterparties and do not measure the Company’s exposure to credit, foreign exchange, interest rate or market risks. However, the amounts exchanged are based on the notional amounts and other provisions of the underlying derivative financial instrument agreements. Notional amounts are denominated in U.S. dollars.

(b)

Balance sheet exposure is denominated in U.S. dollars and denotes the mark-to-market impact of the derivative financial instruments on the reporting date.

 

 

23


 

 

7. Derivative financial instruments (Continued)

 

FASB guidance on derivatives and hedging requires companies to recognize all derivative instruments as either assets or liabilities at fair value in the balance sheet. In accordance with the FASB guidance on derivatives and hedging, the Company designates foreign exchange forward contracts and interest rate swaps as cash flow hedges. Foreign exchange forward contracts are entered into to cover the effects of future exchange rate variability on forecasted revenues and purchases of services, and interest rate swaps are entered into to cover interest rate fluctuation risk. In addition to this program, the Company uses derivative instruments that are not accounted for as hedges under the FASB guidance in order to hedge foreign exchange risks related to balance sheet items, such as receivables and intercompany borrowings, that are denominated in currencies other than the Company’s underlying functional currency.

 

The fair value of the Company’s derivative instruments and their location in the Company’s financial statements are summarized in the table below:

 

 

Cash flow hedges

 

 

Non-designated

 

 

 

As of December 31,

2018

 

 

As of September 30,

2019

 

 

As of December 31,

2018

 

 

As of September 30,

2019

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prepaid expenses and other current assets

 

$

23,038

 

 

$

20,611

 

 

$

11,490

 

 

$

2,169

 

Other assets

 

$

9,571

 

 

$

5,629

 

 

$

 

 

$

3

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accrued expenses and other current liabilities

 

$

15,148

 

 

$

8,149

 

 

$

225

 

 

$

965

 

Other liabilities

 

$

19,872

 

 

$

21,935

 

 

$

 

 

$

4

 

 

Cash flow hedges

 

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain (loss) on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction is recognized in the consolidated statements of income. Gains (losses) on the derivatives, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in earnings as incurred.

 

In connection with cash flow hedges, the gains (losses) recorded as a component of other comprehensive income (loss), or OCI, and the related tax effects are summarized below: 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2018

 

2019

 

2018

 

 

2019

 

 

 

Before-Tax amount

 

Tax (Expense) or Benefit

 

Net of tax Amount

 

Before-Tax amount

 

Tax (Expense) or Benefit

 

 

Net of tax Amount

 

Before-Tax

amount

 

 

Tax (Expense) or Benefit

 

 

Net of tax Amount

 

 

Before-Tax

amount

 

 

Tax (Expense) or Benefit

 

 

Net of tax Amount

 

Opening balance

 

$

(10,277

)

$

1,824

 

$

(8,453

)

$

11,185

 

$

(6,077

)

 

$

5,108

 

$

50,529

 

 

$

(14,436

)

 

$

36,093

 

 

$

(2,411

)

 

$

(5,524

)

 

$

(7,935

)

Adoption of ASU 2018-02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,265

 

 

 

2,265

 

 

 

 

 

 

 

 

 

 

Net gains (losses) reclassified into statement of

income on completion of hedged transactions

 

 

173

 

 

47

 

 

220

 

 

5,915

 

 

(1,950

)

 

 

3,965

 

 

12,734

 

 

 

(2,329

)

 

 

10,405

 

 

 

15,105

 

 

 

(5,553

)

 

 

9,552

 

Changes in fair value of effective portion of

outstanding derivatives, net

 

 

(38,242

)

 

9,544

 

 

(28,698

)

 

(9,115

)

 

1,720

 

 

 

(7,395

)

 

(86,487

)

 

 

21,163

 

 

 

(65,324

)

 

 

13,671

 

 

 

(2,436

)

 

 

11,235

 

Gain (loss) on cash flow hedging derivatives, net

 

 

(38,415

)

 

9,497

 

 

(28,918

)

 

(15,030

)

 

3,670

 

 

 

(11,360

)

 

(99,221

)

 

 

23,492

 

 

 

(75,729

)

 

 

(1,434

)

 

 

3,117

 

 

 

1,683

 

Closing balance

 

$

(48,692

)

$

11,321

 

$

(37,371

)

$

(3,845

)

$

(2,407

)

 

$

(6,252

)

$

(48,692

)

 

$

11,321

 

 

$

(37,371

)

 

$

(3,845

)

 

$

(2,407

)

 

$

(6,252

)

24


 

 

7. Derivative financial instruments (Continued)

The Company’s gains or losses recognized in other comprehensive income (loss) and their effects on financial performance are summarized below: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amount of Gain (Loss)

 

 

 

 

Amount of Gain (Loss) reclassified

 

 

 

recognized in OCI on

 

 

Location of Gain (Loss)

 

from OCI into Statement of Income

 

 

Derivatives in

Derivatives (Effective Portion)

 

 

reclassified

 

(Effective Portion)

 

 

Cash Flow

Three months ended

 

 

Nine months ended

 

 

from OCI into

 

Three months ended

 

 

Nine months ended

 

 

Hedging

September 30,

 

 

September 30,

 

 

Statement of Income

 

September 30,

 

 

September 30,

 

 

Relationships

2018

 

 

2019

 

 

2018

 

 

2019

 

 

(Effective Portion)

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

Forward foreign

exchange contracts

$

(38,960

)

 

$

(7,261

)

 

$

(91,180

)

 

$

22,964

 

 

Revenue

 

$

1,002

 

 

$

1,919

 

 

$

(1,767

)

 

$

4,441

 

 

Interest rate swaps

 

718

 

 

 

(1,854

)

 

 

4,693

 

 

 

(9,293

)

 

Cost of revenue

 

 

(1,510

)

 

 

2,294

 

 

 

9,438

 

 

 

5,274

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and

administrative expenses

 

 

(382

)

 

$

595

 

 

 

2,543

 

 

 

1,497

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

1,063

 

 

 

1,107

 

 

 

2,520

 

 

 

3,893

 

 

 

$

(38,242

)

 

$

(9,115

)

 

$

(86,487

)

 

$

13,671

 

 

 

 

$

173

 

 

$

5,915

 

 

$

12,734

 

 

$

15,105

 

 

 

 

There are no gains (losses) recognized in income on the ineffective portion of derivatives and excluded from effectiveness testing for the three and nine months ended September 30, 2018 and 2019, respectively.

 

Non-designated hedges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amount of Gain (Loss) recognized in Statement of Income on Derivatives

 

 

 

 

 

Three months ended

September 30,

 

 

Nine months ended September 30,

 

Derivatives not designated as hedging instruments

 

Location of Gain (Loss)  recognized in Statement of Income on Derivatives

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Forward foreign exchange

   contracts (Note a)

 

Foreign exchange gains

   (losses), net

 

$

(6,450

)

 

$

           (3,209

)

 

$

(23,279

)

 

$

4,203

 

 

 

 

 

$

(6,450

)

 

$

         (3,209

)

 

$

(23,279

)

 

$

4,203

 

 

(a)

These forward foreign exchange contracts were entered into to hedge fluctuations in foreign exchange rates for recognized balance sheet items such as receivables and intercompany borrowings, and were not originally designated as hedges under FASB guidance on derivatives and hedging. Realized gains (losses) and changes in the fair value of these derivatives are recorded in foreign exchange gains (losses), net in the consolidated statements of income.

 

25


 

 

8. Prepaid expenses and other current assets

 

Prepaid expenses and other current assets consist of the following:

 

 

 

As of December 31,

 

 

As of September 30,

 

 

 

2018

 

 

2019

 

Advance income and non-income taxes

 

$

58,701

 

 

$

103,239

 

Contract asset (Note 19)

 

 

22,472

 

 

 

23,084

 

Prepaid expenses

 

 

25,996

 

 

 

28,509

 

Derivative instruments

 

 

34,528

 

 

 

22,780

 

Employee advances

 

 

3,772

 

 

 

4,093

 

Deposits

 

 

2,758

 

 

 

1,555

 

Advances to suppliers

 

 

1,998

 

 

 

1,454

 

Others

 

 

62,252

 

 

 

52,047

 

 

 

$

212,477

 

 

$

236,761

 

 

 

9. Property, plant and equipment, net

 

The following table provides the gross and net amount of property, plant and equipment:

 

 

 

As of December 31,

 

 

As of September 30,

 

 

 

2018

 

 

2019

 

Property, plant and equipment, gross

 

$

660,754

 

 

$

695,136

 

Less: Accumulated depreciation and amortization

 

 

(448,039

)

 

 

(478,751

)

Property, plant and equipment, net

 

$

212,715

 

 

$

216,385

 

 

Depreciation expense on property, plant and equipment, including computer software, for the nine months ended September 30, 2018 and 2019 was $45,788 and $49,799, respectively, and for the three months ended September 30, 2018 and 2019 was $15,579 and $17,106, respectively.      

 

The depreciation and amortization expenses set forth above include the effect of the reclassification of foreign exchange (gains) losses related to the effective portion of foreign currency derivative contracts, amounting to $(423) and $(224) for the nine months ended September 30, 2018 and 2019, respectively, and $79 and $(94) for the three months ended September 30, 2018 and 2019, respectively.

 

The Company recorded a write-down to computer software during the nine months ended September 30, 2018 as described in Note 10.

 

               

10. Goodwill and intangible assets

 

The following table presents the changes in goodwill:

 

 

As of December 31,

 

 

As of September 30,

 

 

 

2018

 

 

2019

 

Opening balance

 

$

1,337,122

 

 

$

1,393,832

 

Goodwill relating to acquisitions consummated during the period

 

 

91,936

 

 

 

2,547

 

Impact of measurement period adjustments

 

 

816

 

 

 

(988

)

Effect of exchange rate fluctuations

 

 

(36,042

)

 

 

(5,904

)

Closing balance

 

$

1,393,832

 

 

$

1,389,487

 

 

The total amount of goodwill deductible for tax purposes was $187,546 and $190,781 as of December 31, 2018 and September 30, 2019, respectively.

 

26


 

 

The Company’s intangible assets are as follows:

 

 

As of December 31, 2018

 

 

As of September 30,2019

 

 

 

Gross carrying amount

 

 

Accumulated amortization & Impairment

 

 

Net

 

 

Gross carrying amount

 

 

Accumulated amortization & Impairment

 

 

Net

 

Customer-related intangible assets

 

$

368,558

 

 

$

306,582

 

 

$

61,976

 

 

$

366,819

 

 

$

320,866

 

 

$

45,953

 

Marketing-related intangible assets

 

 

54,714

 

 

 

46,591

 

 

 

8,123

 

 

 

55,065

 

 

 

49,060

 

 

 

6,005

 

Technology-related intangible assets

 

 

76,790

 

 

 

33,976

 

 

 

42,814

 

 

 

138,825

 

 

 

54,408

 

 

 

84,417

 

Other intangible assets

 

 

1,204

 

 

 

1,077

 

 

 

127

 

 

 

1,180

 

 

 

1,124

 

 

 

56

 

Intangible assets under development

 

 

64,047

 

 

 

-

 

 

 

64,047

 

 

 

29,651

 

 

 

3,511

 

 

 

26,140

 

 

 

$

565,313

 

 

$

388,226

 

 

$

177,087

 

 

$

591,540

 

 

$

428,969

 

 

$

162,571

 

 

Amortization expenses for intangible assets acquired as a part of business combination and disclosed in the consolidated statements of income under amortization of acquired intangible assets for the nine months ended September 30, 2018 and 2019 were $29,134 and $23,565, respectively, and for the three months ended September 30, 2018 and 2019 were $9,372 and $6,960, respectively.

 

Amortization expenses for internally-developed and other intangible assets disclosed in the consolidated statements of income under cost of revenue and selling, general and administrative expenses for the nine months ended September 30, 2018, and 2019 were $1,389 and $13,244, respectively, and for the three months ended September 30, 2018 and 2019 were $499 and $4,990, respectively.

27


 

 

10. Goodwill and intangible assets (Continued)

 

Amortization expenses for the technology-related, internally-developed intangible assets set forth above include the effect of the reclassification of foreign exchange (gains) losses related to the effective portion of foreign currency derivative contracts, amounting to $(12) and $(62) for the nine months ended September 30, 2018 and 2019, respectively, and $(2) and $(27) for the three months ended September 30, 2018 and 2019, respectively.

 

During the nine months ended September 30, 2018, the Company tested for recoverability a group of assets comprised of computer software and a technology-related intangible asset as a result of the termination of related client contracts. Additionally, during the nine months ended September 30, 2019, the Company tested for recoverability certain other technology-related intangible assets as a result of changes in the Company’s investment strategy. Based on the results of this testing, the Company determined that the carrying values of the assets tested were not recoverable, and the Company recorded complete write-downs of the carrying values of these assets amounting to $1,538 and $3,511 for the nine months ended September 30, 2018 and September 30, 2019, respectively.  These write-downs have been recorded in “other operating (income) expense, net” in the consolidated statement of income. The impairment related to computer software and technology-related intangible assets for the nine months ended September 30, 2018 amounted to $1,200 and $338, respectively, and for the nine months ended September 30, 2019 amounted to $0 and $3,511, respectively. Impairment for the three months ended September 30, 2018 and 2019 related to computer software was $688 and $0, respectively, and has been recorded in “other operating (income) expense, net.”

 

 

11. Short-term borrowings

 

The Company has the following borrowing facilities:

 

 

(a)

Fund-based and non-fund-based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of December 31, 2018 and September 30, 2019, the limits available were $14,281 and $14,245, respectively, of which $7,389 and $7,510, respectively, were utilized, constituting non-funded drawdown.

 

 

(b)

A fund-based and non-fund based revolving credit facility of $500,000, which the Company obtained through an amendment of its existing credit agreement on August 9, 2018, as described in Note 12. Prior to the amendment, the Company’s revolving credit facility was $350,000. The amended credit facility expires on August 8, 2023. The funded drawdown amount under the Company’s revolving credit facility bore interest at a rate equal to the London Inter-bank Offered Rate, or LIBOR, plus a margin of 1.375% as of December 31, 2018 and September 30, 2019. The unutilized amount on the revolving facility bore a commitment fee of 0.20% as of December 31, 2018 and September 30, 2019. As of December 31, 2018 and September 30, 2019, a total of $297,098 and $247,098, respectively, was utilized, of which $295,000 and $245,000, respectively, constituted funded drawdown and $2,098 and $2,098, respectively, constituted non-funded drawdown. The Company’s amended credit agreement contains certain customary covenants, including a maximum leverage covenant and a minimum interest coverage ratio. During the nine months ended September 30, 2019, the Company was in compliance with the financial covenants of the credit agreement.                  

 

12. Long-term debt

 

In August 2018, the Company amended its 2015 credit facility (the “2015 Facility”), which was comprised of an $800,000 term loan and a $350,000 revolving credit facility. The amended facility is comprised of a $680,000 term loan, which represents the outstanding balance under the 2015 Facility as of the date of amendment, and a $500,000 revolving credit facility. The amended facility expires on August 8, 2023. The amendment did not result in a substantial modification of $550,814 of the outstanding term loan under the 2015 Facility. Further, as a result of the amendment, the Company extinguished the outstanding term loan under the 2015 Facility of $129,186 and obtained additional funding of $129,186, resulting in no change to the outstanding principal of the term loan under the amended facility. In connection with the amendment, the Company expensed $2,029, representing partial acceleration of the amortization of the existing unamortized debt issuance costs and an additional fee paid to the Company’s lenders related to the term loan. The overall borrowing capacity under the revolving credit facility increased from $350,000 to $500,000. The amendment of the revolving credit facility resulted in accelerated amortization of $82 relating to existing unamortized debt issuance cost. The remaining unamortized costs and an additional third-party fee paid in connection with the amendment is being amortized over the term of the amended facility, which will expire on August 8, 2023.       

          

28


 

 

12. Long-term debt (Continued)

 

Borrowings under the amended credit facility bear interest at a rate equal to, at the election of the Company, either LIBOR plus an applicable margin equal to 1.375% per annum, compared to a margin of 1.50% under the 2015 facility, or a base rate plus an applicable margin equal to 0.375% per annum, compared to a margin of 0.50% under the 2015 Facility, in each case subject to adjustment based on the Company’s debt ratings provided by Standard & Poor’s Rating Services and Moody’s Investors Service, Inc. Based on the Company’s election and current credit rating, the applicable interest rate is equal to LIBOR plus 1.375% per annum. The amended credit agreement contains certain customary covenants, including a maximum leverage covenant and a minimum interest coverage ratio. During the nine months ended September 30, 2019, the Company was in compliance with the financial covenants.

As of December 31, 2018 and September 30, 2019, the amount outstanding under the term loan, net of debt amortization expense of $2,158 and $1,769, was $660,841 and $635,731, respectively. As of December 31, 2018 and September 30, 2019, the term loan bore interest at a rate equal to LIBOR plus a margin of 1.375% per annum. Indebtedness under the amended credit facility is unsecured. The amount outstanding on the term loan as of September 30, 2019 requires quarterly payments of $8,500, and the balance of the loan is due and payable upon the maturity of the term loan on August 8, 2023.

 

The maturity profile of the term loan outstanding as of September 30, 2019, net of debt amortization expense, is as follows:

 

Year ended

 

Amount

 

2019

 

 

8,372

 

2020

 

 

33,509

 

2021

 

 

33,537

 

2022

 

 

33,564

 

2023

 

 

526,749

 

Total

 

$

635,731

 

 

In March 2017, Genpact Luxembourg S.à.r.l. (the “Issuer”), a wholly owned subsidiary of the Company, issued $350,000 aggregate principal amount of 3.70% senior notes in a private offering, resulting in cash proceeds of approximately $348,519, net of an underwriting fee of $1,481. The issuance was fully guaranteed by the Company. In connection with the offering, the Company incurred other debt issuance costs of $1,161. The total debt issuance cost of $2,642 is being amortized over the life of the notes as additional interest expense. As of December 31, 2018 and September 30, 2019, the amount outstanding under the notes, net of debt amortization expense of $1,713 and $1,319, was $348,287 and $348,681, respectively, which is payable on April 1, 2022. The Issuer will pay interest on the notes semi-annually in arrears on April 1 and October 1 of each year, ending on the maturity date of April 1, 2022. The Company, at its option, may redeem the notes at any time in whole or in part, at a redemption price equal to (i) 100% of the principal amount of the notes redeemed, together with accrued and unpaid interest on the redeemed amount, and (ii) if the notes are redeemed prior to March 1, 2022, a specified “make-whole” premium. The notes are subject to certain customary covenants, including limitations on the ability of the Company and certain of its subsidiaries to incur debt secured by liens, engage in certain sale and leaseback transactions and consolidate, merge, convey or transfer their assets, and during the nine months ended September 30, 2019, the Company and its applicable subsidiaries were in compliance with the covenants. Upon certain change of control transactions, the Issuer will be required to make an offer to repurchase the notes at a price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The interest rate payable on the notes is subject to adjustment if the credit rating of the notes is downgraded, up to a maximum increase of 2.0%. In connection with the 3.70% senior notes private offering, the Issuer and the Company entered into a registration rights agreement with the initial purchasers of the outstanding unregistered notes pursuant to which the Issuer and the Company agreed to complete an exchange offer within 455 days after the date of the private offering upon terms identical in all material respects to the terms of the outstanding unregistered notes, except that the transfer restrictions, registration rights and additional interest provisions applicable to the outstanding unregistered notes would not apply to the exchange notes. On July 24, 2018, the unregistered notes exchange offer was completed and all outstanding unregistered notes were exchanged for freely tradable notes registered under the Securities Act of 1933, as amended.                       

29


 

 

13. Accrued expenses and other current liabilities

 

Accrued expenses and other current liabilities consist of the following:

 

 

 

As of December 31,

 

 

As of September 30,

 

 

 

2018

 

 

2019

 

Accrued expenses

 

$

179,843

 

 

$

181,954

 

Accrued employee cost

 

 

210,251

 

 

 

233,796

 

Earn-out consideration

 

 

16,875

 

 

 

369

 

Statutory liabilities

 

 

42,728

 

 

 

56,161

 

Retirement benefits

 

 

22,921

 

 

 

26,207

 

Derivative instruments

 

 

15,373

 

 

 

9,114

 

Contract liabilities (Note 19)

 

 

64,744

 

 

 

93,414

 

Finance lease liability

 

 

 

 

 

9,323

 

Other liabilities

 

 

16,807

 

 

 

19,813

 

Capital lease obligations

 

 

1,808

 

 

 

 

 

 

$

571,350

 

 

$

630,151

 

 

 

14. Other liabilities

 

Other liabilities consist of the following:

 

 

 

As of December 31,

 

 

As of September 30,

 

 

 

2018

 

 

2019

 

Accrued employee cost

 

$

6,341

 

 

$

8,770

 

Earn-out consideration

 

 

198

 

 

 

108

 

Retirement benefits

 

 

50,370

 

 

 

56,689

 

Derivative instruments

 

 

19,872

 

 

 

21,939

 

Contract liabilities (Note 19)

 

 

53,796

 

 

 

68,340

 

Finance lease liability

 

 

 

 

 

20,962

 

Others

 

 

32,935

 

 

 

17,305

 

Capital lease obligations

 

 

1,714

 

 

 

 

 

 

$

165,226

 

 

$

194,113

 

 

 

15. Employee benefit plans

 

The Company has employee benefit plans in the form of certain statutory and other programs covering its employees.

 

Defined benefit plans

 

In accordance with Indian law, the Company maintains a defined benefit retirement plan covering substantially all of its Indian employees. In accordance with Mexican law, the Company provides termination benefits to all of its Mexican employees. In addition, certain of the Company’s subsidiaries in the Philippines and Japan sponsor defined benefit retirement programs.

30


 

 

15. Employee benefit plans (Continued)

 

Net defined benefit plan costs for the three and nine months ended September 30, 2018 and 2019 include the following components:

 

 

Three months ended September 30,

 

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

 

2018

 

 

2019

 

Service costs

$

1,762

 

 

$

2,108

 

 

 

$

5,815

 

 

$

6,439

 

Interest costs

 

900

 

 

 

1,138

 

 

 

 

2,834

 

 

 

3,479

 

Amortization of actuarial loss

 

344

 

 

 

290

 

 

 

 

899

 

 

 

887

 

Expected return on plan assets

 

(689

)

 

 

(643

)

 

 

 

(2,169

)

 

 

(1,967

)

Net defined benefit plan costs

$

2,317

 

 

$

2,893

 

 

 

$

7,379

 

 

$

8,838

 

 

 

Defined contribution plans

 

During the three and nine months ended September 30, 2018 and 2019, the Company contributed the following amounts to defined contribution plans in various jurisdictions:

 

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

India

 

$

6,269

 

 

$

7,805

 

 

$

18,274

 

 

$

21,757

 

U.S.

 

 

2,463

 

 

 

4,655

 

 

 

9,421

 

 

 

13,676

 

U.K.

 

 

2,033

 

 

 

2,634

 

 

 

7,357

 

 

 

9,290

 

China

 

 

4,388

 

 

 

4,693

 

 

 

13,190

 

 

 

14,111

 

Other regions

 

 

980

 

 

 

1,388

 

 

 

3,312

 

 

 

4,244

 

Total

 

$

16,133

 

 

$

21,175

 

 

$

51,554

 

 

$

63,078

 

 

 Deferred compensation plan

 

On July 1, 2018, Genpact LLC, a wholly-owned subsidiary of the Company, adopted an executive deferred compensation plan (the “Plan”). The Plan provides a select group of U.S.-based members of Company management with the opportunity to defer from 1% to 80% of their base salary and from 1% to 100% of their qualifying bonus compensation (or such other minimums or maximums as determined by the Plan administrator from time to time) pursuant to the terms of the Plan. Participant deferrals are 100% vested at all times. The Plan also allows for discretionary supplemental employer contributions by the Company, in its sole discretion, which will be subject to a two-year vesting schedule (50% vesting on the one-year anniversary of approval of the contribution and 50% vesting on the second year anniversary of approval of the contribution) or such other vesting schedule as determined by the Company.

 

The Plan also provides an option for participants to elect to receive deferred compensation and earnings thereon on either fixed date(s) no earlier than two years following the applicable Plan year (or end of the applicable performance period for performance-based bonus compensation) or following a separation from service, in each case either in a lump sum or in annual installments over a term of up to 15 years. Each Plan participant’s compensation deferrals are credited or debited with notional investment gains and losses equal to the performance of selected hypothetical investment funds offered under the Plan and elected by the participant.

 

The Company has investments in funds held in Company-owned life insurance policies which are held in a Rabbi Trust that are classified as trading securities. Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. The securities are classified as trading securities because they are held for resale in anticipation of short-term fluctuations in market prices. The trading securities are stated at fair value.

31


 

 

15. Employee benefit plans (Continued)

The liability for the deferred compensation plan was $1,582 and $9,642 as of December 31, 2018 and September 30, 2019, respectively, and is included in “other liabilities” in the consolidated balance sheets.

 

In connection with the administration of the Plan, the Company has purchased company-owned life insurance policies insuring the lives of certain employees. The cash surrender value of these policies was $1,613 and $9,906 as of December 31, 2018 and September 30, 2019, respectively. The cash surrender value of these insurance policies is included in “other assets” in the consolidated balance sheets.

 

The change in the fair value of Plan assets during the nine months ended September 30, 2018 and 2019 was $13 and $729, respectively, and for the three months ended September 30, 2018 and 2019 was $13 and $186, respectively, which is included in “other income (expense), net” in the consolidated statements of income. The change in the fair value of deferred compensation liabilities during the nine months ended September 30, 2018 and 2019 was $3 and $496, respectively, and for the three months ended September 30, 2018 and 2019 was $3 and $61, respectively, which is included in “selling, general and administrative expenses.”

 

16. Stock-based compensation

The Company has granted stock-based awards under the Genpact Limited 2007 Omnibus Incentive Compensation Plan (the “2007 Omnibus Plan”) and the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the “2017 Omnibus Plan”) to eligible persons, including employees, directors and certain other persons associated with the Company.

Under the 2007 Omnibus Plan, shares underlying awards forfeited, expired, terminated or cancelled under any of the Company’s predecessor plans were added to the number of shares otherwise available for grant under the 2007 Omnibus Plan. The 2007 Omnibus Plan was amended and restated on April 11, 2012 to increase the number of common shares authorized for issuance by 5,593,200 shares to 15,000,000 shares.

On May 9, 2017, the Company’s shareholders approved the adoption of the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the “2017 Omnibus Plan”), pursuant to which 15,000,000 Company common shares are available for issuance. The 2017 Omnibus Plan was amended and restated on April 5, 2019 to increase the number of common shares authorized for issuance by 8,000,000 shares to 23,000,000 shares. No grants may be made under the 2007 Omnibus Plan after the date of adoption of the 2017 Omnibus Plan.  Grants that were outstanding under the 2007 Omnibus Plan as of the date of Company’s adoption of the 2017 Omnibus Plan remain subject to the terms of the 2007 Omnibus Plan.

Stock-based compensation costs relating to the foregoing plans during the nine months ended September 30, 2018 and 2019 were $31,567 and $60,525, respectively, and for the three months ended September 30, 2018 and 2019 were $13,224 and $21,042, respectively. These costs have been allocated to cost of revenue and selling, general, and administrative expenses.

 

Options

 

All options granted under the 2007 and 2017 Omnibus Plans are exercisable into common shares of the Company, have a contractual period of ten years and vest over four to five years unless specified otherwise in the applicable award agreement. The Company recognizes compensation cost over the vesting period of the option.

 

Compensation cost is determined at the date of grant by estimating the fair value of an option using the Black-Scholes option-pricing model.

32


 

 

16. Stock-based compensation (Continued)

 

The following table shows the significant assumptions used in determining the fair value of options granted in the nine months ended September 30, 2018 and September 30, 2019.

 

 

Nine months ended

September 30, 2018

 

 

Nine months ended

September 30, 2019

 

Dividend yield

0.95% - 1.01%

 

 

 

 

0.82% - 1.08%

 

Expected life (in months)

84

 

 

 

 

84

 

Risk-free rate of interest

2.67%-2.93%

 

 

 

1.56% - 2.63%

 

Volatility

22.55%-22.73%

 

 

 

21.0% - 21.38%

 

 

A summary of option activity during the nine months ended September 30, 2019 is set out below:

 

 

 

Nine months ended September 30, 2019

 

 

 

Shares arising

out of options

 

 

Weighted average

exercise price

 

 

Weighted average

remaining

contractual life

(years)

 

 

Aggregate

intrinsic

value

 

Outstanding as of January 1, 2019

 

 

7,261,675

 

 

$

23.61

 

 

 

6.4

 

 

$

 

Granted

 

 

1,881,068

 

 

 

28.50

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(85,000)

 

 

 

29.91

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(622,494)

 

 

 

15.27

 

 

 

 

 

 

 

13,858

 

Outstanding as of September 30, 2019

 

 

8,435,249

 

 

$

25.25

 

 

 

6.7

 

 

$

114,171

 

Vested as of September 30, 2019 and expected to vest thereafter (Note a)

 

8,046,532

 

 

$

25.08

 

 

 

6.7

 

 

$

 

110,206

Vested and exercisable as of September 30, 2019

 

 

3,186,076

 

 

$

19.08

 

 

 

3.6

 

 

$

62,668

 

Weighted average grant date fair value of grants during the period

 

$

6.98

 

 

 

 

 

 

 

 

 

 

 

 

 

  (a) Options expected to vest reflect the application of an estimated forfeiture rate.

 

As of September 30, 2019, the total remaining unrecognized stock-based compensation cost for options expected to vest amounted to $26,518, which will be recognized over the weighted average remaining requisite vesting period of 3.7 years.

Restricted share units

The Company has granted restricted share units, or RSUs, under the 2007 and 2017 Omnibus Plans. Each RSU represents the right to receive one common share. The fair value of each RSU is the market price of one common share of the Company on the date of the grant. The RSUs granted to date have graded vesting schedules of three months to four years. The compensation expense is recognized on a straight-line basis over the vesting term. A summary of RSU activity during the nine months ended September 30, 2019 is set out below:

 

 

 

Nine months ended September 30, 2019

 

 

 

 

Number of Restricted Share Units

 

 

Weighted Average Grant Date Fair Value

 

Outstanding as of January 1, 2019

 

 

1,528,999

 

 

$

27.45

 

Granted

 

 

218,965

 

 

 

34.34

 

Vested (Note a)

 

 

(611,871

)

 

 

26.38

 

Forfeited

 

 

(65,067

)

 

 

30.51

 

Outstanding as of September 30, 2019

 

 

1,071,026

 

 

$

29.29

 

Expected to vest (Note b)

 

 

983,141

 

 

 

 

 

 

(a)

 611,871 RSUs that vested during the period were net settled upon vesting by issuing 505,512 shares (net of minimum statutory tax withholding).  In addition, 52,875 RSUs that vested in 2017 were settled during the nine month period ended September 30, 2019 by the issuance of 52,405 shares (net of minimum statutory tax withholding).

(b)

The number of RSUs expected to vest reflects the application of an estimated forfeiture rate.

33


 

 

16. Stock-based compensation (Continued)

 

As of September 30, 2019, the total remaining unrecognized stock-based compensation cost related to RSUs amounted to $18,419, which will be recognized over the weighted average remaining requisite vesting period of 1.8 years.

 

Performance units

 

The Company also grants stock-based awards in the form of performance units, or PUs, and has granted PUs under both the 2007 and 2017 Omnibus Plans.

 

Each PU represents the right to receive one common share at a future date based on the Company’s performance against specified targets. PUs granted to date have vesting schedules of six months to three years. The fair value of each PU is the market price of one common share of the Company on the date of grant and assumes that performance targets will be achieved. PUs granted under the plans are subject to cliff vesting. The compensation expense for such awards is recognized on a straight-line basis over the vesting terms. During the performance period, the Company’s estimate of the number of shares to be issued is adjusted upward or downward based upon the probability of achievement of the performance targets. The ultimate number of shares issued and the related compensation cost recognized is based on a comparison of the final performance metrics to the specified targets.

 

A summary of PU activity during the nine months ended September 30, 2019 is set out below:

 

 

 

Nine months ended September 30, 2019

 

 

 

Number of

Performance Units

 

 

Weighted

Average Grant

Date Fair Value

 

 

Maximum Shares

Eligible to Receive

 

Outstanding as of January 1, 2019

 

 

3,712,402

 

 

$

28.40

 

 

 

3,712,402

 

Granted

 

 

1,577,530

 

 

 

34.68

 

 

 

3,155,060

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(183,696

)

 

 

28.74

 

 

 

(200,635

)

Adjustment upon final determination of level of performance goal achievement (Note a)

 

 

(13,996

)

 

 

30.68

 

 

 

 

 

Adjustment upon final determination of level of performance goal achievement (Note a)

 

 

 

 

 

 

 

 

 

 

(13,996

)

Outstanding as of September 30, 2019

 

 

5,092,239

 

 

$

30.33

 

 

 

6,652,830

 

Expected to vest (Note b)

 

 

5,368,588

 

 

 

 

 

 

 

 

 

 

  

 

(a)

Represents an adjustment made in March 2019 to the number of shares subject to the PUs granted in 2018 upon certification of the level of achievement of the performance targets underlying such awards.

 

(b)

The number of PUs expected to vest reflects the application of an estimated forfeiture rate and the expected achievement of higher-than-target performance for the PUs granted during the year.

 

As of September 30, 2019, the total remaining unrecognized stock-based compensation cost related to PUs amounted to $66,249, which will be recognized over the weighted average remaining requisite vesting period of 1.8 years.

 

Employee Stock Purchase Plan (ESPP)

 

On May 1, 2008, the Company adopted the Genpact Limited U.S. Employee Stock Purchase Plan and the Genpact Limited International Employee Stock Purchase Plan (together, the “ESPP”). In April 2018, these plans were amended and restated, and their terms were extended to August 31, 2028.  

 

The ESPP allows eligible employees to purchase the Company’s common shares through payroll deductions at 90% of the closing price of the Company’s common shares on the last business day of each purchase interval. The dollar amount of common shares purchased under the ESPP may not exceed 15% of the participating employee’s base salary, subject to a cap of $25 per employee per calendar year. With effect from September 1, 2009, the offering periods commence on the first business day in March, June, September and December of each year and end on the last business day of the subsequent May, August, November and February. 4,200,000 common shares have been reserved for issuance in the aggregate over the term of the ESPP.

 

34


 

 

16. Stock-based compensation (Continued)

 

During the nine months ended September 30, 2018 and 2019, 181,643 and 195,221 common shares, respectively, were issued under the ESPP.

 

The ESPP is considered compensatory under the FASB guidance on Compensation-Stock Compensation.

 

The compensation expense for the ESPP is recognized in accordance with the FASB guidance on Compensation-Stock Compensation. The compensation expense for the ESPP during the nine months ended September 30, 2018 and 2019 was $591 and $781, respectively, and for the three months ended September 30, 2018 and 2019 was $210 and $278, respectively, and has been allocated to cost of revenue and selling, general, and administrative expenses.

17. Capital stock

 

Share repurchases

 

The Board of Directors of the Company (the “Board”) has authorized repurchases of up to $1,250,000 under the Company’s existing share repurchase program. Since the Company’s share repurchase program was initially authorized in 2015, the Company has repurchased shares amounting to approximately $970,000, representing 37,239,353 common shares, at an average price of $26.04 per share.  This number includes shares repurchased under the Company’s 2017 accelerated share repurchase program.

 

During the nine months ended September 30, 2018 and September 30, 2019, the Company repurchased 4,114,882 and 608,285  of its common shares, respectively, on the open market at a weighted average price of $31.62  and $39.29 per share, respectively, for an aggregate cash amount of $130,103 and $23,901, respectively. Additionally, in the nine months ended September 30, 2018, the Company received a final delivery of 163,975 common shares upon the settlement of the transaction under its 2017 accelerated share repurchase program. All repurchased shares were retired.

 

Dividend

 

On February 12, 2018, the Company announced that its Board had approved a 25% increase in its quarterly cash dividend to $0.075 per share, up from $0.06 per share in 2017, representing an annual dividend of $0.30 per common share, up from $0.24 per share in 2017, payable to holders of the Company’s common shares. On March 21, 2018, June 20, 2018 and September 19, 2018, the Company paid dividends of $0.075 per share, amounting to $14,408, $14,240 and $14,253 in the aggregate, to shareholders of record as of March 9, 2018, June 8, 2018 and September 10, 2018, respectively.

 

On February 7, 2019, the Company announced that its Board had approved a 13% increase in its quarterly cash dividend to $0.085 per share, up from $0.075 per share in 2018, representing a planned annual dividend of $0.34 per common share, up from $0.30 per share in 2018, payable to holders of the Company’s common shares. On March 20, 2019, June 21, 2019 and September 20, 2019, the Company paid dividends of $0.085 per share, amounting to $16,119, $16,188 and $16,208 in the aggregate, to shareholders of record as of March 8, 2019, June 12, 2019 and September 11, 2019, respectively.

 

35


 

 

18. Earnings per share

 

The Company calculates earnings per share in accordance with FASB guidance on earnings per share. Basic and diluted earnings per common share give effect to the change in the number of Company common shares outstanding. The calculation of basic earnings per common share is determined by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the respective periods. Potentially dilutive shares, consisting of outstanding options on common shares, restricted share units, performance units and common shares to be issued under the employee stock purchase plan, have been included in the computation of diluted net earnings per share and the weighted average shares outstanding, except where the result would be anti-dilutive.

 

The number of stock awards outstanding but not included in the computation of diluted earnings per common share because their effect was anti-dilutive is 2,051,062 and 2,375,425 for the nine months ended September 30, 2018 and 2019, respectively, and 3,222,303 and 60,194 for the three months ended September 30, 2018 and 2019, respectively.

 

 

 

Three months ended September 30,

 

 

 

Nine months ended September 30,

 

 

 

2018

 

 

2019

 

 

 

2018

 

 

2019

 

Net income available to Genpact Limited common shareholders

 

$

73,603

 

 

$

88,120

 

 

 

$

202,872

 

 

$

222,683

 

Weighted average number of common shares used in computing basic earnings per common share

 

 

190,024,924

 

 

 

190,599,049

 

 

 

 

190,991,405

 

 

 

190,071,418

 

Dilutive effect of stock-based awards

 

 

3,090,845

 

 

 

5,291,792

 

 

 

 

3,265,366

 

 

 

4,612,281

 

Weighted average number of common shares used in computing dilutive earnings per common share

 

 

193,115,769

 

 

 

195,890,841

 

 

 

 

194,256,771

 

 

 

194,683,699

 

Earnings per common share attributable to Genpact Limited common shareholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.39

 

 

$

0.46

 

 

 

$

1.06

 

 

$

1.17

 

Diluted

 

$

0.38

 

 

$

0.45

 

 

 

$

1.04

 

 

$

1.14

 

 

 

19. Net revenues

 

Disaggregation of revenue

 

In the following tables, the Company’s revenue is disaggregated by customer classification, service type, major industrial vertical and location of service delivery center.

 

 

Three months ended September 30,

Nine months ended September 30,

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

GE

$

64,507

 

 

$

121,096

 

 

$

188,000

 

 

$

348,742

 

 

Global Clients

 

683,471

 

 

 

767,703

 

 

 

1,977,451

 

 

 

2,231,062

 

 

Total net revenues

$

747,978

 

 

$

888,799

 

 

$

2,165,451

 

 

$

2,579,804

 

 

 

 

Three months ended September 30,

Nine months ended September 30,

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

Business process outsourcing

$

622,940

 

 

$

749,322

 

 

$

1,802,912

 

 

$

2,173,562

 

 

Information technology services

 

125,038

 

 

 

139,477

 

 

 

362,539

 

 

 

406,242

 

 

Total net revenues

$

747,978

 

 

$

888,799

 

 

$

2,165,451

 

 

$

2,579,804

 

 

 

 

36


 

 

19. Net revenues (Continued)

 

 

Three months ended September 30,

Nine months ended September 30,

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

Banking, financial services and insurance

$

258,372

 

 

$

279,445

 

 

$

803,771

 

 

$

792,388

 

 

Consumer goods, retail, life sciences and healthcare

 

230,177

 

 

 

272,029

 

 

 

648,705

 

 

 

801,440

 

 

High tech, manufacturing and services

 

259,429

 

 

 

337,325

 

 

 

712,975

 

 

 

985,976

 

 

Total net revenues

$

747,978

 

 

$

888,799

 

 

$

2,165,451

 

 

$

2,579,804

 

 

 

 

 

  Net revenues from geographic areas based on the location of the Company’s service delivery centers are as follows. A portion of net revenues attributable to India also consists of net revenues for services performed at clients’ premises outside of India by business units or personnel normally based in India.

 

 

Three months ended September 30,

Nine months ended September 30,

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

India

$

408,169

 

 

$

472,896

 

 

$

1,262,225

 

 

$

1,395,989

 

 

Asia, other than India

 

83,844

 

 

 

86,009

 

 

 

241,535

 

 

 

261,462

 

 

North and Latin America

 

152,121

 

 

 

233,062

 

 

 

456,241

 

 

 

622,873

 

 

Europe

 

103,844

 

 

 

96,832

 

 

 

205,450

 

 

 

299,480

 

 

Total net revenues

$

747,978

 

 

$

888,799

 

 

$

2,165,451

 

 

$

2,579,804

 

 

 

 

Contract balances

 

Accounts receivable include amounts for services that the Company has performed but for which payment has not been received. The Company typically follows a 30-day billing cycle and, as such, at any point in time may have accrued up to 30 days of revenues that have not been billed. The Company has determined that in instances where the timing of revenue recognition differs from the timing of invoicing, the related contracts generally do not include a significant financing component. Refer to Note 5 for details on the Company’s accounts receivable and reserve for doubtful receivables.

 

The following table provides details of the Company’s contract liabilities:

 

  

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Particulars

Advance from customers

 

 

Deferred transition revenue

 

 

Advance from customers

 

 

Deferred transition revenue

 

 

Advance from customers

 

 

Deferred transition revenue

 

 

Advance from customers

 

 

Deferred transition revenue

 

Opening balance

$

30,341

 

 

$

98,962

 

 

$

39,110

 

 

$

104,276

 

 

$

26,266

 

 

$

101,785

 

 

$

22,892

 

 

$

95,648

 

Impact of opening balance offset with contract asset

 

 

 

$

23,735

 

 

 

7,943

 

 

$

43,648

 

 

 

 

 

$

21,348

 

 

 

3,821

 

 

$

25,604

 

Gross opening balance

$

30,341

 

 

$

122,697

 

 

$

47,053

 

 

$

147,924

 

 

$

26,266

 

 

$

123,133

 

 

$

26,713

 

 

$

121,252

 

Additions

 

9,152

 

 

 

16,881

 

 

 

25,455

 

 

 

31,226

 

 

 

25,888

 

 

 

49,592

 

 

 

67,281

 

 

 

85,203

 

Effect of business combination

 

273

 

 

 

75

 

 

 

 

 

 

 

 

 

273

 

 

 

75

 

 

 

444

 

 

 

 

Revenue recognized

 

(11,934

)

 

 

(21,143

)

 

 

(20,425

)

 

 

(15,832

)

 

 

(23,837

)

 

 

(53,499

)

 

 

(39,955

)

 

 

(43,159

)

Currency translation adjustments

 

(147

)

 

 

(383

)

 

 

(452

)

 

 

(397

)

 

 

(905

)

 

 

(1,174

)

 

 

(450

)

 

 

(375

)

Others

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

(2,402

)

 

 

 

Gross closing balance

$

27,685

 

 

$

118,127

 

 

$

51,631

 

 

$

162,921

 

 

$

27,685

 

 

$

118,127

 

 

$

51,631

 

 

$

162,921

 

Impact of closing balance offset with contract asset

 

 

 

 

(22,586

)

 

 

(8,286

)

 

 

(44,512

)

 

 

 

 

 

(22,586

)

 

 

(8,286

)

 

 

(44,512

)

Closing balance (Note a)

$

27,685

 

 

$

95,541

 

 

$

43,345

 

 

$

118,409

 

 

$

27,685

 

 

$

95,541

 

 

$

43,345

 

 

$

118,409

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

37


 

 

(a) Included in "accrued expenses and other current liabilities" and "other liabilities" in the consolidated balance sheet.

 

19. Net revenues (Continued)

 

The following table includes estimated revenue expected to be recognized in the future related to remaining performance obligations as of September 30, 2019:

 

Particulars

Total

 

 

Less than 1 year

 

 

1-3 years

 

 

3-5 years

 

 

After 5 years

 

Transaction price allocated to remaining performance obligations

$

161,754

 

 

 

93,414

 

 

 

51,454

 

 

 

14,645

 

 

 

2,241

 

 

 

The following table provides details of the Company’s contract assets:

 

Particulars

Three months ended

September 30,

 

 

Nine months ended

September 30,

 

Particulars

2018

 

 

2019

 

 

2018

 

 

2019

 

Opening balance

$

41,671

 

 

$

48,593

 

 

$

43,366

 

 

$

45,035

 

Impact of opening balance offset with contract liability

 

23,735

 

 

 

51,591

 

 

 

21,348

 

 

 

29,425

 

Gross opening balance

$

65,406

 

 

$

100,184

 

 

$

64,714

 

 

$

74,460

 

Additions

 

9,710

 

 

 

9,496

 

 

 

29,228

 

 

 

58,594

 

Reduction in revenue recognized

 

(10,706

)

 

 

(9,899

)

 

 

(29,532

)

 

 

(33,273

)

Gross closing balance

$

64,410

 

 

$

99,781

 

 

$

64,410

 

 

$

99,781

 

Impact of closing balance offset with contract liability

 

(22,586

)

 

 

(52,798

)

 

 

(22,586

)

 

 

(52,798

)

Closing balance (Note b)

$

41,824

 

 

$

46,983

 

 

$

41,824

 

 

$

46,983

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b)

Included in "prepaid expenses and other current assets" and "other assets" in the consolidated balance sheet.

 

The following table provides details of the Company’s contract cost assets:

 

  

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Particulars

Sales incentive programs

 

 

Transition activities

 

 

Sales incentive programs

 

 

Transition activities

 

 

Sales incentive programs

 

 

Transition activities

 

 

Sales incentive programs

 

 

Transition activities

 

Opening balance

$

24,808

 

 

$

137,370

 

 

$

35,593

 

 

$

156,585

 

 

$

23,227

 

 

$

139,284

 

 

$

25,891

 

 

$

134,302

 

Closing balance

 

26,459

 

 

 

133,651

 

 

 

35,146

 

 

 

171,357

 

 

 

26,459

 

 

 

133,651

 

 

 

35,146

 

 

 

171,357

 

Amortization

 

3,666

 

 

 

19,974

 

 

 

4,496

 

 

 

15,106

 

 

 

10,509

 

 

 

54,874

 

 

 

13,044

 

 

 

41,701

 

 

 

 

20. Cost of revenue

 

Cost of revenue consists of the following:

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Personnel expenses

$

326,717

 

 

$

422,508

 

 

$

959,648

 

 

$

1,224,610

 

Operational expenses

 

141,236

 

 

 

129,294

 

 

 

389,702

 

 

 

376,878

 

Depreciation and amortization

 

13,459

 

 

 

21,857

 

 

 

39,284

 

 

 

62,552

 

 

$

481,412

 

 

$

573,659

 

 

$

1,388,634

 

 

$

1,664,040

 

 

 

38


 

 

21. Selling, general and administrative expenses

 

Selling, general and administrative expenses consist of the following:

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Personnel expenses

$

125,838

 

 

$

147,037

 

 

$

380,532

 

 

$

438,427

 

Operational expenses

 

39,551

 

 

 

44,965

 

 

 

126,860

 

 

 

136,461

 

Depreciation and amortization

 

2,621

 

 

 

2,535

 

 

 

7,893

 

 

 

7,363

 

 

$

168,010

 

 

$

194,537

 

 

$

515,285

 

 

$

582,251

 

 

22. Other operating (income) expense, net

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Other operating (income) expense

$

(191

)

 

$

59

 

 

$

(477

)

 

$

(3,421

)

Provision for impairment of intangible assets and property, plant and equipment

 

688

 

 

 

 

 

 

1,538

 

 

 

3,511

 

Change in fair value of earn-out consideration and deferred consideration (relating to business acquisitions)

 

(5,341

)

 

 

 

 

$

(5,974

)

 

$

 

Other operating (income) expense, net

$

(4,844

)

 

$

59

 

 

$

(4,913

)

 

$

90

 

 

 

23. Interest income (expense), net

 

 

Three months ended September 30,

 

 

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Interest income

$

3,328

 

 

$

1,968

 

 

$

8,472

 

 

$

4,758

 

Interest expense

 

(12,467

)

 

 

(12,189

)

 

 

(36,118

)

 

 

(38,245

)

Interest income (expense), net

$

(9,139

)

 

$

(10,221

)

 

$

(27,646

)

 

$

(33,487

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

39


 

 

24. Income taxes

 

The Company determines its tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if its estimated tax rate changes, the Company makes a cumulative adjustment.

 

The Company’s effective tax rate (“ETR”) was 21.9% for the nine months ended September 30, 2019, up from 20.8% for the nine months ended September 30, 2018. The increase in the Company’s ETR is primarily due to the expiration of certain special economic zone benefits in India and changes in the jurisdictional mix of the Company’s income.

 

As of December 31, 2018, the Company had unrecognized tax benefits amounting to $26,722, including an amount of $25,485, which, if recognized, would impact the Company’s ETR.  

  

The following table summarizes activities related to the Company’s unrecognized tax benefits for uncertain tax positions for the nine months ended September 30, 2019: 

 

 

2019

 

Opening balance at January 1

 

$

26,722

 

Decrease related to prior year tax positions

 

 

(56

)

Decrease related to prior year tax position due to lapse of applicable statute of limitation

 

 

(217

)

Increase related to current year tax positions, including recorded in acquisition accounting

 

 

225

 

Effect of exchange rate changes

 

 

(163

)

Closing balance at September 30

 

$

26,511

 

 

The Company’s unrecognized tax benefits as of September 30, 2019 include an amount of $25,273, which, if recognized, would impact the Company’s ETR. As of December 31, 2018 and September 30, 2019 the Company had accrued approximately $5,081 and $5,600, respectively, in interest relating to unrecognized tax benefits. During the year ended December 31, 2018 and the nine months ended September 30, 2019, the Company recognized approximately $467 and $519, respectively, excluding the impact of exchange rate differences, in interest on unrecognized tax benefits. As of December 31, 2018 and September 30, 2019, the Company had accrued approximately $995 and $914, respectively, for penalties.

 

40


 

 

25. Related party transactions

 

The Company has entered into related party transactions with its non-consolidating affiliates. The Company has also entered into related party transactions with a significant shareholder and its affiliates.

 

The Company’s related party transactions can be categorized as follows:

 

Revenue from services

 

During the nine months ended September 30 2018 and 2019, the Company recognized net revenues of $552 and $478, respectively, and for the three months ended September 30, 2018 and 2019, the Company recognized net revenues of $113 and $159, respectively, from a client that is a significant shareholder of the Company.

  

Cost of revenue

 

The Company purchases certain services from its non-consolidating affiliates, mainly relating to training and recruitment, which are included in cost of revenue. For the nine months ended September 30, 2018 and 2019, cost of revenue includes an amount of $863 and $521, respectively, and for the three months ended September 30, 2018 and 2019, cost of revenue includes an amount of $414 and $185, respectively, attributable to the cost of services provided by the Company’s non-consolidating affiliates.

 

Selling, general and administrative expenses

 

The Company purchases certain services from its non-consolidating affiliates, mainly relating to training and recruitment, the costs of which are included in selling, general and administrative expenses. For the nine months ended September 30, 2018 and 2019, selling, general and administrative expenses include an amount of $158 and $101, respectively, and for the three months ended September 30, 2018 and 2019, selling, general and administrative expenses include an amount of $68 and $47, respectively, attributable to the cost of services provided by the Company’s non-consolidating affiliates.

 

During the three and nine months ended September 30, 2018 and 2019, the Company engaged a significant shareholder to provide certain services to the Company, the costs of which are included in selling, general and administrative expenses. For the nine months ended September 30, 2018 and 2019, selling, general and administrative expenses include an amount of $20 and $105, respectively, and for the three months ended September 30, 2018 and 2019, selling, general and administrative expenses include an amount of $10 and $23, respectively, attributable to the cost of services provided by the Company’s significant shareholder.    

 

    

  

 

    

26. Other Income (expense), net

 

 

Three months ended September 30,

Nine months ended September 30,

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

Government incentives

$

5,154

 

 

$

 

 

$

30,850

 

 

$

3,976

 

Other income/(expense)

 

231

 

 

 

704

 

 

 

(167

)

 

 

1,091

 

Other Income (expense), net

$

5,385

 

 

$

704

 

 

$

30,683

 

 

$

5,067

 

 

 

 

 

 

 

 

41


 

 

27. Commitments and contingencies

 

Capital commitments

 

As of December 31, 2018 and September 30, 2019, the Company has committed to spend $4,859 and $8,246, respectively, under agreements to purchase property, plant and equipment. This amount is net of capital advances paid in respect of these purchases.

 

Bank guarantees

 

The Company has outstanding bank guarantees amounting to $9,487 and $9,609 as of December 31, 2018 and September 30, 2019, respectively. Bank guarantees are generally provided to government agencies and excise and customs authorities for the purpose of maintaining a bonded warehouse. These guarantees may be revoked if the government agencies suffer any losses or damages through the breach of any of the covenants contained in the agreements governing such guarantees.

 

Other commitments

 

Certain units of our Indian subsidiaries are established as Software Technology Parks of India units or Special Economic Zone (“SEZ”) units under the relevant regulations issued by the Government of India.  These units are exempt from customs and other  duties on imported and indigenous capital goods, stores and spares.  SEZ units are also exempt from the goods and services tax that was introduced in India in 2017.  The Company has undertaken to pay taxes and duties, if any, in respect of capital goods, stores, spares and services consumed duty-free, in the event that certain terms and conditions are not fulfilled.

 

Contingency

 

In February 2019, there was a judicial pronouncement in India with respect to defined contribution benefit payments interpreting certain statutory defined contribution obligations of employees and employers. It is not currently clear whether the interpretation set out in the pronouncement has retrospective application. If applied retrospectively, the interpretation would result in an increase in contributions payable by the Company for past periods for certain of its India-based employees. There are numerous interpretative challenges concerning the retrospective application of the judgment. Due to such challenges and a lack of interpretive guidance, and based on legal advice the Company has obtained on the matter, it is currently impracticable to reliably estimate the timing and amount of any payments the Company may be required to make. Accordingly, the Company plans to obtain further clarity and will evaluate the amount of a potential provision, if any.

 

42


 

 

28. Leases

 

The Company has leased buildings, vehicles, furniture and fixtures, leased lines, computer equipment and servers, and plants, machinery and equipment from various lessors. Certain lease agreements include options to terminate or extend the leases for up to 5 years. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. The components of lease cost for operating and finance leases for the three and nine months ended September 30, 2019 are summarized below:

 

 

Finance lease cost

Three months ended

September 30, 2019

Nine months ended

September 30, 2019

 

Amortization of ROU assets (Note a)

2,326

6,905

 

Interest on lease liabilities (Note b)

698

2,193

 

Operating lease cost (Note c)

18,510

50,538

 

Short-term lease cost (Note c)

128

356

 

Variable lease cost (Note c)

1,113

2,992

 

Total lease cost

$                          22,775

  $                        62,984

 

 

 

 

a)

Included in “depreciation and amortization” in consolidated statements of income.

 

 

b)

Included in “interest income (expense), net” in consolidated statements of income.

 

 

c)

Included in “cost of revenue” and “selling, general and administrative expenses” in consolidated statements of income.

 

ROU assets relating to finance leases of $34,137 as of September 30, 2019 are included in “other assets.”

 

 

Other information

 

Weighted-average remaining lease term—finance leases

 

4.18 years

Weighted-average remaining lease term—operating leases

 

6.99 years

Weighted-average discount rate—finance leases

 

9.23%

Weighted-average discount rate—operating leases

 

6.93%

 

 

 

 

 

 

 

Three months ended

September 30, 2019

 

Nine months ended

September 30, 2019

Cash paid for amounts included in the measurement of lease liabilities

 

 

 

Operating cash flows from finance leases

                $                698

 

  $           2,182

Operating cash flows from operating leases

                $           18,321

 

   $         52,807

Financing cash flows from finance leases

                 $              2,154

 

   $           6,256

 

43


 

 

28. Leases (Continued)

The following table reconciles the undiscounted cash flows for the operating and finance leases at September 30, 2019 to the operating and finance lease liabilities recorded on the balance sheet:

 

Period range

Finance lease

 

Operating lease

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019

 

2,761

 

 

16,940

 

2020

 

10,451

 

 

69,166

 

2021

 

8,225

 

 

64,634

 

2022

 

5,457

 

 

57,066

 

2023

 

4,090

 

 

51,354

 

2024

 

3,548

 

 

42,851

 

Thereafter

 

1,572

 

 

119,458

 

Total lease payments

 

36,104

 

 

421,469

 

Less: Imputed interest

 

5,819

 

 

92,972

 

Total lease liabilities

 

        $           30,285

 

 

        $            328,497

 

 

         

 

 

29. Subsequent Events

 

Acquisition

 

On October 15, 2019, the Company signed a definitive agreement to acquire substantially all the outstanding equity interests in Rightpoint Consulting LLC (“Rightpoint”), an Illinois limited liability company. The closing of the transaction is subject to certain customary closing conditions. Rightpoint is a digital consultancy business with technology at its core.

 

Dividend

 

On October 17, 2019, the Company announced that its Board has declared a dividend for the third quarter of 2019 of $0.085 per common share, which is payable on December 18, 2019 to shareholders of record as of the close of business on December 9, 2019. The declaration of any future dividends will be at the discretion of the Board of Directors.      

 

 

 

 

 

 

 

 

 

 

 

 

 

44


 

 

 

30. Guarantor financial information

In March 2017, the Issuer issued $350,000 aggregate principal amount of 3.70% senior notes in a private offering. See Note 12 for additional information. The issuance is fully and unconditionally guaranteed by the Company. The Company has prepared the following condensed consolidating financial statements, which set forth consolidated financial statements of the Issuer, the Company as parent guarantor and the non-guarantor subsidiaries of the Company, as well as intercompany elimination adjustments relating to intercompany transactions. Investments in subsidiaries have been accounted for using the equity method.

 

 

 


45


 

 


Condensed Consolidating Balance Sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of September 30, 2019

 

 

 

Issuer/

Subsidiary

 

 

Guarantor/Parent

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

14,292

 

 

$

5,068

 

 

$

437,512

 

 

$

 

 

$

456,872

 

Intercompany Accounts receivable, net

 

 

91,478

 

 

 

 

 

 

 

 

 

(91,478

)

 

 

 

Accounts receivable, net

 

 

 

 

 

 

 

 

863,232

 

 

 

 

 

 

863,232

 

Intercompany loans

 

 

664,702

 

 

 

10,900

 

 

 

2,034,993

 

 

 

(2,710,596

)

 

 

 

Intercompany other receivable

 

 

40,040

 

 

 

131,757

 

 

 

141,369

 

 

 

(313,166

)

 

 

 

Prepaid expenses and other current assets

 

 

2,618

 

 

 

1,602

 

 

 

232,541

 

 

 

 

 

 

236,761

 

Total current assets

 

$

813,130

 

 

$

149,327

 

 

$

3,709,647

 

 

$

(3,115,239

)

 

$

1,556,865

 

Property, plant and equipment, net

 

 

203

 

 

 

 

 

 

216,182

 

 

 

 

 

 

216,385

 

Operating lease right-of-use assets

 

 

 

 

 

 

 

 

299,868

 

 

 

 

 

 

299,868

 

Intercompany loans

 

 

100,000

 

 

 

 

 

 

500,000

 

 

 

(600,000

)

 

 

 

Deferred tax assets

 

 

 

 

 

 

 

 

80,583

 

 

 

 

 

 

80,583

 

Investment in subsidiaries

 

 

563,063

 

 

 

3,279,928

 

 

 

623,954

 

 

 

(4,466,945

)

 

 

 

Investment in equity affiliates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intercompany Investment in debentures

 

 

480,023

 

 

 

118,393

 

 

 

 

 

 

(598,416

)

 

 

 

Intercompany other receivable

 

 

 

 

 

57,861

 

 

 

 

 

 

(57,861

)

 

 

 

Intangible assets, net

 

 

 

 

 

 

 

 

162,571

 

 

 

 

 

 

162,571

 

Goodwill

 

 

 

 

 

 

 

 

1,389,487

 

 

 

 

 

 

1,389,487

 

Contract cost assets

 

 

 

 

 

 

 

 

206,503

 

 

 

 

 

 

206,503

 

Other assets

 

 

435

 

 

 

 

 

 

185,064

 

 

 

 

 

 

185,499

 

Total assets

 

$

1,956,854

 

 

$

3,605,510

 

 

$

7,373,859

 

 

$

(8,838,462

)

 

$

4,097,761

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term borrowings

 

$

75,000

 

 

$

 

 

$

170,000

 

 

$

 

 

$

245,000

 

Current portion of Intercompany loans

 

 

229,457

 

 

 

1,965,037

 

 

 

516,102

 

 

 

(2,710,596

)

 

 

 

Current portion of long-term debt

 

 

4,972

 

 

 

 

 

 

28,532

 

 

 

 

 

 

33,504

 

Accounts payable

 

 

176

 

 

 

13

 

 

 

20,765

 

 

 

 

 

 

20,954

 

Intercompany accounts payable

 

 

 

 

 

 

 

 

91,478

 

 

 

(91,478

)

 

 

 

Income taxes payable

 

 

 

 

 

 

 

 

84,537

 

 

 

 

 

 

84,537

 

Intercompany other payable

 

 

54,260

 

 

 

94,452

 

 

 

164,454

 

 

 

(313,166

)

 

 

 

Accrued expenses and other current liabilities

 

 

9,046

 

 

 

5,820

 

 

 

615,286

 

 

 

 

 

 

630,151

 

Operating leases liability

 

 

 

 

 

 

 

 

50,048

 

 

 

 

 

 

50,048

 

Total current liabilities

 

$

372,910

 

 

$

2,065,321

 

 

$

1,741,202

 

 

$

(3,115,239

)

 

$

1,064,194

 

Long-term debt, less current portion

 

 

437,326

 

 

 

 

 

 

513,582

 

 

 

 

 

 

950,908

 

Operating leases liability

 

 

 

 

 

 

 

 

278,449

 

 

 

 

 

 

278,449

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

4,413

 

 

 

 

 

 

4,413

 

Intercompany other payable

 

 

 

 

 

 

 

 

57,861

 

 

 

(57,861

)

 

 

 

Intercompany loans and debenture, less current portion

 

 

500,000

 

 

 

 

 

 

698,416

 

 

 

(1,198,416

)

 

 

 

Other liabilities

 

 

109

 

 

 

136

 

 

 

193,869

 

 

 

 

 

 

194,113

 

Total liabilities

 

$

1,310,345

 

 

$

2,065,457

 

 

$

3,487,792

 

 

$

(4,371,517

)

 

$

2,492,077

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

646,509

 

 

 

1,540,053

 

 

 

3,886,067

 

 

 

(4,466,945

)

 

 

1,605,684

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and equity

 

$

1,956,854

 

 

$

3,605,510

 

 

$

7,373,859

 

 

$

(8,838,462

)

 

$

4,097,761

 

 

 

 

 

 

 

46


 

 

30. Guarantor financial information (continued)

 

Condensed Consolidating Balance Sheet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2018

 

 

 

Issuer/

Subsidiary

 

 

Guarantor/Parent

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

12,797

 

 

$

2,505

 

 

$

353,094

 

 

$

 

 

$

368,396

 

Intercompany accounts receivable, net

 

 

89,958

 

 

 

 

 

 

 

 

 

(89,958

)

 

 

 

Accounts receivable, net

 

 

 

 

 

 

 

 

774,184

 

 

 

 

 

 

774,184

 

Intercompany loans

 

 

447,578

 

 

 

1,300

 

 

 

1,835,608

 

 

 

(2,284,486

)

 

 

 

Intercompany other receivable

 

 

33,224

 

 

 

52,783

 

 

 

117,537

 

 

 

(203,544

)

 

 

 

Prepaid expenses and other current assets

 

 

2,242

 

 

 

1,278

 

 

 

208,957

 

 

 

 

 

 

212,477

 

Total current assets

 

$

585,799

 

 

$

57,866

 

 

$

3,289,380

 

 

$

(2,577,988

)

 

$

1,355,057

 

Property, plant and equipment, net

 

 

388

 

 

 

 

 

 

212,327

 

 

 

 

 

 

212,715

 

Intercompany loans

 

 

100,000

 

 

 

 

 

 

500,000

 

 

 

(600,000

)

 

 

 

Deferred tax assets

 

 

 

 

 

 

 

 

74,566

 

 

 

 

 

 

74,566

 

Investment in subsidiaries

 

 

548,654

 

 

 

3,073,467

 

 

 

557,089

 

 

 

(4,179,210

)

 

 

 

Investment in equity affiliates

 

 

 

 

 

 

 

 

836

 

 

 

 

 

 

836

 

Intercompany investment in debentures

 

 

571,919

 

 

 

50,393

 

 

 

 

 

 

(622,312

)

 

 

 

Intercompany other receivable

 

 

 

 

 

83,169

 

 

 

 

 

 

(83,169

)

 

 

 

Intangible assets, net

 

 

 

 

 

 

 

 

177,087

 

 

 

 

 

 

177,087

 

Goodwill

 

 

 

 

 

 

 

 

1,393,832

 

 

 

 

 

 

1,393,832

 

Contract cost assets

 

 

 

 

 

 

 

 

160,193

 

 

 

 

 

 

160,193

 

Other assets

 

 

682

 

 

 

 

 

 

154,477

 

 

 

 

 

 

155,159

 

Total assets

 

$

1,807,442

 

 

$

3,264,895

 

 

$

6,519,787

 

 

$

(8,062,679

)

 

$

3,529,445

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term borrowings

 

$

100,000

 

 

$

 

 

$

195,000

 

 

$

 

 

$

295,000

 

Current portion of intercompany loans

 

 

128,572

 

 

 

1,849,537

 

 

 

306,377

 

 

 

(2,284,486

)

 

 

 

Current portion of long-term debt

 

 

4,961

 

 

 

 

 

 

28,522

 

 

 

 

 

 

33,483

 

Accounts payable

 

 

1,636

 

 

 

520

 

 

 

40,428

 

 

 

 

 

 

42,584

 

Intercompany accounts payable

 

 

 

 

 

 

 

 

89,958

 

 

 

(89,958

)

 

 

 

Income taxes payable

 

 

 

 

 

 

 

 

33,895

 

 

 

 

 

 

33,895

 

Intercompany other payable

 

 

47,844

 

 

 

70,973

 

 

 

84,727

 

 

 

(203,544

)

 

 

 

Accrued expenses and other current liabilities

 

 

5,248

 

 

 

5,157

 

 

 

560,945

 

 

 

 

 

 

571,350

 

Total current liabilities

 

$

288,261

 

 

$

1,926,187

 

 

$

1,339,852

 

 

$

(2,577,988

)

 

$

976,312

 

Long-term debt, less current portion

 

 

440,665

 

 

 

 

 

 

534,980

 

 

 

 

 

 

975,645

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

8,080

 

 

 

 

 

 

8,080

 

Intercompany other payable

 

 

 

 

 

 

 

 

83,169

 

 

 

(83,169

)

 

 

 

Intercompany loans and debenture, less current portion

 

 

500,000

 

 

 

 

 

 

722,312

 

 

 

(1,222,312

)

 

 

 

Other liabilities

 

 

197

 

 

 

154

 

 

 

164,875

 

 

 

 

 

 

165,226

 

Total liabilities

 

$

1,229,123

 

 

$

1,926,341

 

 

$

2,853,268

 

 

$

(3,883,469

)

 

$

2,125,263

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

578,319

 

 

 

1,338,554

 

 

 

3,666,519

 

 

 

(4,179,210

)

 

 

1,404,182

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and equity

 

$

1,807,442

 

 

$

3,264,895

 

 

$

6,519,787

 

 

$

(8,062,679

)

 

$

3,529,445

 

 


47


 

 

30. Guarantor financial information (continued)

 

Condensed Consolidating Statement of Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30, 2019

 

 

 

Issuer/

Subsidiary

 

 

Parent/

Guarantor

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net revenues

 

$

18,089

 

 

$

 

 

$

888,799

 

 

$

(18,089

)

 

$

888,799

 

Cost of revenue

 

 

 

 

 

 

 

 

573,659

 

 

 

 

 

 

573,659

 

Gross profit

 

$

18,089

 

 

$

 

 

$

315,140

 

 

$

(18,089

)

 

$

315,140

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

2,357

 

 

 

7,915

 

 

 

202,354

 

 

 

(18,089

)

 

 

194,537

 

Amortization of acquired intangible assets

 

 

 

 

 

 

 

 

6,960

 

 

 

 

 

 

6,960

 

Other operating (income) expense, net

 

 

 

 

 

 

 

 

59

 

 

 

 

 

 

59

 

Income (loss) from operations

 

$

15,731

 

 

$

(7,915

)

 

$

105,767

 

 

 

 

 

$

113,584

 

Foreign exchange gains (losses), net

 

 

91

 

 

 

103

 

 

 

6,533

 

 

 

 

 

 

6,727

 

Interest income (expense), net

 

 

(5,275

)

 

 

 

 

 

(4,946

)

 

 

 

 

 

(10,221

)

Intercompany interest income (expense), net

 

 

21,427

 

 

 

(4,048

)

 

 

(17,379

)

 

 

 

 

 

 

Other income (expense), net

 

 

 

 

 

 

 

 

704

 

 

 

 

 

 

704

 

Income (loss) before equity-method investment activity, net and income tax expense

 

$

31,974

 

 

$

(11,860

)

 

$

90,680

 

 

$

 

 

$

110,794

 

Gain (loss) on equity-method investment activity, net

 

 

10,957

 

 

 

99,980

 

 

 

30,311

 

 

 

(141,253

)

 

 

(5

)

Income before income tax expense

 

$

42,932

 

 

$

88,120

 

 

$

120,990

 

 

$

(141,253

)

 

$

110,789

 

Income tax expense

 

 

1,665

 

 

 

 

 

 

21,004

 

 

 

 

 

 

22,669

 

Net income

 

$

41,267

 

 

$

88,120

 

 

$

99,986

 

 

$

(141,253

)

 

$

88,120

 

Net loss attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

41,267

 

 

$

88,120

 

 

$

99,986

 

 

$

(141,253

)

 

$

88,120

 

 

 

Condensed Consolidating Statement of Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30, 2019

 

 

 

Issuer/

Subsidiary

 

 

Parent/

Guarantor

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net revenues

 

$

44,112

 

 

$

 

 

$

2,579,804

 

 

$

(44,112

)

 

$

2,579,804

 

Cost of revenue

 

 

 

 

 

 

 

 

1,664,040

 

 

 

 

 

 

1,664,040

 

Gross profit

 

$

44,112

 

 

$

 

 

$

915,764

 

 

$

(44,112

)

 

$

915,764

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

7,746

 

 

 

22,690

 

 

 

595,927

 

 

 

(44,112

)

 

 

582,251

 

Amortization of acquired intangible assets

 

 

 

 

 

 

 

 

23,565

 

 

 

 

 

 

23,565

 

Other operating (income) expense, net

 

 

 

 

 

 

 

 

90

 

 

 

 

 

 

90

 

Income (loss) from operations

 

$

36,366

 

 

$

(22,690

)

 

$

296,181

 

 

$

 

 

$

309,858

 

Foreign exchange gains (losses), net

 

 

593

 

 

 

70

 

 

 

2,983

 

 

 

 

 

 

3,646

 

Interest income (expense), net

 

 

(16,090

)

 

 

 

 

 

(17,397

)

 

 

 

 

 

(33,487

)

Intercompany interest income (expense), net

 

 

57,869

 

 

 

(13,384

)

 

 

(44,485

)

 

 

 

 

 

 

Other income (expense), net

 

 

30

 

 

 

0

 

 

 

5,037

 

 

 

 

 

 

5,067

 

Income (loss) before equity-method investment activity, net and income tax expense

 

$

78,769

 

 

$

(36,003

)

 

$

242,319

 

 

$

 

 

$

285,084

 

Gain (loss) on equity-method investment activity, net

 

 

13,056

 

 

 

258,686

 

 

 

73,643

 

 

 

(345,402

)

 

 

(16

)

Income before income tax expense

 

$

91,825

 

 

$

222,683

 

 

$

315,963

 

 

$

(345,402

)

 

$

285,068

 

Income tax expense

 

 

5,125

 

 

 

 

 

 

57,260

 

 

 

 

 

 

62,385

 

Net income

 

$

86,700

 

 

$

222,683

 

 

$

258,702

 

 

$

(345,402

)

 

$

222,683

 

Net loss attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

86,700

 

 

$

222,683

 

 

$

258,702

 

 

$

(345,402

)

 

$

222,683

 


48


 

 

30. Guarantor financial information (continued)

 

 

Condensed Consolidating Statement of Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30, 2018

 

 

 

Issuer/

Subsidiary

 

 

Parent/

Guarantor

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net revenues

 

$

13,243

 

 

$

 

 

$

747,978

 

 

$

(13,243

)

 

$

747,978

 

Cost of revenue

 

 

 

 

 

707

 

 

 

480,705

 

 

 

 

 

 

481,412

 

Gross profit

 

$

13,243

 

 

$

(707

)

 

$

267,273

 

 

$

(13,243

)

 

$

266,566

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

4,935

 

 

 

5,154

 

 

 

171,164

 

 

 

(13,243

)

 

 

168,010

 

Amortization of acquired intangible assets

 

 

 

 

 

 

 

 

9,372

 

 

 

 

 

 

9,372

 

Other operating (income) expense, net

 

 

 

 

 

 

 

 

(4,844

)

 

 

 

 

 

(4,844

)

Income (loss) from operations

 

$

8,308

 

 

$

(5,861

)

 

$

91,581

 

 

$

 

 

$

94,028

 

Foreign exchange gains (losses), net

 

 

(299

)

 

 

372

 

 

 

7,377

 

 

 

 

 

 

7,450

 

Interest income (expense), net

 

 

(4,651

)

 

 

 

 

 

(4,488

)

 

 

 

 

 

(9,139

)

Intercompany interest income (expense), net

 

 

18,031

 

 

 

(6,291

)

 

 

(11,740

)

 

 

 

 

 

 

Other income (expense), net

 

 

 

 

 

 

 

 

5,385

 

 

 

 

 

 

5,385

 

Income (loss) before equity-method investment activity, net and income tax expense

 

$

21,389

 

 

$

(11,780

)

 

$

88,115

 

 

$

 

 

$

97,724

 

Gain (loss) on equity-method investment activity, net

 

 

11,069

 

 

 

85,383

 

 

 

19,820

 

 

 

(116,279

)

 

 

(7

)

Income before income tax expense

 

$

32,458

 

 

$

73,603

 

 

$

107,935

 

 

$

(116,279

)

 

$

97,717

 

Income tax expense

 

 

1,567

 

 

 

 

 

 

22,547

 

 

 

 

 

 

24,114

 

Net income

 

$

30,891

 

 

$

73,603

 

 

$

85,388

 

 

$

(116,279

)

 

$

73,603

 

Net loss attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

30,891

 

 

$

73,603

 

 

$

85,388

 

 

$

(116,279

)

 

$

73,603

 

 

 

Condensed Consolidating Statement of Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months ended September 30, 2018

 

 

 

Issuer/

Subsidiary

 

 

Parent/

Guarantor

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

Net revenues

 

$

37,301

 

 

$

 

 

$

2,165,451

 

 

$

(37,301

)

 

$

2,165,451

 

Cost of revenue

 

 

 

 

 

707

 

 

 

1,387,927

 

 

 

 

 

 

1,388,634

 

Gross profit

 

$

37,301

 

 

$

(707

)

 

$

777,524

 

 

$

(37,301

)

 

$

776,817

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

8,936

 

 

 

16,916

 

 

 

526,800

 

 

 

(37,367

)

 

 

515,285

 

Amortization of acquired intangible assets

 

 

48

 

 

 

 

 

 

29,086

 

 

 

 

 

 

29,134

 

Other operating (income) expense, net

 

 

17

 

 

 

 

 

 

(4,930

)

 

 

 

 

 

(4,913

)

Income (loss) from operations

 

$

28,300

 

 

$

(17,623

)

 

$

226,568

 

 

$

66

 

 

$

237,311

 

Foreign exchange gains (losses), net

 

 

862

 

 

 

874

 

 

 

13,317

 

 

 

 

 

 

15,053

 

Interest income (expense), net

 

 

(11,629

)

 

 

 

 

 

(16,017

)

 

 

 

 

 

(27,646

)

Intercompany interest income (expense), net

 

 

58,156

 

 

 

(13,594

)

 

 

(44,562

)

 

 

 

 

 

 

Other income (expense), net

 

 

 

 

 

 

 

 

30,683

 

 

 

 

 

 

30,683

 

Income (loss) before equity-method investment activity, net and income tax expense

 

$

75,689

 

 

$

(30,343

)

 

$

209,989

 

 

$

66

 

 

$

255,401

 

Gain (loss) on equity-method investment activity, net

 

 

22,100

 

 

 

233,215

 

 

 

81,864

 

 

 

(337,201

)

 

 

(22

)

Income before income tax expense

 

$

97,789

 

 

$

202,872

 

 

$

291,853

 

 

$

(337,135

)

 

$

255,379

 

Income tax expense

 

 

4,854

 

 

 

 

 

 

48,414

 

 

 

 

 

 

53,268

 

Net income

 

$

92,935

 

 

$

202,872

 

 

$

243,439

 

 

$

(337,135

)

 

$

202,111

 

Net loss attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

(761

)

 

 

 

 

 

(761

)

Net income attributable to Genpact Limited shareholders

 

$

92,935

 

 

$

202,872

 

 

$

244,200

 

 

$

(337,135

)

 

$

202,872

 

 

 

49


 

 

30. Guarantor financial information (continued)

 

Condensed Consolidating Statement of Comprehensive Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30,  2019

 

 

Issuer/ Subsidiary

 

 

Parent/ Guarantor

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Genpact Limited Shareholders

 

 

Redeemable Non-controlling interest

 

Net income (loss)

$

41,267

 

 

$

88,121

 

 

$

99,986

 

 

$

(141,253

)

 

$

88,120

 

 

$

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation adjustments

 

(21,772

)

 

 

(39,404

)

 

 

(39,404

)

 

 

61,175

 

 

 

(39,404

)

 

$

 

Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)

 

1,485

 

 

 

(11,360

)

 

 

(11,360

)

 

 

9,875

 

 

 

(11,360

)

 

 

 

Retirement benefits, net of taxes

 

54

 

 

 

346

 

 

 

346

 

 

 

(400

)

 

 

346

 

 

$

 

Other comprehensive income (loss)

 

(20,233

)

 

 

(50,418

)

 

 

(50,418

)

 

 

70,650

 

 

 

(50,418

)

 

 

 

Comprehensive income (loss)

$

21,034

 

 

$

37,703

 

 

$

49,569

 

 

$

(70,603

)

 

$

37,702

 

 

$

 

 

 

 

 

Nine months ended September 30, 2019

 

 

Issuer/ Subsidiary

 

 

Parent/ Guarantor

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Genpact Limited Shareholders

 

 

Redeemable Non-controlling interest

 

Net income (loss)

$

86,700

 

 

$

222,683

 

 

$

258,702

 

 

$

(345,402

)

 

$

222,683

 

 

$

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation adjustments

 

(14,307

)

 

 

(24,677

)

 

 

(24,677

)

 

 

38,984

 

 

 

(24,677

)

 

$

 

Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)

 

(53

)

 

 

1,683

 

 

 

1,683

 

 

 

(1,630

)

 

 

1,683

 

 

 

 

Retirement benefits, net of taxes

 

63

 

 

 

773

 

 

 

773

 

 

 

(836

)

 

 

773

 

 

$

 

Other comprehensive income (loss)

 

(14,297

)

 

 

(22,221

)

 

 

(22,221

)

 

 

36,518

 

 

 

(22,221

)

 

 

 

Comprehensive income (loss)

$

72,403

 

 

$

200,462

 

 

$

236,481

 

 

$

(308,885

)

 

$

200,462

 

 

$

 

 

 

Three months ended September 30,  2018

 

 

Issuer/ Subsidiary

 

 

Parent/ Guarantor

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Genpact Limited Shareholders

 

 

Redeemable Non-controlling interest

 

Net income (loss)

$

30,891

 

 

$

73,603

 

 

$

85,388

 

 

$

(116,279

)

 

$

73,603

 

 

$

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation adjustments

 

(35,035

)

 

 

(58,134

)

 

 

(58,134

)

 

 

93,169

 

 

 

(58,134

)

 

 

 

Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)

 

(29,242

)

 

 

(28,918

)

 

 

(28,918

)

 

 

58,160

 

 

 

(28,918

)

 

 

 

Retirement benefits, net of taxes

 

(6

)

 

 

692

 

 

 

692

 

 

 

(686

)

 

 

692

 

 

 

 

Other comprehensive income (loss)

 

(64,283

)

 

 

(86,360

)

 

 

(86,360

)

 

 

150,643

 

 

 

(86,360

)

 

 

 

Comprehensive income (loss)

$

(33,392

)

 

$

(12,757

)

 

$

(972

)

 

$

34,364

 

 

$

(12,757

)

 

$

 

 

 

 

Nine months ended September 30,  2018

 

 

 

Issuer/ Subsidiary

 

 

Parent/ Guarantor

 

 

Non-Guarantor Subsidiaries

 

 

Eliminations

 

 

Genpact Limited Shareholders

 

 

Redeemable Non-controlling interest

 

Net income (loss)

$

92,935

 

 

$

202,872

 

 

$

244,200

 

 

$

(337,135

)

 

$

202,872

 

 

$

(761

)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation adjustments

 

(88,743

)

 

 

(141,150

)

 

 

(141,150

)

 

 

229,893

 

 

 

(141,150

)

 

 

(424

)

Net income (loss) on cash flow hedging derivatives, net of taxes (Note 7)

 

(71,352

)

 

 

(75,729

)

 

 

(74,279

)

 

 

145,631

 

 

 

(75,729

)

 

 

 

Retirement benefits, net of taxes

 

67

 

 

 

1,822

 

 

 

1,198

 

 

 

(1,265

)

 

 

1,822

 

 

 

 

Other comprehensive income (loss)

 

(160,028

)

 

 

(215,057

)

 

 

(214,231

)

 

 

374,259

 

 

 

(215,057

)

 

 

(424

)

Comprehensive income (loss)

$

(67,093

)

 

$

(12,185

)

 

$

29,969

 

 

$

37,124

 

 

$

(12,185

)

 

$

(1,185

)


50


 

 

30. Guarantor financial information (continued)

 

Condensed Consolidating Statement of Cash Flow

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September  30,  2019

 

 

 

Issuer/

Subsidiary

 

 

Parent/

Guarantor

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash (used for) provided by operating activities

 

$

(148,906

)

 

$

(15,281

)

 

$

79,397

 

 

$

426,110

 

 

$

341,319

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

 

 

 

 

 

 

(55,072

)

 

 

 

 

 

(55,071

)

Payment for internally generated intangible assets (including intangibles under development)

 

 

 

 

 

 

 

 

(26,261

)

 

 

 

 

 

(26,261

)

Proceeds from sale of property, plant and equipment

 

 

 

 

 

 

 

 

1,621

 

 

 

 

 

 

1,621

 

Investment in subsidiaries

 

 

(6,848

)

 

 

 

 

 

 

 

 

6,848

 

 

 

 

Dividend received

 

 

 

 

 

30,000

 

 

 

 

 

 

(30,000

)

 

 

 

Payment for purchase of bonds, intercompany

 

 

 

 

 

(103,100

)

 

 

 

 

 

103,100

 

 

 

 

Proceeds from redemption of debentures, intercompany

 

 

86,818

 

 

 

35,100

 

 

 

 

 

 

(121,918

)

 

 

 

Payment for business acquisitions, net of cash acquired

 

 

 

 

 

 

 

 

(6,305

)

 

 

 

 

 

(6,305

)

Payment for purchase of redeemable non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash (used for) provided by investing activities

 

$

79,970

 

 

$

(38,000

)

 

 

(86,017

)

 

$

(41,970

)

 

$

(86,016

)

Financing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayment of capital lease obligations

 

 

 

 

 

 

 

 

(6,256

)

 

 

 

 

 

(6,256

)

Proceeds from long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayment of long-term debt

 

 

(3,750

)

 

 

 

 

 

(21,750

)

 

 

 

 

 

(25,500

)

Proceeds from short-term borrowings

 

 

 

 

 

 

 

 

50,000

 

 

 

 

 

 

50,000

 

Repayment of short-term borrowings

 

 

(25,000

)

 

 

 

 

 

(75,000

)

 

 

 

 

 

(100,000

)

Proceeds from intercompany loans

 

 

105,885

 

 

 

122,500

 

 

 

245,037

 

 

 

(473,422

)

 

 

 

Repayment of intercompany loans

 

 

(5,000

)

 

 

(7,000

)

 

 

(35,312

)

 

 

47,312

 

 

 

 

Proceeds from issuance of common shares under stock-based compensation plans

 

 

 

 

 

15,949

 

 

 

 

 

 

 

 

 

15,949

 

Proceeds from issuance of common shares

 

 

 

 

 

 

 

 

6,848

 

 

 

(6,848

)

 

 

 

Payment for net settlement of stock-based awards

 

 

 

 

 

(3,177

)

 

 

 

 

 

 

 

 

(3,177

)

Payment of earn-out/deferred consideration

 

 

 

 

 

 

 

 

(12,790

)

 

 

 

 

 

(12,790

)

Dividend paid

 

 

 

 

 

(48,515

)

 

 

(30,000

)

 

 

30,000

 

 

 

(48,515

)

Payment for stock repurchased and retired

 

 

 

 

 

(23,901

)

 

 

 

 

 

 

 

 

(23,901

)

Payment for expenses related to stock repurchase

 

 

 

 

 

(12

)

 

 

 

 

 

 

 

 

(12

)

Proceeds from issuance of bonds, intercompany

 

 

 

 

 

 

 

 

103,100

 

 

 

(103,100

)

 

 

 

Payment for redemption of debentures, intercompany

 

 

 

 

 

 

 

 

(121,918

)

 

 

121,918

 

 

 

 

Net cash (used for) provided by financing activities

 

$

72,134

 

 

$

55,844

 

 

$

101,959

 

 

$

(384,140

)

 

$

(154,202

)

Effect of exchange rate changes

 

 

(1,703

)

 

-

 

 

 

(10,922

)

 

 

 

 

 

(12,625

)

Net increase (decrease) in cash and cash equivalents

 

 

3,198

 

 

 

2,563

 

 

 

95,340

 

 

 

 

 

 

101,101

 

Cash and cash equivalents at the beginning of the period

 

 

12,797

 

 

 

2,505

 

 

 

353,094

 

 

 

 

 

 

368,396

 

Cash and cash equivalents at the end of the period

 

$

14,292

 

 

$

5,068

 

 

$

437,512

 

 

$

 

 

$

456,872

 

 


51


 

 

30. Guarantor financial information (continued)

 

Condensed Consolidating Statement of Cash Flow

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30,  2018

 

 

 

Issuer/

Subsidiary

 

 

Parent/

Guarantor

 

 

Non-

Guarantor

Subsidiaries

 

 

Eliminations

 

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash (used for) provided by operating activities

 

$

(169,540

)

 

$

(896

)

 

$

(9,110

)

 

$

382,352

 

 

$

202,806

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(1

)

 

 

 

 

 

(68,026

)

 

 

 

 

 

(68,027

)

Payment for internally generated intangible assets

 

 

 

 

 

 

 

 

(19,397

)

 

 

 

 

 

(19,397

)

Proceeds from sale of property, plant and equipment

 

 

 

 

 

 

 

 

499

 

 

 

 

 

 

499

 

Investment in equity affiliates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in subsidiaries

 

 

(109,759

)

 

 

 

 

 

8,861

 

 

 

100,898

 

 

 

 

Proceeds from redemption of debentures, intercompany

 

 

91,761

 

 

 

 

 

 

 

 

 

(91,761

)

 

 

 

Payment for business acquisitions, net of cash acquired

 

 

 

 

 

 

 

 

(108,105

)

 

 

 

 

 

(108,105

)

Payment for purchase of redeemable non-controlling interest

 

 

 

 

 

 

 

 

(4,730

)

 

 

 

 

 

(4,730

)

Net cash (used for) provided by investing activities

 

$

(17,999

)

 

$

 

 

$

(190,898

)

 

$

9,137

 

 

$

(199,760

)

Financing activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repayment of capital lease obligations

 

 

 

 

 

 

 

 

(1,954

)

 

 

 

 

 

(1,954

)

Payment of debt issuance costs

 

 

 

 

 

 

 

 

(4,293

)

 

 

 

 

 

(4,293

)

Proceeds from long-term debt

 

 

100,000

 

 

 

 

 

 

29,186

 

 

 

 

 

 

129,186

 

Repayment of long-term debt

 

 

(1,225

)

 

 

 

 

 

(156,461

)

 

 

 

 

 

(157,686

)

Proceeds from short-term borrowings

 

 

100,000

 

 

 

 

 

 

125,000

 

 

 

 

 

 

225,000

 

Repayment of short-term borrowings

 

 

 

 

 

 

 

 

(65,000

)

 

 

 

 

 

(65,000

)

Proceeds from intercompany loans

 

 

58,638

 

 

 

226,500

 

 

 

298,467

 

 

 

(583,605

)

 

 

 

Repayment of intercompany loans

 

 

(62,979

)

 

 

(51,500

)

 

 

(86,839

)

 

 

201,318

 

 

 

 

Proceeds from issuance of common shares under stock-based compensation plans

 

 

 

 

 

12,275

 

 

 

100,963

 

 

 

(100,963

)

 

 

12,275

 

Payment for net settlement of stock-based awards

 

 

 

 

 

(14,947

)

 

 

 

 

 

 

 

 

(14,947

)

Payment of earn-out/deferred consideration

 

 

 

 

 

 

 

 

(1,559

)

 

 

 

 

 

(1,559

)

Dividend paid

 

 

 

 

 

(42,901

)

 

 

 

 

 

 

 

 

(42,901

)

Payment for stock repurchased and retired

 

 

 

 

 

(130,103

)

 

 

 

 

 

 

 

 

(130,103

)

Payment for expenses related to stock repurchase

 

 

 

 

 

(82

)

 

 

 

 

 

 

 

 

(82

)

Payment for redemption of debentures, intercompany

 

 

 

 

 

 

 

 

(91,761

)

 

 

91,761

 

 

 

 

Net cash (used for) provided by financing activities

 

$

194,434

 

 

$

(758

)

 

$

145,749

 

 

$

(391,489

)

 

$

(52,064

)

Effect of exchange rate changes

 

 

(5,375

)

 

 

 

 

 

(48,845

)

 

 

 

 

 

(54,220

)

Net increase (decrease) in cash and cash equivalents

 

 

6,895

 

 

 

(1,654

)

 

 

(54,259

)

 

 

 

 

 

(49,018

)

Cash and cash equivalents at the beginning of the period

 

 

4,507

 

 

 

2,136

 

 

 

497,825

 

 

 

 

 

 

504,468

 

Cash and cash equivalents at the end of the period

 

$

6,027

 

 

$

482

 

 

$

394,721

 

 

$

 

 

$

401,230

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

52


 

 

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our consolidated financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2018 and with the information under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2018. In addition to historical information, this discussion includes forward-looking statements and information that involves risks, uncertainties and assumptions, including but not limited to those listed below and under “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 and our Annual Report on Form 10-K for the year ended December 31, 2018.

Special Note Regarding Forward-Looking Statements

We have made statements in this Quarterly Report on Form 10-Q (the “Quarterly Report”) in, among other sections, Part I, Item 2—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” that are forward-looking statements. In some cases, you can identify these statements by forward-looking terms such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “could,” “may,” “shall,” “will,” “would” and variations of such words and similar expressions, or the negative of such words or similar expressions. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, which in some cases may be based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. In particular, you should consider the numerous risks outlined in Part II, Item 1A—“Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 and Part I, Item 1A—“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018.

These forward-looking statements include, but are not limited to, statements relating to:

 

our ability to retain existing clients and contracts;

 

our ability to win new clients and engagements;

 

the expected value of the statements of work under our master service agreements;

 

our beliefs about future trends in our market;

 

political, economic or business conditions in countries where we have operations or where our clients operate, including the uncertainty related to the proposed withdrawal of the United Kingdom from the European Union, commonly known as Brexit, and heightened economic and political uncertainty within and among other European Union member states;

 

expected spending on business process outsourcing and information technology services by clients;

 

foreign currency exchange rates;

 

our ability to convert bookings to revenue;

 

our rate of employee attrition;

 

our effective tax rate; and

 

competition in our industry.

Factors that may cause actual results to differ from expected results include, among others:

 

our ability to develop and successfully execute our business strategies;

 

our ability to grow our business and effectively manage growth and international operations while maintaining effective internal controls;

 

our dependence on favorable policies and tax laws that may be changed or amended in a manner adverse to us or be unavailable to us in the future, including as a result of recently adopted tax legislation in the United States, and our ability to effectively execute our tax planning strategies;

53


 

 

 

our ability to comply with data protection laws and regulations and to maintain the security and confidentiality of personal and other sensitive data of our clients, employees or others;

 

our dependence on revenues derived from clients in the United States and Europe and clients that operate in certain industries, such as the financial services industry;

 

our ability to successfully consummate or integrate strategic acquisitions;

 

our ability to maintain pricing and asset utilization rates;

 

our ability to hire and retain enough qualified employees to support our operations;

 

increases in wages in locations in which we have operations;

 

our ability to service our defined contribution and benefit plan payment obligations;

 

clarification as to the possible retrospective application of a judicial pronouncement in India regarding our defined contribution and benefit plan payment obligations;

 

our relative dependence on the General Electric Company (“GE”) and our ability to maintain our relationships with divested GE businesses;

 

financing terms, including, but not limited to, changes in the London Interbank Offered rate, or LIBOR, including the pending global phase-out of LIBOR, and changes to our credit ratings;

 

our ability to meet our corporate funding needs, pay dividends and service debt, including our ability to comply with the restrictions that apply to our indebtedness that may limit our business activities and investment opportunities;

 

restrictions on visas for our employees traveling to North America and Europe;

 

fluctuations in currency exchange rates between the currencies in which we transact business, primarily the U.S. dollar, Australian dollar, Chinese renminbi, Euro, Indian rupee, Japanese yen, Mexican peso, Philippine peso, Polish zloty, Romanian leu, Hungarian Forint and U.K. pound sterling;

 

our ability to retain senior management;

 

the selling cycle for our client relationships;

 

our ability to attract and retain clients and our ability to develop and maintain client relationships on attractive terms;

 

legislation in the United States or elsewhere that adversely affects the performance of business process outsourcing and information technology services offshore;

 

increasing competition in our industry;

 

telecommunications or technology disruptions or breaches, cyberattacks or natural or other disasters;

 

our ability to protect our intellectual property and the intellectual property of others;

 

deterioration in the global economic environment and its impact on our clients, including the bankruptcy of our clients;

 

regulatory, legislative and judicial developments, including the withdrawal of governmental fiscal incentives;

 

the international nature of our business;

 

technological innovation;

 

our ability to derive revenues from new service offerings and acquisitions; and

 

unionization of any of our employees.

Although we believe the expectations reflected in the forward-looking statements are reasonable at the time they are made, we cannot guarantee future results, level of activity, performance or achievements. Achievement of future results is subject to risks, uncertainties, and potentially inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements.

54


 

 

We undertake no obligation to update any of these forward-looking statements after the date of this filing to conform our prior statements to actual results or revised expectations. You are advised, however, to consult any further disclosures we make on related subjects in our Form 10-K, Form 10-Q and Form 8-K reports to the Securities and Exchange Commission, or the SEC.

Overview

We are a global professional services firm that focuses on business transformation. We drive digital-led innovation and run digitally-enabled intelligent operations for our clients, guided by our experience running thousands of processes for hundreds of Fortune Global 500 clients. We have over 93,000 employees serving clients in key industry verticals from more than 30 countries. Our registered office is located at Victoria Place, 5th Floor, 31 Victoria Street, Hamilton HM 10, Bermuda.

In the quarter ended September 30, 2019, we had net revenues of $888.8 million, of which $767.7 million, or 86.4%, was from clients other than GE, which we refer to as Global Clients, with the remaining $121.1 million, or 13.6%, coming from GE.

Acquisitions

 

On January 7, 2019, we acquired 100% of the outstanding equity interest in riskCanvas Holdings, LLC, a Delaware limited liability company, for total purchase consideration of $5.75 million. This amount includes cash consideration of $5.7 million, net of adjustments for working capital. This acquisition expands our services in the areas of financial institution fraud, anti-money laundering and financial transaction surveillance and enhances our consulting capabilities for clients in the financial services industry. Goodwill arising from the acquisition amounted to $2.5 million, which has been allocated to our India reporting unit and is deductible for tax purposes. The goodwill represents primarily the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with our existing operations.

 

On August 30, 2018, we acquired 100% of the outstanding equity/partnership interests in Barkawi Management Consultants GmbH & Co. KG, a German limited partnership, and certain affiliated entities in the United States, Germany and Austria for total purchase consideration of $101.3 million. This amount includes cash consideration of $95.6 million, net of cash acquired of $5.7 million. This acquisition enhances our supply chain management consulting capabilities. Goodwill arising from the acquisition amounted to $79.9 million, which has been allocated to our India reporting unit and is partially deductible for tax purposes. The goodwill represents primarily the acquired consulting expertise, operating synergies and other benefits expected to result from combining the acquired operations with those of our existing operations.

 

On July 3, 2018, we acquired 100% of the outstanding equity interest in Commonwealth Informatics Inc., a Massachusetts corporation, for purchase consideration of $17.9 million. This amount includes cash consideration of $16.1 million, net of cash acquired of $1.5 million, and adjustments for working capital and indebtedness. This acquisition enhances our signal management and pharmacovigilance capabilities for clients in the life sciences industry. Goodwill arising from the acquisition amounted to $11.6 million, which has been allocated to our India reporting unit and is deductible for tax purposes. The goodwill represents primarily the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with our existing operations.

Secondary Offerings

On February 15, 2019, we completed a secondary offering of our common shares, pursuant to which certain of our shareholders affiliated with Bain Capital Investors, LLC, namely Glory Investments A Limited and its affiliated assignees, together with their co-investor, GIC Private Limited (collectively, the “Selling Shareholders”), sold 10.0 million common shares at a price of $32.215 per share in an underwritten public offering, with Goldman Sachs & Co. acting as the sole underwriter. All of the common shares were sold by the Selling Shareholders and, as a result, we did not receive any of the proceeds from the offering.

55


 

 

On May 24, 2019, we completed a secondary offering of our common shares, pursuant to which certain of our shareholders affiliated with Bain Capital Investors, LLC, namely Glory Investments A Limited and its affiliated assignees, together with their co-investor, GIC Private Limited (collectively, the “Selling Shareholders”), sold 10.0 million common shares at a price of $36.01 per share in an underwritten public offering, with Citigroup Global Markets, Inc. acting as the sole underwriter. All of the common shares were sold by the Selling Shareholders and, as a result, we did not receive any of the proceeds from the offering.

On August 16, 2019, we completed a secondary offering of our common shares, pursuant to which certain of our shareholders affiliated with Bain Capital Investors, LLC, namely Glory Investments A Limited and its affiliated assignees, together with their co-investor, GIC Private Limited (collectively, the “Selling Shareholders”), sold 12.5 million common shares at a price of $40.59 per share in an underwritten public offering, with Goldman Sachs & Co. LLC acting as the sole underwriter. All of the common shares were sold by the Selling Shareholders and, as a result, we did not receive any of the proceeds from the offering.

Critical Accounting Policies and Estimates

For a description of our critical accounting policies, see Note 2—“Summary of significant accounting policies” under Part I, Item 1—“ Unaudited Consolidated Financial Statements” above, Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates,” and Note 2—“Summary of significant accounting policies” under Part IV, Item 15—“Exhibits and Financial Statement Schedules” in our Annual Report on Form 10-K for the year ended December 31, 2018.

We adopted the new accounting standard for leases effective January 1, 2019, using the modified retrospective adoption approach. For further discussion and additional disclosure regarding our adoption of this standard, see Note 2 “Summary of significant accounting policies” and Note 28 — “Leases” under Part I, Item 1— “Unaudited Consolidated Financial Statements” above.

56


 

 

Results of Operations

The following table sets forth certain data from our consolidated statements of income for the three and nine months ended September 30, 2018 and 2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase/(Decrease)

 

 

 

 

Three months ended 

September 30,

 

 

Nine months ended September 30,

 

 

 

Three months

ended September 30,

 

 

 

Nine months

ended September 30,

 

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

 

2019 vs. 2018

 

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues—GE

 

$

64.5

 

 

$

121.1

 

 

$

188.0

 

 

$

348.7

 

 

 

 

87.7

 

%

 

 

85.5

 

%

Net revenues—Global Clients

 

 

683.5

 

 

 

767.7

 

 

 

1,977.5

 

 

 

2,231.1

 

 

 

 

12.3

 

%

 

 

12.8

 

%

Total net revenues

 

 

748.0

 

 

 

888.8

 

 

 

2,165.5

 

 

 

2,579.8

 

 

 

 

18.8

 

%

 

 

19.1

 

%

Cost of revenue

 

 

481.4

 

 

 

573.7

 

 

 

1,388.6

 

 

 

1,664.0

 

 

 

 

19.2

 

%

 

 

19.8

 

%

Gross profit

 

 

266.6

 

 

 

315.1

 

 

 

776.8

 

 

 

915.8

 

 

 

 

18.2

 

%

 

 

17.9

 

%

Gross profit margin

 

 

35.6

 

%

 

35.5

 

%

 

35.9

 

%

 

35.5

 

%

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

168.0

 

 

 

194.5

 

 

 

515.3

 

 

 

582.3

 

 

 

 

15.8

 

%

 

 

13.0

 

%

Amortization of acquired intangible assets

 

 

9.4

 

 

 

7.0

 

 

 

29.1

 

 

 

23.6

 

 

 

 

(25.7

)

%

 

 

(19.1

)

%

Other operating (income) expense, net

 

 

(4.8)

 

 

 

0.1

 

 

 

(4.9

)

 

 

0.1

 

 

 

 

(101.2

)

%

 

 

(101.8

)

%

Income from operations

 

 

94.0

 

 

 

113.6

 

 

 

237.3

 

 

 

309.9

 

 

 

 

20.8

 

%

 

 

30.6

 

%

Income from operations as a percentage of net revenues

 

 

12.6

 

%

 

12.8

 

%

 

11.0

 

%

 

12.0

 

%

 

 

 

 

 

 

 

 

 

 

Foreign exchange gains (losses), net

 

 

7.5

 

 

 

6.7

 

 

 

15.1

 

 

 

3.6

 

 

 

 

(9.7

)

%

 

 

(75.8

)

%

Interest income (expense), net

 

 

(9.1

)

 

 

(10.2

)

 

 

(27.6

)

 

 

(33.5

)

 

 

 

11.8

 

%

 

 

21.1

 

%

Other income (expense), net

 

 

5.4

 

 

 

0.7

 

 

 

30.7

 

 

 

5.1

 

 

 

 

(86.9

)

%

 

 

(83.5

)

%

Income before equity-method investment activity, net and income tax expense

 

 

97.7

 

 

 

110.8

 

 

 

255.4

 

 

 

285.1

 

 

 

 

13.4

 

%

 

 

11.6

 

%

Equity-method investment activity, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

%

 

 

 

%

Income before income tax expense

 

 

97.7

 

 

 

110.8

 

 

 

255.4

 

 

 

285.1

 

 

 

 

13.4

 

%

 

 

11.6

 

%

Income tax expense

 

 

24.1

 

 

 

22.7

 

 

 

53.3

 

 

 

62.4

 

 

 

 

(6.0

)

%

 

 

17.1

 

%

Net income

 

 

73.6

 

 

 

88.1

 

 

 

202.1

 

 

 

222.7

 

 

 

 

19.7

 

%

 

 

10.2

 

%

Net income attributable to redeemable non-controlling interest

 

 

 

 

 

 

 

 

0.8

 

 

 

 

 

 

 

 

%

 

 

(100.0

)

%

Net income attributable to Genpact Limited common shareholders

 

$

73.6

 

 

$

88.1

 

 

$

202.9

 

 

$

222.7

 

 

 

 

19.7

 

%

 

 

9.8

 

%

Net income attributable to Genpact Limited common shareholders as a percentage of net revenues

 

 

9.8

 

%

 

9.9

 

%

 

9.4

 

%

 

8.6

 

%

 

 

 

 

 

 

 

 

 

 

 

57


 

 

Three Months Ended September 30, 2019 Compared to the Three Months Ended September 30, 2018

Net revenues. Our net revenues were $888.8 million in the third quarter of 2019, up $140.8 million, or 18.8%, from $748.0 million in the third quarter of 2018. The growth in our net revenues was driven primarily by an increase in business process outsourcing, or BPO, services delivered both to Global Clients and GE, in particular our transformation services (analytics, consulting and digital), including incremental revenues associated with recent large deals. Adjusted for foreign exchange, primarily the impact of changes in the value of the euro and the U.K. pound sterling against the U.S. dollar, our net revenues grew 19% compared to the third quarter of 2018 on a constant currency basis. Revenue growth on a constant currency basis is a non-GAAP measure. We provide information about our revenue growth on a constant currency basis so that our revenue may be viewed without the impact of foreign currency exchange rate fluctuations, thereby facilitating period-to-period comparisons of our business performance. Total net revenues on a constant currency basis are calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates and are adjusted for hedging gains/(losses).

Our average headcount increased by 15.4% to approximately 92,900 in the third quarter of 2019 from approximately 80,500 in the third quarter of 2018.

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Three months ended September 30,

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

 

 

Global Clients:

 

 

 

 

 

 

 

 

 

 

 

 

 

BPO services

 

$

585.8

 

 

$

666.1

 

 

 

13.7

 

%

IT services

 

 

97.7

 

 

 

101.6

 

 

 

4.0

 

 

Total net revenues from Global Clients

 

$

683.5

 

 

$

767.7

 

 

 

12.3

 

%

GE:

 

 

 

 

 

 

 

 

 

 

 

BPO services

 

 

37.2

 

 

 

83.2

 

 

 

124.0

 

%

IT services

 

 

27.3

 

 

 

37.9

 

 

 

38.4

 

 

Total net revenues from GE

 

$

64.5

 

 

$

121.1

 

 

 

87.7

 

%

Total net revenues from BPO services

 

 

622.9

 

 

 

749.3

 

 

 

20.3

 

%

Total net revenues from IT services

 

 

125.0

 

 

 

139.5

 

 

 

11.5

 

 

Total net revenues

 

$

748.0

 

 

$

888.8

 

 

 

18.8

 

%

 

Net revenues from Global Clients in the third quarter of 2019 were $767.7 million, up $84.2 million, or 12.3%, from $683.5 million in the third quarter of 2018. This increase was primarily driven by growth in several of our verticals, including capital markets, high tech, banking and financial services and consumer goods. As a percentage of total net revenues, net revenues from Global Clients decreased from 91.4% in the third quarter of 2018 to 86.4% in the third quarter of 2019 due to the significant growth in GE revenues.

Net revenues from GE in the third quarter of 2019 were $121.1 million, up $56.6 million, or 87.7%, from the third quarter of 2018, driven by services delivered in connection with a large new contract signed in the fourth quarter of 2018, as well as an increase in transformation services project engagements in the third quarter of 2019. Net revenues from GE increased as a percentage of our total net revenues from 8.6% in the third quarter of 2018 to 13.6% in the third quarter of 2019.

Net revenues from BPO services in the third quarter of 2019 were $749.3 million, up $126.4 million, or 20.3%, from $622.9 million in the third quarter of 2018. This increase was primarily attributable to an increase in transformation services, in particular those services associated with large deals signed in the fourth quarter of 2018 and the first quarter of 2019, and growth in several of our verticals, including capital markets, high tech, manufacturing and services, banking and financial services and consumer goods. Net revenues from IT services were $139.5 million in the third quarter of 2019, up $14.4 million, or 11.5%, from $125.0 million in the third quarter of 2018.

Net revenues from BPO services as a percentage of total net revenues increased to 84.3% in the third quarter of 2019 from 83.3% in the third quarter of 2018, with a corresponding decline in the percentage of total net revenues attributable to IT services.

58


 

 

Cost of revenue and gross margin. The following table sets forth the components of our cost of revenue and the resulting gross margin:

 

 

 

Three Months Ended September 30,

 

 

As a Percentage of Total Net Revenues

 

 

 

 

2018

 

 

2019

 

 

2018

 

 

 

2019

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

 

 

 

Personnel expenses

 

$

326.7

 

 

$

422.5

 

 

 

43.7

 

%

 

 

47.5

 

%

Operational expenses

 

 

141.2

 

 

 

129.3

 

 

 

18.9

 

 

 

 

14.5

 

 

Depreciation and amortization

 

13.5

 

 

 

21.9

 

 

 

1.8

 

 

 

 

2.5

 

 

Cost of revenue

 

$

481.4

 

 

$

573.7

 

 

 

64.4

 

%

 

 

64.5

 

%

Gross margin

 

 

35.6

%

 

 

35.5

%

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue was $573.7 million in the third quarter of 2019, up $92.3 million, or 19.2%, from the third quarter of 2018. Increases in our operational headcount, including in the number of onshore personnel, for transformation services delivery and additional headcount from large deals, wage inflation and higher stock-based compensation expense contributed to the increase in cost of revenue, partially offset by lower consultancy charges and improved utilization of transformation services resources in the third quarter of 2019 compared to the third quarter of 2018.

 

Our gross margin decreased from 35.6% in the third quarter of 2018 to 35.5% in the third quarter of 2019, driven primarily by lower initial gross margins associated with large new deals and an increase in stock-based compensation expense, partially offset by improved utilization of transformation services resources and improved operating leverage.

Personnel expenses. Personnel expenses as a percentage of total net revenues increased from 43.7% in the third quarter of 2018 to 47.5% in the third quarter of 2019. Personnel expenses in the third quarter of 2019 were $422.5 million, up $95.8 million, or 29.3%, from $326.7 million in the third quarter of 2018. A 15.3% net increase in our operational headcount, including an increase in the number of onshore personnel, particularly related to large new deals and transformation services delivery, the impact of wage inflation and higher stock-based compensation expense resulted in higher personnel expenses in the third quarter of 2019 compared to the third quarter of 2018.

Operational expenses. Operational expenses as a percentage of total net revenues decreased from 18.9% in the third quarter of 2018 to 14.5% in the third quarter of 2019, largely due to improved operational efficiencies and the other factors described below. Operational expenses in the third quarter of 2019 were $129.3 million, down $11.9 million, or 8.5%, from the third quarter of 2018, primarily due to lower contractor costs and a reduction in communication expenses.

Depreciation and amortization expenses. Depreciation and amortization expenses as a percentage of total net revenues increased from 1.8% in the third quarter of 2018 to 2.5% in the third quarter of 2019. Depreciation and amortization expenses as a component of cost of revenue were $21.9 million, up $8.4 million, or 62.4%, from the third quarter of 2018. This increase was primarily due to the expansion of certain existing facilities, the acquisition of new assets, including technology-related intangible assets capitalized after the third quarter of 2018, and additional finance leases recognized on the adoption of a new lease standard in 2019.

Selling, general and administrative expenses. The following table sets forth the components of our selling, general and administrative, or SG&A, expenses:

 

 

 

Three Months Ended September 30,

 

 

As a Percentage of Total Net Revenues

 

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

Personnel expenses

 

$

125.8

 

 

$

147.0

 

 

 

16.8

 

%

 

16.5

 

%

Operational expenses

 

 

39.6

 

 

 

45.0

 

 

 

5.3

 

 

 

5.1

 

 

Depreciation and amortization

 

 

2.6

 

 

 

2.5

 

 

 

0.4

 

 

 

0.3

 

 

Selling, general and administrative expenses

 

$

168.0

 

 

$

194.5

 

 

 

22.5

 

%

 

21.9

 

%

 

SG&A expenses as a percentage of total net revenues decreased from 22.5% in the third quarter of 2018 to 21.9% in the third quarter of 2019, primarily due to operating leverage driven by higher revenues. SG&A expenses were $194.5 million, up $26.5 million, or 15.8%, from the third quarter of 2018. This increase in expenses was primarily due to wage

59


 

 

inflation, a net increase in our support personnel headcount and higher stock-based compensation and marketing expenses, partially offset by lower infrastructure costs.

Personnel expenses. As a percentage of total net revenues, personnel expenses decreased from 16.8% in the third quarter of 2018 to 16.5% in the third quarter of 2019. This decrease was primarily due to improved operating leverage and expected savings from functional efficiency initiatives. Personnel expenses as a component of SG&A expenses were $147.0 million, up $21.2 million, or 16.8%, from the third quarter of 2018. This increase is primarily due to wage inflation, a net increase in our support personnel headcount and higher stock-based compensation expense in the third quarter of 2019 compared to the third quarter of 2018.

Operational expenses. As a percentage of total net revenues, operational expenses decreased from 5.3% in the third quarter of 2018 to 5.1% in the third quarter of 2019. Operational expenses as a component of SG&A expenses were $45.0 million, up $5.4 million, or 13.7%, from the third quarter of 2018. This increase was primarily due to higher marketing expenses, consultancy expenses and travel expenses in the third quarter of 2019 compared to the third quarter of 2018.

Depreciation and amortization. As a percentage of total net revenues, depreciation and amortization expenses decreased from 0.4% in the third quarter of 2018 to 0.3% in the third quarter of 2019. Depreciation and amortization expenses as a component of SG&A expenses were $2.5 million, down $0.1 million, or 3.3%, from the third quarter of 2018.

Amortization of acquired intangibles. Non-cash charges related to amortization of acquired intangibles were $7.0 million in the third quarter of 2019, down $2.4 million, or 25.7%, from the third quarter of 2018.

 

Other operating (income) expense, net. Other operating expense, net of income, was $0.1 million in the third quarter of 2019, compared to other operating income, net of expense of $4.8 million in the third quarter of 2018. We recorded a gain of $5.3 million in the third quarter of 2018 due to changes in the fair value of earn-out consideration payable in connection with an acquisition. No such changes were recorded in the third quarter of 2019. Additionally, we recorded a $0.7 million non-recurring charge in the third quarter of 2018 relating to a computer software and technology-related intangible asset, discussed in Note 10—“Goodwill and intangible assets” under Part I, Item 1—“Unaudited Consolidated Financial Information” above. No such charge was recorded in the third quarter of 2019.

 

Income from operations. As a result of the foregoing factors, income from operations as a percentage of total net revenues increased from 12.6% in the third quarter of 2018 to 12.8% in the third quarter of 2019. Income from operations was $113.6 million in the third quarter of 2019, up $19.6 million from $94.0 million in the third quarter of 2018.

Foreign exchange gains (losses), net. We recorded a net foreign exchange gain of $6.7 million in the third quarter of 2019, compared to $7.5 million in the third quarter of 2018. The gains in the third quarters of 2018 and 2019 resulted primarily from the depreciation of the Indian rupee against the U.S. dollar during these quarters.

Interest income (expense), net. The following table sets forth the components of interest income (expense), net:

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Three Months Ended September 30,

 

 

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

Interest income

 

$

3.3

 

 

$

2.0

 

 

 

(40.9

)

%

Interest expense

 

 

(12.5

)

 

 

(12.2

)

 

 

(2.2)

 

 

Interest income (expense), net

 

$

(9.1

)

 

$

(10.2

)

 

 

11.8

 

%

Interest income (expense), net as a percentage of total net revenues

 

 

(1.2

)

%

 

(1.1

)

%

 

 

 

 

 

Our net interest expense increased by $1.1 million in the third quarter of 2019 compared to the third quarter of 2018 due to a $1.3 million decrease in interest income partially offset by a $0.3 million decrease in interest expense. The decrease in interest expense was primarily due to (i) lower interest expense on the term loan under our LIBOR-linked credit facility in the third quarter of 2019 compared to the third quarter of 2018, which is discussed in the section titled “Liquidity and Capital Resources—Financial Condition” below, and (ii) additional interest expense resulting from the amendment of our June 2015 credit facility in the third quarter of 2018. No such expense was incurred in the third quarter of 2019. The decrease was partially offset by (i) higher drawdown on our revolving credit facility in the third quarter of

60


 

 

2019 compared to the third quarter of 2018 and (ii) higher interest expense recognized under finance leases (including those recognized under the new accounting pronouncement on leases adopted in 2019). Our interest income decreased by $1.3 million in the third quarter of 2019 compared to the third quarter of 2018, primarily due to lower account balances in India, where we earn higher interest rates on our deposits compared to other jurisdictions where we have deposits. The weighted average rate of interest on our debt, including the net impact of interest rate swaps, decreased from 3.3% in the third quarter of 2018 to 3.2% in the third quarter of 2019.

Other income (expense), net. The following table sets forth the components of other income (expense), net:

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Three months ended September 30,

 

 

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs 2018

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

Government incentives

 

$

5.2

 

 

$

-

 

 

 

NM*

 

%

Other income/(expense)

 

 

0.2

 

 

0.7

 

 

 

204.7

 

 

Other income (expense), net

 

$

5.4

 

 

$

0.7

 

 

 

(86.9

)

%

Other income (expense), net as a percentage of total net revenues

 

 

0.7

 

%

 

0.1

 

%

 

 

 

 

 

*Not Measurable

 

Our net other income was $0.7 million in the third quarter of 2019, down $4.7 million from net other income of $5.4 million in the third quarter of 2018. This decrease is primarily due to the fact that we recorded no income in the third quarter of 2019 in connection with an export subsidy in comparison to $5.2 million recorded in connection with an export subsidy in the third quarter of 2018. This subsidy was introduced under the Foreign Trade Policy of India to encourage the export of specified services from India and was available for eligible export services until March 31, 2019.

Income tax expense. Our income tax expense was $22.7 million in the third quarter of 2019, down from $24.1 million in the third quarter of 2018, representing an effective tax rate, or ETR, of 20.5%, down from 24.7% in the third quarter of 2018. The reduction in ETR is primarily due to the recording of a non-recurring expense related to U.S. tax reform in the third quarter of 2018 and certain discrete tax benefits recorded in the third quarter of 2019, partially offset by changes in the jurisdictional mix of our income.

Net income attributable to Genpact Limited shareholders. As a result of the foregoing factors, net income attributable to our common shareholders as a percentage of total net revenues was 9.9% in the third quarter of 2019, up from 9.8% in the third quarter of 2018. Net income attributable to our common shareholders increased by $14.5 million, from $73.6 million in the third quarter of 2018 to $88.1 million in the third quarter of 2019.

61


 

 

Nine months ended September 30, 2019 Compared to the Nine months ended September 30, 2018

Net revenues. Our net revenues were $2,579.8 million in the nine months ended September 30, 2019, up $414.4 million, or 19.1%, from $2,165.5 million in the nine months ended September 30, 2018. The growth in our net revenues was driven primarily by an increase in BPO services delivered to our Global Clients and GE, in particular transformation services, and incremental revenues from recent large deals. Adjusted for foreign exchange, primarily the impact of changes in the value of the euro and the U.K. pound sterling against the U.S. dollar, our net revenues grew 20.3% compared to the nine months ended September 30, 2018 on a constant currency basis. Revenue growth on a constant currency basis is a non-GAAP measure. We provide information about our revenue growth on a constant currency basis so that our revenue may be viewed without the impact of foreign currency exchange rate fluctuations, thereby facilitating period-to-period comparisons of our business performance. Total net revenues on a constant currency basis are calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates and are adjusted for hedging gains/(losses).

Our average headcount increased by 14.3% to approximately 90,000 in the nine months ended September 30, 2019 from approximately 78,700 in the nine months ended September 30, 2018.

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Nine months ended September 30,

 

 

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

Global Clients:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BPO services

 

$

 

1,694.6

 

 

 

 

1,931.3

 

 

 

14.0

 

%

IT services

 

 

 

282.8

 

 

 

 

299.8

 

 

 

6.0

 

 

Total net revenues from Global Clients

 

$

 

1,977.5

 

 

 

 

2,231.1

 

 

 

12.8

 

%

GE:

 

 

 

 

 

 

 

 

 

 

 

BPO services

 

 

 

108.3

 

 

 

 

242.3

 

 

 

123.7

 

%

IT services

 

 

 

79.7

 

 

 

 

106.5

 

 

 

33.6

 

 

Total net revenues from GE

 

$

 

188.0

 

 

 

 

348.7

 

 

 

85.5

 

%

Total net revenues from BPO services

 

 

 

1,802.9

 

 

 

 

2,173.6

 

 

 

20.6

 

%

Total net revenues from IT services

 

 

 

362.5

 

 

 

 

406.2

 

 

 

12.1

 

 

Total net revenues

 

$

 

2,165.5

 

 

 

 

2,579.8

 

 

 

19.1

 

%

 

Net revenues from Global Clients in the nine months ended September 30, 2019 were $2,231.1 million, up $253.6 million, or 12.8%, from $1,977.5 million in the nine months ended September 30, 2018. This increase was primarily driven by growth in several of our verticals, including capital markets, high tech, consumer goods and life sciences. As a percentage of total net revenues, net revenues from Global Clients decreased from 91.3% in the nine months ended September 30, 2018 to 86.5% in the nine months ended September 30, 2019 due to strong growth in net revenues from GE.

Net revenues from GE in the nine months ended September 30, 2019 were $348.7 million, up $160.7 million, or 85.5%, from the nine months ended September 30, 2018, driven by services delivered in connection with a large new contract signed in the fourth quarter of 2018, as well as an increase in transformation services project engagements in the nine months ended September 30, 2019. Net revenues from GE increased as a percentage of our total net revenues from 8.7% in the nine months ended September 30, 2018 to 13.5% in the nine months ended September 30, 2019.

Net revenues from BPO services in the nine months ended September 30, 2019 were $2,173.6 million, up $370.7 million, or 20.6%, from $1,802.9 million in the nine months ended September 30, 2018. This increase was primarily attributable to an increase in transformation services, in particular those associated with large new deals signed in the fourth quarter of 2018 and the first quarter of 2019. Net revenues from IT services were $406.2 million in the nine months ended September 30, 2019, up $43.7 million, or 12.1%, from $362.5 million in the nine months ended September 30, 2018.

Net revenues from BPO services as a percentage of total net revenues increased to 84.3% in the nine months ended September 30, 2019 from 83.2% in the nine months ended September 30, 2018, with a corresponding decline in the percentage of total net revenues attributable to IT services.

62


 

 

Cost of revenue and gross margin. The following table sets forth the components of our cost of revenue and the resulting gross margin:

 

 

 

Nine months ended September 30,

 

 

As a Percentage of Total Net Revenues

 

 

 

 

2018

 

 

2019

 

 

2018

 

 

 

2019

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

 

 

 

Personnel expenses

 

$

959.6

 

 

$

1,224.6

 

 

 

44.3

 

%

 

 

47.5

%

 

Operational expenses

 

 

389.7

 

 

 

376.9

 

 

 

18.0

 

 

 

 

14.6

 

 

Depreciation and amortization

 

39.3

 

 

 

62.5

 

 

 

1.8

 

 

 

 

2.4

 

 

Cost of revenue

 

$

1,388.6

 

 

$

1,664.0

 

 

 

64.1

 

%

 

 

64.5

%

 

Gross margin

 

 

35.9

%

 

 

35.5%

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue was $1,664.0 million in the nine months ended September 30, 2019, up $275.4 million, or 19.8%, from the nine months ended September 30, 2018. Increases in our operational headcount, including in the number of onshore personnel, in particular for large new deals, transformation services delivery and additional headcount from large deals, wage inflation, and higher stock-based compensation expense contributed to the increase in cost of revenue, offset by improved utilization of transformation services resources in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

 

Our gross margin decreased from 35.9% in the nine months ended September 30, 2018 to 35.5% in the nine months ended September 30, 2019, driven primarily by lower initial gross margins associated with large new deals and higher stock-based compensation expense, partially offset by improved utilization of transformation services resources and improved operating leverage.

Personnel expenses. Personnel expenses as a percentage of total net revenues increased from 44.3% in the nine months ended September 30, 2018 to 47.5% in the nine months ended September 30, 2019. Personnel expenses were $1,224.6 million in the nine months ended September 30, 2019, up $265.0 million, or 27.6%, from $959.6 million in the nine months ended September 30, 2018. A 14.9% net increase in our operational headcount, including in the number of onshore personnel, particularly related to large new deals and transformation services delivery, the impact of wage inflation, and higher stock-based compensation expense resulted in higher personnel expenses in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

Operational expenses. Operational expenses as a percentage of total net revenues decreased from 18.0% in the nine months ended September 30, 2018 to 14.6% in the nine months ended September 30, 2019, largely due to improved operational efficiencies and the other factors described below. Operational expenses were $376.9 million in the nine months ended September 30, 2019, down $12.8 million, or 3.3%, from the nine months ended September 30, 2018, primarily due to a decrease in communication costs and contractor costs, partially offset by higher infrastructure expenses.

Depreciation and amortization expenses. Depreciation and amortization expenses as a percentage of total net revenues increased from 1.8% in the nine months ended September 30, 2018 to 2.4% in the nine months ended September 30, 2019. Depreciation and amortization expenses as a component of cost of revenue were $62.5 million in the nine months ended September 30, 2019, up $23.2 million, or 59.2%, from the nine months ended September 30, 2018. This increase was primarily due to the expansion of certain existing facilities and the acquisition of new assets, including technology-related intangible assets, capitalized after the nine months ended September 30, 2018, and additional finance leases recognized on the adoption of a new lease standard in 2019.

Selling, general and administrative expenses. The following table sets forth the components of our selling, general and administrative, or SG&A, expenses:

 

 

 

Nine months ended September 30,

 

 

As a Percentage of Total Net Revenues

 

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

Personnel expenses

 

$

380.5

 

 

$

438.4

 

 

 

17.6

 

%

 

17.0

 

%

Operational expenses

 

 

126.9

 

 

 

136.5

 

 

 

5.9

 

 

 

5.3

 

 

Depreciation and amortization

 

 

7.9

 

 

 

7.4

 

 

 

0.4

 

 

 

0.3

 

 

Selling, general and administrative expenses

 

$

515.3

 

 

$

582.3

 

 

 

23.8

 

%

 

22.6

 

%

63


 

 

 

SG&A expenses as a percentage of total net revenues decreased from 23.8% in the nine months ended September 30, 2018 to 22.6% in the nine months ended September 30, 2019 primarily due to operating leverage driven by an increase in revenues. SG&A expenses were $582.3 million in the nine months ended September 30, 2019, up $67.0 million, or 13.0%, from the nine months ended September 30, 2018. This increase in expense was primarily due to wage inflation, higher stock-based compensation, marketing expenses and infrastructure costs, partially offset by lower travel and contractor costs.

Personnel expenses. As a percentage of total net revenues, personnel expenses decreased from 17.6% in the nine months ended September 30, 2018 to 17.0% in the nine months ended September 30, 2019. This decrease was primarily due to improved operating leverage and savings from functional efficiency initiatives. Personnel expenses as a component of SG&A expenses were $438.4 million in the nine months ended September 30, 2019, up $57.9 million, or 15.2%, from the nine months ended September 30, 2018. This increase is primarily due to wage inflation, a net increase in our support personnel headcount and higher stock-based compensation expense in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

Operational expenses. As a percentage of total net revenues, operational expenses decreased from 5.9% in the nine months ended September 30, 2018 to 5.3% in the nine months ended September 30, 2019. Operational expenses as a component of SG&A expenses were $136.5 million in the nine months ended September 30, 2019, up $9.6 million, or 7.6%, from the nine months ended September 30, 2018. This increase is primarily due to an increase in marketing expenses and infrastructure costs, partially offset by lower contractor costs and travel expenses in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018.

Depreciation and amortization. Depreciation and amortization expenses as a percentage of total net revenues were 0.3% in the nine months ended September 30, 2019, compared to 0.4% in the nine months ended September 30, 2018. Depreciation and amortization expenses as a component of SG&A expenses were $7.4 million in the nine months ended September 30, 2019, down $0.5 million, or 6.7%, from the nine months ended September 30, 2018.

Amortization of acquired intangibles. Non-cash charges on account of amortization of acquired intangibles were $23.6 million in the nine months ended September 30, 2019, down $5.6 million, or 19.1%, from the nine months ended September 30, 2018.

 

Other operating (income) expense, net. Other operating expense, net of income, was $0.1 million in the nine months ended September 30, 2019 compared to other operating income, net of expense, of $4.9 million in the nine months ended September 30, 2018. In the nine months ended September 30, 2019, we recorded a gain of $3.4 million related to a doubtful capital advance for a parcel of land in India. No such gain was recorded in the nine months ended September 30, 2018. We recorded a gain of $6.0 million in the nine months ended September 30, 2018 due to changes in the fair value of earn-out consideration payable in connection with certain acquisitions, and no such gain was recorded in the nine months ended September 30, 2019. Additionally, we recorded a $1.5 million and $3.5 million non-recurring charge in the nine months ended September 30, 2018 and 2019, respectively, relating to certain computer software and technology-related intangible assets, which charge we discuss in Note 10—“Goodwill and intangible assets” under Part I, Item 1—“ Unaudited Consolidated Financial Statements.”

 Income from operations. As a result of the foregoing factors, income from operations as a percentage of total net revenues increased from 11.0% in the nine months ended September 30, 2018 to 12.0% in the nine months ended September 30, 2019. Income from operations was $309.9 in the nine months ended September 30, 2019, up $72.5 million from $237.3 million in the nine months ended September 30, 2018.

Foreign exchange gains (losses), net.  We recorded a net foreign exchange gain of $3.6 million in the nine months ended September 30, 2019, compared to a net foreign exchange gain of $15.1 million in the nine months ended September 30, 2018. The gains in the nine months ended September 30, 2018 and 2019 resulted primarily from the depreciation of the Indian rupee against the U.S. dollar during such periods.

Interest income (expense), net. The following table sets forth the components of interest income (expense), net:

64


 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Nine months ended September 30,

 

 

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

Interest income

 

$

8.5

 

 

$

4.8

 

 

 

(43.8

)

%

Interest expense

 

 

(36.1

)

 

 

(38.2

)

 

 

5.9

 

 

Interest income (expense), net

 

$

(27.6

)

 

$

(33.5

)

 

 

21.1

 

%

Interest income (expense), net as a percentage of total net revenues

 

 

(1.3

)

%

 

(1.3

)

%

 

 

 

 

 

Our net interest expense was $33.5 million in the nine months ended September 30, 2019, up $5.8 million from $27.6 million in the nine months ended September 30, 2018, primarily due to a $2.1 million increase in interest expense and a $3.7 million decrease in interest income. The increase in interest expense was primarily due to (i) higher drawdown on our revolving credit facility in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, and (ii) higher interest expense recognized under finance leases (including those recognized under the new accounting pronouncement on leases adopted in 2019). This increase was partially offset by (i) lower interest expenses on earn-outs in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 and (ii) additional interest expense resulting from the amendment of our June 2015 credit facility in the nine months ended September 30 2018 for which there was no corresponding expense incurred in the nine months ended September 30, 2019. Our interest income decreased by $3.7 million in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to lower account balances in India, where we earn higher interest rates on our deposits compared to other jurisdictions where we have deposits. The weighted average rate of interest on our debt, including the net impact of interest rate swaps, increased from 3.2% in the nine months ended September 30, 2018 to 3.4% in the nine months ended September 30, 2019.

Other income (expense), net. The following table sets forth the components of other income (expense), net:

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Nine months ended September 30,

 

 

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

Government incentives

 

$

30.9

 

 

$

4.0

 

 

 

(87.1

)

%

Other income/(expense)

 

(0.2)

 

 

1.1

 

 

 

(754.7

)

 

Other income (expense), net

 

$

30.7

 

 

$

5.1

 

 

 

(83.5

)

%

Other income (expense), net as a percentage of total net revenues

 

 

1.4

 

%

 

0.2

 

%

 

 

 

 

 

Our net other income was $5.1 million in the nine months ended September 30, 2019, down $25.6 million from $30.7 million in the nine months ended September 30, 2018. This decrease is primarily due to the fact that we recorded $4.0 million in income in the nine months ended September 30, 2019 in connection with an export subsidy in comparison to $30.9 million in the nine months ended September 30, 2018. This subsidy was introduced under the Foreign Trade Policy of India to encourage the export of specified services from India and was available for eligible export services until March 31, 2019.

Income tax expense. Our income tax expense was $62.4 million in the nine months ended September 30, 2019, up $9.1 million from $53.3 million in the nine months ended September 30, 2018, representing an ETR of 21.9%, compared to 20.8% in the nine months ended September 30, 2018. The increase in our ETR is primarily due to the expiration of certain special economic zone benefits in India and changes in the jurisdictional mix of our income.

Net income attributable to redeemable non-controlling interest. Non-controlling interest primarily refers to the loss associated with the redeemable non-controlling interest in the operations of Strategic Sourcing Excellence LLC (“SSE”), which we acquired in the first quarter of 2016. We purchased the remainder of the outstanding equity interest in SSE in the nine months ended September 30, 2018.

Net income attributable to Genpact Limited shareholders. As a result of the foregoing factors, net income attributable to our common shareholders as a percentage of total net revenues decreased from 9.4% in the nine months

65


 

 

ended September 30, 2018 to 8.6% in the nine months ended September 30, 2019. Net income attributable to our common shareholders was $222.7 million in the nine months ended September 30, 2019, up $19.8 million from $202.9 million in the nine months ended September 30, 2018.

Liquidity and Capital Resources

Overview

Information about our financial position as of December 31, 2018 and September 30, 2019 is presented below:

 

 

 

As of December 31,

2018

 

 

As of September 30,

2019

 

 

Percentage Change

Increase/(Decrease)

 

 

 

 

(dollars in millions)

 

 

2019 vs. 2018

 

 

Cash and cash equivalents

 

$

368.4

 

 

$

456.9

 

 

 

24.0

 

%

Short-term borrowings

 

 

295.0

 

 

 

245.0

 

 

 

(16.9)

 

 

Long-term debt due within one year

 

33.5

 

 

 

33.5

 

 

 

0.1

 

 

Long-term debt other than the current portion

 

 

975.6

 

 

 

950.9

 

 

 

(2.5

)

 

Genpact Limited total shareholders’ equity

 

$

1,404.2

 

 

$

1,605.7

 

 

 

14.4

 

%

 

 

Financial Condition

We have historically financed our operations and our expansion, including acquisitions, with cash from operations and borrowing facilities.

On February 7, 2019, our Board of Directors approved a 13% increase in our quarterly cash dividend to $0.085 per share, up from $0.075 per share in 2018, representing a planned annual dividend of $0.34 per common share, up from $0.30 per common share in 2018, payable to holders of our common shares. On March 20, 2019, June 21, 2019 and September 20, 2019, we paid a dividend of $0.085 per share, amounting to $16.1 million, $16.2 million and $16.2 million in the aggregate, to shareholders of record as of March 8, 2019, June 12, 2019 and September 11, 2019, respectively.

As of September 30, 2019, $451.1 million of our $456.9 million in cash and cash equivalents was held by our foreign (non-Bermuda) subsidiaries. $16.9 million of this cash is held by foreign subsidiaries for which we expect to incur and have accrued a deferred tax liability on the repatriation of $15.1 million of retained earnings. $434.2 million of the cash and cash equivalents is held by foreign subsidiaries in jurisdictions where no tax is expected to be imposed upon repatriation of retained earnings or is being indefinitely reinvested.

The total authorization under our existing share repurchase program is $1,250.0 million. Since our share repurchase program was initially authorized in 2015, we have repurchased 37,239,353 of our common shares at an average price of $26.04 per share, for an aggregate amount of approximately $970.0 million. This amount includes shares repurchased under our 2017 accelerated share repurchase program.

During the nine months ended September 30, 2018 and September 30, 2019, the Company repurchased 4,114,882 and 608,285 of its common shares, respectively, on the open market at a weighted average price of $31.62 and $39.29 per share, respectively, for an aggregate cash amount of $130.1 million and $23.9 million, respectively. Additionally, in the nine months ended September 30, 2018, the Company received a final delivery of 163,975 common shares upon the settlement of the transaction under its 2017 accelerated share repurchase program. All repurchased shares were retired.

For additional information, see Note 17— “Capital stock” under Part I, Item 1— “Unaudited Consolidated Financial Statements” above.

We expect that in the future our cash from operations, cash reserves and debt capacity will be sufficient to finance our operations, our growth and expansion plans, dividend payments and additional share repurchases we may make under our share repurchase program. In addition, we may raise additional funds through public or private debt or equity financings. Our working capital needs are primarily to finance our payroll and other administrative and information technology expenses in advance of the receipt of accounts receivable. Our primary capital requirements include opening

66


 

 

new delivery centers, expanding existing operations to support our growth, financing acquisitions and enhancing capabilities, including building digital solutions.

Cash flows from operating, investing and financing activities, as reflected in our consolidated statements of cash flows, are summarized in the following table:

 

 

 

 

 

 

 

 

 

 

 

Percentage Change

 

 

 

 

Nine months ended September 30,

 

 

Increase/(Decrease)

 

 

 

 

2018

 

 

2019

 

 

2019 vs. 2018

 

 

 

 

(dollars in millions)

 

 

 

 

 

 

Net cash provided by (used for)

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating activities

 

$

202.8

 

 

$

341.3

 

 

 

68.3

 

%

Investing activities

 

 

(199.8

)

 

 

(86.0

)

 

 

(56.9

)

 

Financing activities

 

(52.1

)

 

 

(154.2

)

 

 

196.2

 

 

Net increase (decrease) in cash and cash equivalents

 

$

(49.0

)

 

$

101.1

 

 

 

(306.3)

 

%

 

Cash flows from operating activities. Net cash provided by operating activities was $341.3 million in the nine months ended September 30, 2019, compared to $202.8 million in the nine months ended September 30, 2018. This increase is primarily due to (i) a $20.6 million increase in net income in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, (ii) a $74.9 million net decrease in our working capital in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, mainly driven by the collection of an export subsidy relating to earlier years, employee-related accruals, statutory liabilities, and advances from customers, partially offset by an increase in accounts receivable and customer acquisition costs, and (iii) a $43.0 million increase in non-cash expenses in the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, mainly stock-based compensation and depreciation and amortization.

Cash flows from investing activities. Our net cash used for investing activities was $86.0 million in the nine months ended September 30, 2019 compared to $199.8 million in the nine months ended September 30, 2018. We made payments related to acquisitions totaling $6.3 million in the nine months ended September 30, 2019 compared to $112.8 million in the nine months ended September 30, 2018. Payments for internally generated intangible assets and purchases of property, plant and equipment (net of sales proceeds) were $7.2 million lower in the nine months ended September 30, 2019 than in the nine months ended September 30, 2018.

Cash flows from financing activities. Our net cash used for financing activities was $154.2 million in the nine months ended September 30, 2019, compared to net cash used for financing activities of $52.1 million in the nine months ended September 30, 2018. During the nine month period ended September 30, 2019, our short-term borrowings and long-term debts decreased by approximately $74.7 million, and during the nine month period ended September 30, 2018, our short-term borrowings and long-term debts increased by $131.4 million. For additional information, see Note 11—“Short-term borrowings” and Note 12—“Long-term debt” under Part I, Item 1—“Unaudited Consolidated Financial Statements” above.

We received proceeds from long-term debt (net of debt-issuance cost) of $124.9 million in the nine months ended September 30, 2018, and no such proceeds were received in the nine months ended September 30, 2019. We repaid $25.5 million and $157.7 million of our long-term debt during the nine months ended September 30, 2019 and 2018, respectively. We received proceeds from short-term borrowings of $50.0 million and $225.0 million in the nine months ended September 30, 2019 and 2018, respectively. Of the short-term borrowings, we also repaid $100.0 million and $65.0 million during the nine months ended September 30, 2019 and 2018, respectively.

Payments for share repurchases (including expenses) were $130.2 million in the nine months ended September 30, 2018, compared to $23.9 million in the nine months ended September 30, 2019. Payments related to earn-out or deferred consideration were $11.2 million higher in the nine months ended September 30, 2019 than in the nine months ended September 30, 2018. In the nine months ended September 30, 2019, we paid cash dividends in an aggregate amount of $48.5 million, compared to $42.9 million in the nine months ended September 30, 2018. For additional information, see Notes 11 and 12 to our consolidated financial statements. Additionally, proceeds in connection with the issuance of common shares under stock-based compensation plans (net of payments) were $12.8 million in the nine months ended September 30, 2019, compared to payments (net of proceeds) of $2.7 million in the nine months ended September 30, 2018.

67


 

 

Financing Arrangements

In August 2018, we amended the 2015 Facility which was comprised of a term loan of $800.0 million and a revolving credit facility of $350.0 million. The amended facility is comprised of a $680.0 million term loan, which represents the outstanding balance under the 2015 Facility as of the date of amendment, and a $500.0 million revolving credit facility. The amended facility expires on August 8, 2023. The amendment did not result in a substantial modification of $550.8 million of the outstanding term loan under the 2015 Facility. Further, as a result of the amendment, we extinguished the outstanding term loan under the 2015 Facility of $129.2 million and obtained additional funding of $129.2 million from different lenders, resulting in no change to the outstanding principal of the term loan under the amended facility. In connection with the amendment, we expensed $2.0 million, representing partial acceleration of the amortization of the existing unamortized debt issuance costs and an additional fee paid to our lenders related to the term loan.

The overall borrowing capacity under the revolving facility increased from $350.0 million to $500.0 million. The amendment of the revolving credit facility resulted in accelerated amortization of $0.82 million relating to existing unamortized debt issuance cost. The remaining unamortized costs and an additional third-party fee paid in connection with the amendment is being amortized over the term of the amended facility, which terminates on August 8, 2023. For additional information, see Note 12— “Long-Term Debt” under Part I, Item 1— “Unaudited Consolidated Financial Statements.”

Borrowings under the amended facility bear interest at a rate equal to, at our election, either LIBOR plus an applicable margin equal to 1.375% per annum, compared to a margin of 1.50% under the 2015 facility, or a base rate plus an applicable margin equal to 0.375% per annum, compared to a margin of 0.50% under the 2015 facility, in each case subject to adjustment based on our debt ratings provided by Standard & Poor’s Rating Services and Moody’s Investors Service, Inc. Based on our election and current credit rating, the applicable interest rate is equal to LIBOR plus 1.375% per annum.

As of December 31, 2018 and September 30, 2019, our outstanding term loan, net of debt amortization expense of $2.2 million and $1.8 million, respectively, was $660.8 million and $635.7 million, respectively. We also have fund-based and non-fund based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of December 31, 2018 and September 30, 2019, the limits available under such facilities were $14.3 million and $14.2 million, respectively, of which $7.4 million and $7.5 million, respectively, were utilized, constituting non-funded drawdown. As of December 31, 2018 and September 30, 2019, a total of $297.1 million and $247.1 million, respectively, of our revolving credit facility was utilized, of which $295.0 million and $245.0 million, respectively, constituted funded drawdown and $2.1 million and $2.1 million, respectively, constituted non-funded drawdown.

As of December 31, 2018 and September 30, 2019, the amount outstanding under our 3.70% senior notes issued in March 2017 and exchanged in July 2018 for freely tradable notes registered under the Securities Act of 1933, as amended, net of debt amortization expense of $1.7 million and $1.3 million, was $348.3 million and 348.7 million, respectively, which is payable on April 1, 2022 when the notes mature. For additional information, see Notes 11 and 12—“Short-term borrowings” and “Long-term debt” under Part I, Item 1—“Unaudited Consolidated Financial Statements” above.

68


 

 

Off-Balance Sheet Arrangements

Our off-balance sheet arrangements consist of foreign exchange contracts. For additional information, see Part I, Item 1A—Risk Factors— “Currency exchange rate fluctuations in various currencies in which we do business, especially the Indian rupee, the euro and the U.S. dollar, could have a material adverse effect on our business, results of operations and financial condition” in our Annual Report on Form 10-K for the year ended December 31, 2018, the section titled “Contractual Obligations” below, and Note 7 in Part I, Item 1—“ Unaudited Consolidated Financial Statements” above.

Contractual Obligations

The following table sets forth our total future contractual obligations as of September 30, 2019:

 

 

 

Total

 

 

Less than

1 year

 

 

1-3 years

 

 

3-5 years

 

 

After 5 years

 

 

 

(dollars in millions)

 

Long-term debt

 

$

1,093.2

 

 

$

67.9

 

 

$

474.8

 

 

$

550.5

 

$

 

— Principal payments

 

 

984.4

 

 

 

33.5

 

 

 

415.9

 

 

 

535.0

 

 

 

— Interest payments*

 

 

108.8

 

 

 

34.4

 

 

 

58.9

 

 

 

15.5

 

 

 

Short-term borrowings

 

 

247.1

 

 

 

247.1

 

 

 

 

 

 

 

— Principal payments

 

 

245.0

 

 

 

245.0

 

 

 

 

 

 

 

— Interest payments**

 

 

2.1

 

 

 

2.1

 

 

 

 

 

 

 

Finance leases

 

 

36.1

 

 

 

11.1

 

 

 

15.0

 

 

 

7.9

 

 

2.2

 

— Principal payments

 

 

30.3

 

 

 

9.3

 

 

 

12.5

 

 

 

6.6

 

 

 

2.0

 

— Interest payments***

 

 

5.8

 

 

 

1.8

 

 

 

2.5

 

 

 

1.3

 

 

 

0.2

 

Operating leases

 

 

421.5

 

 

 

69.6

 

 

 

124.9

 

 

 

99.0

 

 

 

128.0

 

— Principal payments

 

 

328.5

 

 

 

50.1

 

 

 

98.8

 

 

 

78.3

 

 

101.3

 

— Interest payments***

 

 

93.0

 

 

 

19.5

 

 

 

26.1

 

 

 

20.7

 

 

26.7

 

Purchase obligations

 

 

40.8

 

 

 

29.6

 

 

 

11.2

 

 

 

 

 

 

Capital commitments net of advances

 

 

8.2

 

 

 

8.2

 

 

 

 

 

 

 

Earn-out consideration

 

 

0.5

 

 

 

0.4

 

 

 

0.1

 

 

 

 

 

 

— Reporting date fair value

 

 

0.5

 

 

 

0.4

 

 

 

0.1

 

 

 

 

 

 

— Interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other liabilities

 

 

68.2

 

 

 

28.9

 

 

 

35.4

 

 

 

3.9

 

 

 

Total contractual obligations

 

$

1,915.6

 

 

$

462.8

 

 

$

661.2

 

 

$

661.2

 

 

$

130.4

 

 

*

Our interest payments on long-term debt are calculated based on our current debt rating at a rate equal to LIBOR plus a margin of 1.375% per annum as of September 30, 2019, which excludes the impact of interest rate swaps. Interest payments on long-term debt include interest on our senior notes due in 2022 at a rate of 3.70% per annum, which is not based on LIBOR.

**

Our interest payments on short-term debt are calculated based on our current debt rating at a rate equal to LIBOR plus a margin of 1.375% per annum as of September 30, 2019 and our expectation for the repayment of such debt.

***

Our interest payments on finance and operating leases are based on the incremental borrowing rates prevailing in different geographies.

69


 

 

Recent Accounting Pronouncements

Recently adopted accounting pronouncements

For a description of recently adopted accounting pronouncements, see Note 2(h)— “Recently issued accounting pronouncements” under Item 1— “Unaudited Consolidated Financial Statements” above and Part II, Item 7— “Management’s Discussion and Analysis of Financial Condition and Results of Operations”— “Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2018.

Recently issued accounting pronouncements

For a description of recently issued accounting pronouncements, see Note 2(h)—“Recently issued accounting pronouncements” under Item 1—“ Unaudited Consolidated Financial Statements” above and Part II, Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations”—“Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2018.

 

70


 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are exposed to interest rate risk arising from changes in interest rates on the floating rate indebtedness under our term loan and 3.70% senior notes issued in March 2017. Borrowings under our term loan bear interest at floating rates based on LIBOR, but in no event less than the floor rate of 0.0% plus an applicable margin. The interest rate on our 3.70% senior notes is subject to adjustment based on the ratings assigned to the notes by Moody’s and S&P from time to time. A decline in such ratings could result in an increase of up to 2% in the rate of interest on the notes. Accordingly, fluctuations in market interest rates or decline in ratings may increase or decrease our interest expense which will, in turn, increase or decrease our net income and cash flow.

We manage a portion of our interest rate risk related to floating rate indebtedness by entering into interest rate swaps under which we receive floating rate payments based on the greater of LIBOR and the floor rate under our term loan and make payments based on a fixed rate. As of September 30, 2019, we were party to interest rate swaps covering a total notional amount of $485.1 million. Under these swap agreements, the rate that we pay to banks in exchange for LIBOR ranges between 0.88% and 2.65%.

For a discussion of our market risk associated with foreign currency risk, interest rate risk and credit risk, see Part II, Item 7A—“Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2018.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are the Company’s controls and other procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 (“Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer along with the Company’s Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to the Exchange Act Rule 13a-15(b). Based upon that evaluation, the Company’s Chief Executive Officer along with the Company’s Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC filings.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarterly period ended September 30, 2019 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 

71


 

 

PART II – OTHER INFORMATION

Item 1.

There are no legal proceedings pending against us that we believe are likely to have a material adverse effect on our business, results of operations and financial condition.

Item 1A.

Risk Factors

We have disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 the risk factors that materially affect our business, financial condition or results of operations. You should carefully consider the risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2018, in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 and the other information that appears elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2018, in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 and in this Quarterly Report on Form 10-Q. Except as set forth under the heading “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, there have been no material changes in our risk factors since those published in our Annual Report on Form 10-K for the year ended December 31, 2018. You should be aware that these risk factors and other information may not describe every risk facing our Company. Additional risks and uncertainties not currently known to us also may materially adversely affect our business, financial condition and/or results of operations.  

Item 2.

Unregistered Sale of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

None.

Use of Proceeds

None.

Purchase of Equity Securities by the Issuer and Affiliated Purchasers

Share repurchase activity during the three months ended September 30, 2019 was as follows:

 

Period

 

Total Number of Shares Purchased

 

Average Price Paid per Share ($)

 

Total Number of Shares
Purchased as Part of           Publicly Announced Plan or Program

 

Approximate Dollar Value of Shares that May Yet Be
Purchased Under the Plan or Program ($)

July 1 – July 31, 2019

 

-

 

-

 

-

 

304,041,985

August 1-August 31, 2019

 

-

 

-

 

-

 

304,041,985

September 1 – September 30, 2019

 

608,285

 

39.29

 

608,285

 

280,141,245

 

Approximately $280 million remained available for share repurchases under our existing share repurchase program as of September 30, 2019. This repurchase program does not obligate us to acquire any specific number of shares and does not specify an expiration date. All shares repurchased under the plan have been cancelled. For additional information, see note 17 to our consolidated financial statements.

Item 6.

Exhibits

 

 Exhibit

Number

 

Description

 

 

 

72


 

 

    3.1

 

Memorandum of Association of the Registrant (incorporated by reference to Exhibit 3.1 to Amendment No. 2 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on July 16, 2007).

 

 

 

    3.2

 

Bye-laws of the Registrant (incorporated by reference to Exhibit 3.3 to Amendment No. 4 of the Registrant’s Registration Statement on Form S-1 (File No. 333-142875) filed with the SEC on August 1, 2007).

 

 

 

  31.1*

 

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

  31.2*

 

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

  32.1*

 

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

  32.2*

 

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS

 

Inline XBRL Instance Document —the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104

 

Cover Page Interactive Data File (formatted as XBRL and contained in Exhibit 101)

 

*

Filed with this Quarterly Report on Form 10-Q.

Indicates a management contract or compensatory plan, contract or arrangement in which any director or executive officer participates.

 

 

73


 

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 8, 2019

GENPACT LIMITED

 

By:

 

/s/ N.V. TYAGARAJAN

 

 

N.V. Tyagarajan

 

 

Chief Executive Officer

 

 

 

By:

 

/s/ EDWARD J. FITZPATRICK

 

 

Edward J. Fitzpatrick

 

 

Chief Financial Officer

 

 

74